Page last updated: 2024-09-27

Hyponatremia

Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed)

Synonyms(1)

Synonym
Hyponatremia

Research Excerpts

Overview

ExcerptReference
"Hyponatremia is a potential consequence of theophylline therapy for apnea."( Harkavy, KL; Jose, P; Scanlon, JW, 1979)
"(2) Hyponatremia is often unrecognized for a long time because the symptoms are not specific."( Berger, W; Bründler, H, 1978)
"Symptomatic hyponatremia is usually characterized by severe alterations in cerebral function including coma and grand mal seizures; it develops especially in less competitive athletes who have maintained high rates of fluid intake during endurance events lasting at least 5 hours."( Noakes, TD, 1992)
"Hyponatremia is common following subarachnoid hemorrhage and has alternatively been attributed to either the inappropriate secretion of antidiuretic hormone or natriuresis causing intravascular volume contraction."( Diringer, MN; Hanley, DF; Verbalis, JG; Wu, KC, 1992)
"However, hyponatremia is supposed to occur even more often than with CBZ."( Paulus, W; Steinhoff, BJ; Stodieck, SR; Stoll, KD, 1992)
"In most instances, hyponatremia is caused by inappropriate concentration of urine because of either appropriate or inappropriate antidiuretic hormone secretion."( Carroll, HJ; Oh, MS, 1992)
"Hyponatremia is the most common abnormality of Na metabolism in patients with cancers such as lung cancer, malignant lymphoma, thymoma and so on."( Ariyoshi, Y, 1991)
"Hyponatremia is not uncommon in patients on CAPD, despite the presence of an intraabdominal solution that should preserve normal serum sodium concentration."( Page, DE, 1990)
"Profound hyponatremia is a life-threatening emergency which can result in permanent neurological damage."( Fauchald, P; Holst-Larsen, H; Kongsgaard, UE; Lie, B, 1990)
"Pseudohyponatremia is a falsely low serum sodium measurement."( Weisberg, LS, 1989)
"Pseudo-hyponatremia is a rare condition characterized by a decrease in plasma sodium concentration associated with a normal or increased effective plasma osmolarity."( Bertin, P; Costa, M; Quiroga, T; Robino, X; Valdivieso, A, 1989)
"The hyponatremia is frequently associated with intracranial disorders such as brain tumor, subarachnoid hemorrhage and head injury."( Kuwayama, A; Matsui, N; Miyamoto, N; Seo, H; Terashima, K; Yamamoto, N, 1987)
"Hyponatremia is a frequently encountered condition that requires careful management to avoid both complications of prolonged severe hyponatremia and life-threatening brain damage resulting from too-rapid correction of the problem."( Clifford, DB, 1988)
"Because hyponatremia is frequently associated with preceding diuretic treatment and unrestricted fluid intake--conditions which have not been addressed sufficiently in published literature--we studied the pathophysiology and the clinical setting of such hyponatremia in a large group of internal medicine patients."( Gross, P; Hackenthal, E; Hausmann, C; Ketteler, M; Rascher, W; Reinhard, C; Ritz, E; Schömig, A, 1988)
"A case of hyponatremia is presented with water intoxication due to treatment with oxcarbazepine (OxCZ)."( Johannessen, AC; Nielsen, OA, 1987)
"Dilutional hyponatremia is an important complication of treatment with diuretics."( Beermann, B, 1986)
"The dangers of hyponatremia are reviewed, and the rational use of loop diuretics and hypertonic saline is outlined."( Chusid, P; Narins, RG, 1986)
"Hyponatremia is a common complication of chronic advanced CHF unresponsive to the usual therapeutic measures."( Lemberg, L; Valle, GA, 1987)
"Hyponatremia is usual during myxedema coma."( Archambeaud-Mouveroux, F; Dejax, C; Hessel, L; Jadaud, JM; Laroumagne, G; Laubie, B; Vincent, D, 1987)
"Pseudohyponatremia is caused by an increased serum protein or lipid concentration producing a "space-occupying lesion" in serum water."( Faye, S; Payne, RB, 1986)
"The treatment of hyponatremia is controversial: some authorities have cautioned that rapid correction causes central pontine myelinolysis, and others warn that severe hyponatremia has a high mortality rate unless it is corrected rapidly."( Riggs, JE; Schochet, SS; Sterns, RH, 1986)
"Hyponatremia is always present in patients with water intoxication and accounts for many of the life-threatening symptoms and signs found in this population."( David, JJ; Rowe, WT; Spradlin, WW; Vieweg, WV, 1985)
"Hyponatremia is a common hospital-acquired electrolyte disturbance that is an indicator of poor prognosis."( Anderson, RJ; Chung, HM; Kluge, R; Schrier, RW, 1985)
"Pseudohyponatremia is caused by a displacement of serum water by elevated concentrations of serum lipids or proteins."( Aw, TC; Kiechle, FL, 1985)
"The extent of this hyponatremia is much more severe than previously reported."( Hammerman, C; Wu, HH; Zaia, W, 1985)
"The hyponatremia is usually of the dilutional type."( Orinius, E, 1984)
""Amiloride hyponatremia" is suggested to be due to a direct effect of amiloride + hydrochlorothiazide on the distal nephrons."( Huikko, M; Rossi, M; Tarssanen, L, 1980)
"Acute severe hyponatremia is a medical emergency."( Davidson, E; Gozal, D; Gozal, Y, 1995)
"Hyponatremia is a common clinical problem and can result in severe morbidity and even death."( Caruana, RJ; Mulloy, AL, 1995)
"--Hyponatremia is frequently seen during the treatment of acute lymphoblastic leukemia: its causes are numerous."( Berthier, JC; Bertrand, Y; Combet, S; Foray, P; Kebaili, K; Pangaud, N; Philippe, N; Taylor, P, 1994)
"Hyponatremia is a common cause of morbidity in the elderly, and thiazide diuretics are often implicated."( Clark, BA; Epstein, FH; Rosa, RM; Shannon, RP, 1994)
"Chronic hyponatremia is known to cause inhibition of pituitary vasopressin (AVP) and oxytocin (OT) secretion in response to most physiological stimuli, as well as a marked inhibition of synthesis of these peptides."( Blackburn, RE; Dohanics, J; Smith, MS; Verbalis, JG, 1994)
"Severe, symptomatic hyponatremia is often treated urgently to increase the serum sodium to 120 to 130 mmol/L."( Cappuccio, JD; Cohen, EP; Silver, SM; Sterns, RH, 1994)
"Hyponatremia is closely aligned with an unfavorable clinical course."( Dei Cas, L; Leier, CV; Metra, M, 1994)
"CBZ-induced hyponatremia is a moderately well described side effect and may be responsible for some of the more highly reported signs and symptoms associated with CBZ adverse effects."( Gandelman, MS, 1994)
"Hyponatremia is a common electrolyte disorder in patients hospitalized with AIDS or ARC and is frequently associated with gastrointestinal losses or SIADH as well as increased morbidity and mortality."( Feinstein, EI; Kaptein, EM; Massry, SG; Tang, WW, 1993)
"In AIDS patients hyponatremia is a frequent finding and it is responsible for ISADH in most cases."( Aguirre Miñana, T; Bandrés Franco, E; Borque de Larrea, L; Brea Hernando, AI; Ezquerra Lezcano, M, 1993)
"Although hyponatremia is a rare consequence of therapy with prostaglandin inhibitors, certain individuals are at increased risk and should be monitored for this side effect."( Rault, RM, 1993)
"Hyponatremia is seen in all age groups, but there are important differences in the elderly."( Arieff, AI; Ayus, JC, 1996)
"Hyponatremia is the most frequent electrolyte disorder in clinical medicine."( Büssemaker, E; Gross, P; Wehrle, R, 1996)
"Hyponatremia is a potential adverse effect in patients with nocturnal enuresis who are treated with DDAVP."( Leung, AK; Nørgaard, JP; Robson, WL, 1996)
"Hyponatremia is a common electrolyte abnormality that causes symptoms as a result of swelling of brain cells."( Chen, CB; Gowrishankar, M; Halperin, ML; Mallie, JP, 1996)
"Hyponatremia is more frequently observed in elderly patients associated with exaggerated response of ADH release and attenuated response of renin-aldosterone system."( Saito, T, 1996)
"Hyponatremia is commonly observed following transurethral resection of the prostate or endometrial resection when the operative field is irrigated with hypotonic glycine."( Arieff, AI; Ayus, JC, 1997)
"(3) When acute hyponatremia is superimposed on a chronic preexisting hyponatremic state, the acute component of serum sodium concentration decrease could be rapidly corrected (serum sodium concentration: +35 mEq/L/21 hr) without fear of permanent brain damage."( Decaux, G; Penninckx, R; Soupart, A; Stenuit, A, 1997)
"Hyponatremia is an uncommon but widely reported complication of selective serotonin uptake inhibitors (SSRIs), and most of the case reports involve elderly patients."( Chiu, HF; Lam, LC; Leung, VP, 1998)
"Polydipsia-hyponatremia is a poorly understood disorder that causes considerable mortality and morbidity."( Abraham, G; de Leon, J; Nair, C; Phillips, MI; Simpson, GM; Stanilla, JK; Verghese, C, 1998)
"Hyponatremia is common in advanced heart failure and relates to the severity of the disease."( Martin, PY; Schrier, RW, 1998)
"Hyponatremia is a common problem following surgery to remove brain tumors."( Bermúdez, JL; Carrascosa, AJ; Gallego, ME; Lledó, G; Salcedo, E; Yuste, JA, 1999)
"We conclude that hyponatremia is very uncommon, whereas mild to moderate elevation in serum creatinine level is not uncommon in patients with short-term uncomplicated hypothyroidism."( Baajafer, FS; Hammami, MM; Mohamed, GE, 1999)
"In general, hyponatremia is corrected acutely by giving Na+ to patients who are volume-depleted and by restricting water intake in patients who are normovolemic or edematous."( Aroldi, M; Garini, G; Guariglia, A, 1999)
"Hyponatremia is commonly seen in patients with severe and moderate head injury, but it is rarely reported in those with mild head injury."( Ishibashi, A; Yokokura, Y, 1999)
"In man, hyponatremia is frequently associated with azotemia and hemo-dialysis usually corrects rapidly the serum sodium (SNa) but only few patients apparently develop demyelination."( Decaux, G; Penninckx, R; Soupart, A; Stenuit, A, 2000)
"Hyponatremia is almost always a condition of water excess while hypernatremia is due water deficiency."( Gross, P; Palm, C; Reimann, D, 2000)
"In many situations, hyponatremia is corrected at unexpectedly rapid rates."( Chen, PV; Pham, PC; Pham, PT, 2000)
"Hyponatremia is a frequent event in neurosurgery practice and is usually associated with subarachnoid hemorrhage, head trauma, infections and neoplasms."( Akalan, N; Oruckaptan, HH; Ozisik, P, 2000)
"Hyponatremia is seen in 40% to 60% of hospitalized acquired immune deficiency syndrome (AIDS) patients."( Akalin, E; Chandrakantan, A; Hamburger, RJ; Keane, J, 2001)
"Hyponatremia is a common electrolyte disturbance following intracranial disorders."( Bolk, JH; Coenraad, MJ; Meinders, AE; Taal, JC, 2001)
"Hyponatremia is a common disorder."( de Meijer, PH; Meinders, AE; Schmitz, PH, 2001)
"Hyponatremia is a common occurrence in this population."( Hillery, J; Kelly, BD, 2001)
"Hyponatremia is a well known complication of traumatic and nontraumatic cerebral injury, often related to the syndrome of inappropriate antidiuretic hormone secretion (SIADH)."( Donati-Genet, PC; Dubuis, JM; Girardin, E; Rimensberger, PC, 2001)
"Hyponatremia is modest in these patients and has little clinical significance."( Anpalahan, M, 2001)
"Exercise-related hyponatremia is an infrequent but potentially life-threatening accompaniment of prolonged exercise."( Montain, SJ; Sawka, MN; Wenger, CB, 2001)
"Hyponatremia is a common complication of intracranial disease or surgery."( Akalan, N; Baykan, A; Kandemir, N; Kinik, ST; Yordam, N, 2001)
"While hyponatremia is known to occur in patients with hypopituitarism, severe hyponatremia occurring as the presenting feature of hypopituitarism is very rare."( Hung, YH; Lin, SH; Lin, YF, 2002)
"Incidence of hyponatremia is higher during the peak southwest monsoon season with similar pattern for the study period of two years."( Chakrapani, M; Pillai, A; Shenoy, D, 2002)
"Since most cases of hyponatremia are associated with low effective osmolality, cell overhydration is a hallmark of acute hyponatremia."( Oh, MS, 2002)
"Hyponatremia is a relatively common disorder occurring in up to 6% of hospitalized patients and can occur through any mechanism that produces a relative excess of body water to body sodium."( Cho, BS; Han, DS, 2002)
"Hyponatremia is also reported, and its manifestations are frequently delayed several hours after the drug is ingested."( Hoffman, RS; Nelson, LS; Traub, SJ, 2002)
"While severe hyponatremia is reported to be more frequent in adults treated with oxcarbazepine (OXC) than with carbamazepine (CBZ), there is not sufficient data about the incidence of hyponatremia in childhood during treatment with OXC."( Boenigk, HE; Holtmann, M; Korn-Merker, E; Krause, M; Opp, J; Tokarzewski, M, 2002)
"Dilutional hyponatremia is a frequent complication of cirrhosis partly because of nonosmotic vasopressin release."( Decaux, G; Djian, J; Gandjini, H; Gerbes, AL; Ginès, P; Gross, P; Gülberg, V, 2003)
"Severe hyponatremia is associated with increased morbidity and mortality."( Baffoe-Bonnie, H; Dai, S; Falana, B; Nzerue, CM; You, W, 2003)
"Hyponatremia is the most common electrolyte disorder encountered in the clinical setting."( Janicic, N; Verbalis, JG, 2003)
"Hyponatremia is a common electrolyte disturbance occurring in a broad spectrum of patients, from asymptomatic to critically ill."( Koźniewska, E; Podlecka, A; Rafałowska, J, 2003)
"Interestingly, hyponatremia is usually seen in elderly patients with hypopituitarism due to various causes."( Damjanovic, S; Djurovic, M; Doknic, M; Miljic, D; Pekic, S; Petakov, M; Popovic, V, 2003)
"Data suggest hyponatremia is a common adverse event in elderly patients prescribed paroxetine and implicates inappropriate secretion of ADH as the potential mechanism."( Amico, JA; Fabian, TJ; Kroboth, PD; Mulsant, BH; Pollock, BG; Reynolds, CF, 2003)
"Hyponatremia is a common but generally mild condition while hypernatremia is uncommon."( Hawkins, RC, 2003)
"Hyponatremia is a frequent finding and asks for a rapid diagnostic evaluation."( Berwert, L; Kaeser, P; Livio, F; Vollenweider, P; Waeber, G, 2003)
"Hyponatremia is occasionally seen with the older anticonvulsant carbamazepine, and oxcarbazepine is a derivative of that older drug."( Adkoli, S, 2003)
"Hyponatremia is an under recognized and potentially serious complication of paroxetine treatment in older patients."( Amico, JA; Begley, AE; Bensasi, SG; Corey, SE; Dew, MA; Fabian, TJ; Kroboth, PD; Mulsant, BH; Pollock, BG; Reynolds, CF; Weber, E, 2004)
"Hyponatremia is a relatively common adverse effect of the use of desmopressin for the treatment of nocturia and caution and regular monitoring should be part of the use of this management option for nocturia in older adults."( Weatherall, M, 2004)
"Hyponatremia is a common electrolyte disorder in hospitalized patients."( Iguchi, A; Kaneda, M; Kobayashi, K; Kobayashi, R; Kuroki, F; Mino, E; Nakajima, M; Sato, T; Suzuki, Y; Yoshida, M, 2004)
"Hyponatremia is frequently associated with hypovolemia or fluid overload."( Benoit, R; Svendsen, A, 2004)
"Hyponatremia is defined as a plasma sodium concentration lower than 135 mmol/L."( Castillo Garzón, MJ; Gutiérrez Sainz, A; Ortega Porcel, FB; Ruiz Ruiz, J, 2004)
"Hyponatremia is common in cirrhosis, where it impairs encephalopathy."( Bartoli, E; Castello, L; Pirisi, M; Sainaghi, PP, 2005)
"Severe hyponatremia is most frequently caused by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH)."( Arata, T; Ejima, Y; Hatano, R; Kazama, I; Matsubara, M; Michimata, M; Miyama, N; Sasaki, S; Sato, A; Satomi, S; Suzuki, K; Suzuki, M, 2005)
"When chronic hyponatremia is rapidly corrected, reaccumulation of brain organic osmolytes is delayed and brain cell shrinkage occurs, leading to the osmotic demyelination syndrome (ODS)."( Rojiani, AM; Schroeder, BM; Silver, SM; Sterns, RH, 2006)
"Hyponatremia is frequently associated with neurological disease, neurosurgical procedures, and use of psychoactive drugs."( Bhardwaj, A, 2006)
"Hyponatremia is a common complication in patients with aneurysmal subarachnoid hemorrhage (SAH)."( Katayama, Y; Kawai, H; Kawamata, T; Kojima, J; Mori, T; Moro, N; Yoneko, M, 2005)
"Hyponatremia is common and is associated with a poor prognosis."( Czerwiec, F; Gheorghiade, M; Gottlieb, SS; Konstam, MA; Orlandi, C; Ouyang, J; Udelson, JE, 2006)
"Hyponatremia is a common electrolyte disorder that frequently is overlooked and undertreated."( Pham, PC; Pham, PM; Pham, PT, 2006)
"Hyponatremia is a common fluid-electrolyte disturbance, particularly in patients with neurologic disorders, in part because of the major role the central nervous system (CNS) plays in the regulation of sodium and water homeostasis."( Diringer, MN; Zazulia, AR, 2006)
"In most cases, hyponatremia is associated with hypotonicity, which causes water to move into the brain."( Diringer, MN; Zazulia, AR, 2006)
"Hyponatremia is a frequent and symptomatic electrolyte disorder for which specific treatments have been lacking."( Gross, P; Quittnat, F, 2006)
"Although hyponatremia is not likely to be a major risk factor for the general population, ultra-endurance athletes and people with occupational physical activity and heat exposure may benefit from these recommendations."( Sharp, RL, 2006)
"Hyponatremia is a common electrolyte disorder associated with potentially serious or life-threatening consequences."( Morton, AR; Yeates, KE, 2006)
"Hyponatremia is primarily a result of excessive water retention caused by a combination of excessive intake and inappropriate antidiuresis."( Robertson, GL, 2006)
"Consequences of hyponatremia are generally mild and remain unnoticed by both physician and patient."( Decaux, G, 2006)
"Hyponatremia is the most frequent electrolyte disorder encountered in hospitalized patients."( Gross, P; Herbrig, K; Palm, C; Pistrosch, F, 2006)
"Hyponatremia is an important and common electrolyte disorder in critically ill neurosurgical patients that has been reported in association with a number of different primary diagnoses."( Fraser, JF; Stieg, PE, 2006)
"Hyponatremia is a serious comorbidity in neurosurgical patients that requires particular attention as its treatment varies by cause and its consequences can affect neurological outcome."( Fraser, JF; Stieg, PE, 2006)
"Hyponatremia is a common electrolyte disorder among hospitalized patients and has been associated with increased mortality."( Douglas, I, 2006)
"Hyponatremia is a very common electrolyte disorder often caused by the dysregulation of arginine vasopressin (AVP) secretion and the effects of the hormone at its receptors and is associated with significant morbidity and mortality."( Olson, BR, 2006)
"Hyponatremia is frequently observed in hospitalised patients."( Vervoort, G; Wetzels, JF, 2006)
"Hyponatremia is often associated with arginine vasopressin (AVP) dysregulation that is regulated by the hypothalamo-neurohypophyseal tract in response to changes in plasma osmolality, commonly in patients with the syndrome of inappropriate antidiuretic hormone secretion (SIADH)."( McFarlane, S; Rai, A; Sowers, JR; Whaley-Connell, A, 2006)
"Hyponatremia is a common electrolyte disorder with the potential to cause serious neurological complications."( Arai, Y; Fujimori, A; Sasamata, M; Sudoh, K, 2007)
"Pseudohyponatremia is a clinical condition characterized by an increased fraction of protein or lipid in plasma, thereby resulting in an artificially low plasma sodium concentration ([Na(+)](p))."( Butch, AW; Kurtz, I; Nguyen, MK; Ornekian, V, 2007)
"Hyponatremia is a complex electrolyte disorder that results mainly from dysregulation of arginine vasopressin (AVP) by osmotic and nonosmotic mechanisms."( Cawley, MJ, 2007)
"Hyponatremia is common and associated with adverse outcomes in patients with congestive heart failure (CHF)."( Goldsmith, SR, 2006)
"Hyponatremia is common after aneurysmal subarachnoid hemorrhage (SAH)."( Haraoka, J; Hirabayashi, H; Katayama, Y; Kawamata, T; Kawamoto, K; Kitahara, T; Kojima, J; Kuroiwa, T; Mori, T; Moro, N; Nagata, I; Ogawa, A; Ohno, K; Seiki, Y; Shiokawa, Y; Teramoto, A; Tominaga, T; Yoshimine, T, 2007)
"Hyponatremia is a common clinical problem in hospitalized patients and nursing home residents."( Lien, YH; Shapiro, JI, 2007)
"Hyponatremia is among the metabolic disturbances encountered in oncology."( Raftopoulos, H, 2007)
"Hyponatremia is a frequently observed electrolyte abnormality in patients with central nervous system disease."( Igarashi, T; Katayama, Y; Kawamata, T; Kojima, J; Mori, T; Moro, N, 2007)
"Mild hyponatremia is relatively common in patients hospitalized with heart failure (HF)."( Butler, J; Cotts, W; DeMarco, T; DiSalvo, TG; Fonarow, GC; Francis, GS; Gheorghiade, M; Hare, JM; Hellkamp, AS; O'Connor, CM; Pauly, DF; Piña, IL; Rogers, J; Rossi, JS; Shin, DD; Stough, WG, 2007)
"Although hyponatremia is a common metabolic disorder in hospitalized patients, it is generally not well known as a hazard in the labor and delivery room."( Bornstein, J; Odeh, M; Ophir, E; Solt, I, 2007)
"Hyponatremia is a common and potentially serious electrolyte disorder, most often caused by excessive arginine vasopressin (AVP) secretion."( Hussain, SM; Marcus, RJ; Sureshkumar, KK, 2007)
"Hyponatremia is a well-known side effect of antidepressant treatment with serotonin reuptake inhibitors (SSRI) or combined serotonin and noradrenaline reuptake inhibitors (SNRI), and is linked to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in most cases."( Arolt, V; Domschke, K; Hetzel, G; Koelkebeck, K; Lang, D; Zwanzger, P, 2009)
"Although hyponatremia is a common, usually mild, and relatively asymptomatic disorder of electrolytes, acute severe hyponatremia can cause substantial morbidity and mortality, particularly in patients with concomitant disease."( Goldsmith, SR; Greenberg, A; Schrier, RW; Sterns, RH; Verbalis, JG, 2007)
"Hyponatremia is the most frequently encountered electrolyte disturbance in hospitalized patients."( Głuszek, J; Olszewski, W, 2007)
"Hyponatremia is a known complication of cytotoxic treatment."( Brodmann, S; Cathomas, R; Girardi, V; Gyr Klaas, E; von Moos, R, 2007)
"Hyponatremia is an important and common electrolyte disorder in tumor patients and one that has been reported in association with a number of different primary diagnoses."( Doi, SA; Kio, E; Onitilo, AA, 2007)
"Hyponatremia is a potentially serious complication of the use of SSRIs and is statistically more prevalent in the elderly and in females."( Schroeter, S; Wright, SK, 2008)
"In conclusion, hyponatremia is a significant independent predictor of 6-mo and 1-yr direct medical costs."( Curtis, LH; Hammill, BG; Schulman, KA; Shea, AM; Szczech, LA, 2008)
"Mild hyponatremia is common in patients hospitalized for worsening heart failure, and it is a major predictor of post-discharge mortality and morbidity irrespective of left ventricular ejection fraction."( Brandimarte, F; De Luca, L; Fedele, F; Fonarow, GC; Gheorghiade, M, 2007)
"Exercise-associated hyponatremia is the most common medical complication of ultradistance exercise and is usually caused by excessive hypotonic fluid intake."( Rosengren, DJ; Rothwell, SP, 2008)
"Hyponatremia is the most common electrolyte abnormality in hospitalized patients and is associated with increased mortality, morbidity, and longer hospital stays."( Ghali, JK, 2008)
"Hyponatremia is the most common electrolyte abnormality in hospitalized patients."( Achinger, SG; Arieff, A; Ayus, JC, 2008)
"Hyponatremia is the most frequent electrolyte disorder in critically neurological patients."( Cano-Pérez, JF; Cerdà-Esteve, M; Chillaron, JJ; Cuadrado-Godia, E; Cucurella, G; Fernández, M; Goday, A; Pont-Sunyer, C; Rodríguez-Campello, A; Roquer, J, 2008)
"Hyponatremia is an electrolyte disorder that is defined by a serum sodium concentration of less than 136 mmol/L."( Gross, P, 2008)
"Hyponatremia is the most common electrolyte abnormality."( Laczi, F, 2008)
"Hyponatremia is a frequent complication of advanced cirrhosis related to an impairment in the renal capacity to eliminate solute-free water that causes a retention of water that is disproportionate to the retention of sodium, thus causing a reduction in serum sodium concentration and hypo-osmolality."( Ginès, P; Guevara, M, 2008)
"Hyponatremia is the most common electrolyte abnormality found in hospitalized patients with heart failure."( Farmakis, D; Filippatos, G; Gheorghiade, M; Kremastinos, DT; Parissis, J, 2009)
"Hyponatremia is independently associated with adverse outcomes in patients with congestive heart failure (CHF)."( Goldsmith, SR, 2009)
"Hyponatremia is the most common electrolyte disorder present in hospitalized patients."( Bansal, S; Schrier, RW, 2008)
"Hyponatremia is an important predictor of increased mortality and the available therapies to treat congestion and/or hyponatremia are often ineffective and/or unsafe."( Cavalcante, JL; Gheorghiade, M; Khan, S, 2008)
"Hyponatremia is the most common electrolyte disorder in hospitalized patients and is associated with the risk of intractable seizures and death."( Arai, Y; Fujimori, A; Miyata, K; Sasamata, M, 2009)
"Hyponatremia is an important cause of morbidity in some groups of hospitalized children."( Negroto, A; Rando, K; Zunini, G, 2009)
"Sever hyponatremia is associated with a high mortality rate."( Achkouty, R; Mrad, R; Ziadé, D, 2009)
"Hyponatremia is a previously unrecognized entity as an adverse effect of flecainide."( Ahmed, M; Akhtar, M; Mortada, ME; Sra, J, 2009)
"Even when the hyponatremia is carefully corrected, the encephalopathy may deteriorate in the course of treatment."( Eckrich, K; Fritzsch, J, 2009)
"A common cause of hyponatremia is impaired renal water excretion either due to low extracellular fluid volume or inappropriate secretion of ADH."( Agarwal, M; Agrawal, V; Ghosh, AK; Joshi, SR, 2008)
"Hyponatremia is not uncommon, serious cases can cause dangerous complications as seizures, brain damage and even death."( Bergum, D; Hakli, TF; Lonnée, H, 2009)
"Hyponatremia is associated with reduced survival in patients with cirrhosis awaiting orthotopic liver transplantation (OLT)."( Benson, JT; Biggins, SW; Kim, WR; Klintmalm, GB; Kremers, WK; Rosen, CB; Therneau, TM; Yun, BC, 2009)
"Hyponatremia is often associated with, and worsens, the prognosis of severe aneurysmal subarachnoid hemorrhage (SAH)."( Audibert, G; Baumann, A; Dao, P; de Talancé, N; Laurens, MH; Longrois, D; Mertes, PM; Steinmann, G, 2009)
"Hyponatremia is often seen in SCLC, and is thought to be caused by the paraneoplastic syndrome SIADH."( Hansen, KH; Hansen, O; Sørensen, P, 2010)
"Exercise-associated hyponatremia is hyponatremia occurring during or up to 24 hours after prolonged exertion."( Hew-Butler, T; Rogers, IR, 2009)
"Hyponatremia is a common electrolyte disorder reported to be a predictor of poor prognosis among hospitalized patients, but individuals with high levels also tend to have less favorable outcomes."( Bekta, P; Chmielak, Z; Ciszewski, A; Demkow, M; Kalinczuk, L; Karcz, M; Kepka, C; Klopotowski, M; Kruk, M; Malek, LA; Pregowski, J; Przyluski, J; Ruzyllo, W; Witkowski, A, 2009)
"Hyponatremia is a simple laboratory marker independently associated with increased risk of death in STEMI patients treated with primary angioplasty."( Bekta, P; Chmielak, Z; Ciszewski, A; Demkow, M; Kalinczuk, L; Karcz, M; Kepka, C; Klopotowski, M; Kruk, M; Malek, LA; Pregowski, J; Przyluski, J; Ruzyllo, W; Witkowski, A, 2009)
"Overcorrection of hyponatremia is a medical emergency."( Hix, JK; Sterns, RH, 2009)
"Hyponatremia is associated with increased mortality in patients with end-stage liver disease and a greater risk of perioperative mortality with liver transplantation."( Davis, GL; O'Leary, JG, 2009)
"Acute hyponatremia is a serious condition, which poses major challenges."( Bluhme, H; Frøkiaer, J; Larsson, A; Overgaard-Steensen, C; Ring, T; Tønnesen, E, 2010)
"Hyponatremia is the most common electrolyte abnormality encountered in children."( Ayus, JC; Moritz, ML, 2010)
"Hyponatremia is commonly defined as a serum sodium concentration of 135 mEq/L or less, which is reported to occur in 0."( Hashizume, K; Sato, A; Sato, Y; Shi, S; Suzuki, S; Takei, M; Yamazaki, M, 2009)
"Hyponatremia is among the most common biochemical abnormalities in hospital inpatients."( Ho, KK; Lee, P, 2010)
"Hyponatremia is the most frequent electrolyte disorder in critically ill neurological patients."( Aycan, Z; Degerliyurt, A; Metin, A; Ozdemir, H, 2010)
"Hyponatremia is the most common electrolyte disorder encountered in hospitalized patients."( Jaber, BL; Madias, NE; Price, LL; Upadhyay, A; Wald, R, 2010)
"Hospital-associated hyponatremia is a common occurrence."( Jaber, BL; Madias, NE; Price, LL; Upadhyay, A; Wald, R, 2010)
"Hyponatremia is common and serious enough to merit clinical concern."( Audino, B; Curtis, J; Filmyer, DM; Josiassen, RC; Shaughnessy, RA; Skuban, N, 2010)
"Furthermore, hyponatremia is an important pathogenetic factor in patients with hepatic encephalopathy."( Heins, J; Zwingmann, C, 2010)
"Hyponatremia is a well-known predictor of mortality in patients with acutely decompensated heart failure."( Bayes-Genis, A; Januzzi, JL; Mohammed, AA; Moore, SA; Pinto, Y; Richards, M; van Kimmenade, RR, 2010)
"Hyponatremia is associated with adverse outcome in patients with acutely decompensated heart failure; however, the prognostic value of low Na is mainly evident in those with more pronounced elevation of NT-proBNP concentrations."( Bayes-Genis, A; Januzzi, JL; Mohammed, AA; Moore, SA; Pinto, Y; Richards, M; van Kimmenade, RR, 2010)
"Hyponatremia is common in patients prior to cardiopulmonary bypass (CPB), usually secondary to diuretic therapy."( Johnson, I; Palmer, K; Poullis, M; Warwick, R, 2010)
"Hyponatremia is one of the most commonly seen electrolyte abnormalities in hospitalized patients."( Janneck, M; Lang, M; Stahl, RA, 2010)
"Hyponatremia is one of the most common electrolyte disorders encountered in clinical practice."( Carluccio, AL; Merlin, MA; Zenenberg, RD, 2010)
"This hyponatremia is frequently attributed to a SIADH induced by this drug."( de Bragança, AC; Magaldi, AJ; Moyses, ZP, 2010)
"Hyponatremia is frequently encountered in patients with heart failure (HF), and its association with adverse outcomes is well-established in this population."( Kazory, A, 2010)
"Hyponatremia is common in neurocritical care and is associated with poor outcome, but the optimal treatment is not known."( Alberts, MJ; Bassin, SL; Bernstein, RA; Leibling, SM; Levasseur, K; Liebling, SM; Muro, K; Naidech, AM; Paparello, J, 2010)
"Hyponatremia is associated with excess morbidity and mortality."( Hoorn, EJ; Zietse, R, 2010)
"Hyponatremia is independently associated with adverse outcomes in patients with congestive heart failure (CHF)."( Goldsmith, SR, 2010)
"Hyponatremia is due to the nonosmotic release of arginine vasopressin (AVP) along with neurohormonal activation of the renin-angiotensin-aldosterone and sympathetic nervous systems."( Ronco, C; Rosner, MH, 2010)
"Hyponatremia is the most prevalent electrolyte disorder in hospitalized patients."( Khanna, A; Menon, MC, 2010)
"Post-operative hyponatremia is a common complication in children which results from hypotonic fluid administration in the presence of arginine vasopressin (AVP) excess."( Hashimura, Y; Iijima, K; Kaito, H; Kanda, K; Matsuo, M; Moritz, ML; Nakanishi, K; Ninchoji, T; Nozu, K; Yoshikawa, N, 2011)
"Hyponatremia is a common electrolyte disorder in patients with heart failure (HF) associated with cognitive dysfunction and increased mortality and rehospitalization rates."( Abraham, WT; Aranda, JM; Boehmer, JP; Elkayam, U; Feldman, AM; Gilbert, EM; Gottlieb, SS; Hasenfuss, G; Kukin, M; Lowes, BD; O'Connell, JB; Orlandi, C; Tavazzi, L; Ticho, B, 2010)
"Hyponatremia is common and is increasingly recognized as an independent prognostic marker that adversely affects morbidity and mortality in various disease states, including heart failure."( Chiong, JR; Jao, GT, 2010)
"Hyponatremia is encountered quite frequently in everyday clinical practice."( Hensen, J, 2010)
"Hyponatremia is the most common electrolyte disturbance."( Marco Martínez, J, 2010)
"Hyponatremia is a well-known adverse prognostic factor in patients with chronic heart failure."( Cantillo, DS; Comín Colet, J; Robledo, GG, 2010)
"Hyponatremia is the most common electrolyte disorder in patients with cirrhosis."( Ginès, P; Guevara, M, 2010)
"Hyponatremia is the most common electrolyte disorder in hospitalized patients and may be associated with non negligible morbidity and mortality."( Vollenweider, P; Vuagniaux, A, 2010)
"Hyponatremia is one of the most common electrolyte disorders encountered in clinical practice of medical anticancer treatment."( Fujii, M; Habu, N; Tokumaru, Y; Yajima, Y, 2010)
"Hyponatremia is an electrolyte disorder that is defined by a serum sodium concentration of less than 135 mmol/L."( Gross, P; Palm, C; Wagner, A, 2011)
"Although hyponatremia is a recognized complication of several inflammatory diseases, its pathophysiology in this setting has remained elusive until recently."( Betjes, MG; Hoorn, EJ; Swart, RM; Zietse, R, 2011)
"Hyponatremia is a common diagnostic challenge."( Hassing, RJ; Hoorn, EJ; Hotho, D; Zietse, R, 2011)
"Hyponatremia is associated with headache, nausea, vomiting, dizziness, and can cause somnolence, loss of consciousness and death."( Claassen, JA; Reichert, LJ; ten Doesschate, T, 2010)
"We studied whether hyponatremia is associated with fractures, falls, and/or bone mineral density (BMD)."( Hofman, A; Hoorn, EJ; Pols, HA; Rivadeneira, F; Stricker, BH; Uitterlinden, AG; van Meurs, JB; Ziere, G; Zietse, R; Zillikens, MC, 2011)
"Hyponatremia is a common electrolyte disturbance in the hospitalized elderly sick patients."( Anil Kumar, T; Mahesh, E; Punith, K; Rao, MY; Saravanan, S; Sudhir, U, 2010)
"Hypervolemia and hyponatremia are common features in heart failure and have been associated with increased morbidity and mortality."( Daifallah, S; Ghali, JK; Khan, NS; Zmily, HD, 2011)
"Hyponatremia is a known prognostic factor for mortality in patients with heart failure but has not been extensively studied in patients with myocardial infarction (MI)."( Gustafsson, F; Køber, L; Schou, M; Torp-Pedersen, C; Valeur, N, 2011)
"The degree of hyponatremia is related to the perioperative fluid volume administered."( Casselbrant, ML; Davidson, HC; Kitsko, DJ; Stapleton, AL, 2011)
"Hyponatremia is the main complication of inappropriate antidiuretic hormone secretion (SIADH), sometimes fatal."( Cachat, F; Chehade, H; Girardin, E; Rosato, L, 2012)
"Hyponatremia is a common electrolyte abnormality among patients hospitalized with heart failure and it is a marker for increased short-term and long-term mortality."( Madan, VD; Novak, E; Rich, MW, 2011)
"Hyponatremia is a marker of different underlying diseases and it can be a cause of morbidity itself; this implies the importance of a correct approach to the problem."( Bianzina, S; Dal Canton, A; Esposito, P; Malul, Y; Piotti, G, 2011)
"Hyponatremia is the most frequent electrolyte abnormality observed in post-operative pediatric patients receiving intravenous maintenance fluid therapy."( Fläring, U; Frenckner, B; Ingolfsson, I; Kowalski, J; Krmar, RT; Lönnqvist, PA; Stigzelius, S; Svensson, JF; Wallensteen, L, 2011)
"TMP-SMX-induced hyponatremia is a rare occurrence."( Dunn, RL; Smith, WJ; Stratton, MA, 2011)
"Hyponatremia is the most common electrolyte imbalance seen in patients with aneurysmal subarachnoid hemorrhage, occurring in one-third to one-half of patients."( Bruder, N; Rabinstein, AA, 2011)
"Hyponatremia is a common problem encountered in patients presenting with nonspecific symptoms."( Agarwal, SM; Agrawal, A, 2011)
"Hyponatremia is a very common electrolyte abnormality."( Cassagnol, M; Saad, M; Shogbon, AO, 2011)
"Hyponatremia is a common electrolyte disturbance associated with considerable morbidity and mortality."( Elisaf, M; Liamis, G; Milionis, HJ, 2011)
"Hyponatremia is frequently observed on the basis of syndrome of inappropriate antidiuretic hormone hypersecretion (SIADH) in patients suffering from lung cancer."( Grohé, C; Petereit, C; Teber, I; Zaba, O, 2011)
"Hyponatremia is very frequent in neonates, especially in VLBW."( Dessi, A; Fanos, V; Irmesi, R; Marcialis, MA; Pintus, MC, 2011)
"Hyponatremia is a common clinical problem that results from various causes."( Nozu, T; Ohira, M; Okumura, T; Yoshida, Y, 2011)
"While chronic hyponatremia is known to have deleterious effects on quality of life, motor and gait disturbances represent manifestations of mild hyponatremia that have until now gone unrecognized."( Curtis, JL; Filmyer, DM; Geboy, AG; Josiassen, RC; Martin, DM; Orlandi, C; Salzman, A; Shaughnessy, RA, 2012)
"Hyponatremia is prevalent in hospitalized patients and predicts a poor prognosis."( Gargani, L; Gheorghiade, M; Schmidt, PH, 2011)
"Hyponatremia is one of the major side effects that occurs after CDDP-based cancer chemotherapy."( Gotoh, M; Higuchi, M; Hoshino, M; Kitamura, M; Kudoh, A; Midorikawa, S; Ohsugi, J; Saito, T; Suzuki, H, 2011)
"Hyponatremia is common in patients with conditions such as congestive heart failure and is associated with increased mortality in hospitalized patients."( Kalantar-Zadeh, K; Kovesdy, CP; Lott, EH; Lu, JL; Ma, JZ; Malakauskas, SM; Molnar, MZ, 2012)
"Hyponatremia is frequent following cranial -neurosurgery or acute brain injury like subarachnoid hemorrhage (SAH), and increases mortality by 30%."( Buchfelder, M; Kleindienst, A; Linde, L; Schlaffer, SM; Sharma, N; Verbalis, JG, 2012)
"Hyponatremia is a common electrolyte abnormality caused by an actual sodium deficiency or extracellular compartment fluid excess."( Caimi, G; Urso, C, 2012)
"Severe hyponatremia is a serious medical condition that is associated with morbidity and mortality."( Choi, BS; Choi, SR; Chung, BH; Hwang, HS; Kang, SH; Kim, HW; Kim, YS; Lee, SY; Park, CW; Park, HS; Sun, IO; Yang, CW, 2012)
"Admission hyponatremia is associated with an increased rate of significant medical deteriorations of psychiatric inpatients and should trigger enhanced clinical monitoring to identify and treat somatic disorders."( Correll, CU; De Hert, M; Kane, JM; Manu, P; Ray, K; Rein, JL, 2012)
"Chronic hyponatremia is known to have deleterious effects on the quality of life for many patient groups."( Curtis, JL; Czerwiec, F; Filmyer, DM; Geboy, AG; Josiassen, RC; Ouyang, J; Shaughnessy, RA; Skuban, N, 2012)
"Hyponatremia is a relatively common side effect of medical treatment with SSRI or SSNRI in elderly patients."( Frank, D; Janssens, U; Meyer, I, 2012)
"When hyponatremia is caused by SIADH, hypertonic saline is indicated for acute, symptomatic cases, whereas fluid restriction is recommended to achieve a slower rate of correction for chronic asymptomatic hyponatremia."( Castillo, JJ; Justice, E; Vincent, M, 2012)
"Hyponatremia is the most common electrolyte disorder in hospitalized patients and is known to be associated with increased mortality."( Hiesmayr, M; Lassnigg, A; Lindner, G; Schwarz, C; Wisser, W; Zapletal, B, 2012)
"Most often, hyponatremia is associated with hypotonicity and intracellular hyperhydration, which may exacerbate a cerebral edema."( Audibert, G; Baumann, A; Hoche, J; Mertes, PM, 2012)
"Hyponatremia is rare and may be more likely in younger patients or those with cystic loculations."( Aversano, MW; Bauman, JA; Heuer, GG; Lang, SS; Sanborn, MR; Storm, PB; Vossough, A, 2012)
"Hyponatremia is common in patients with cirrhosis and portal hypertension, and is characterized by excessive renal retention of water relative to sodium due to reduced solute-free water clearance."( Chiodo, J; Gaglio, P; Marfo, K, 2012)
"Hyponatremia is the most common electrolyte disorder in hospitalized patients, and is frequently a marker of a significant underlying disease."( Chen, KH; Chien, YY; Huang, WY; Hung, CC; Lee, M; Peng, TI; Weng, WC; Wu, CL, 2012)
"Hyponatremia is a frequent complication of the advanced liver disease, being, as the hepatorenal syndrome, a consequence of the important circulatory dysfunction of cirrhosis."( Babiuc, RD; Bengus, A, 2012)
"Hyponatremia is the most common electrolyte disorder in hospitalized patients."( Lindner, G; Schwarz, C, 2012)
"Dilutional hyponatremia is the most common electrolyte disorder occurring in heart failure (HF)."( Dabrowska, MD; Krysiak, R; Okopień, B, 2012)
"Hyponatremia is the most common electrolyte abnormality in clinical practice, but little is known about the association between febrile urinary tract infection (UTI) and hyponatremia or its significance to clinical outcomes."( Choi, MJ; Kim, KH; Oh, YS; Park, SJ; Shin, JI, 2012)
"Hyponatremia is reported to be associated with poor survival in localized renal cell carcinoma and metastatic renal cell carcinoma treated with immunotherapy."( Arai, Y; Kawashima, A; Nakai, Y; Nin, M; Nishimura, K; Nonomura, N; Takayama, H; Tanigawa, G; Tsujimura, A; Uemura, M, 2012)
"Hyper- and hyponatremia are frequently observed in patients after subarachnoidal hemorrhage, and are potentially related to worse outcome."( Bendel, S; Jakob, SM; Lehmann, L; Reinert, M; Schafer, M; Takala, J; Uehlinger, DE, 2013)
"In SIAD, hyponatremia is associated with normovolaemia but the assessment of extracellular volume can be difficult."( Frouget, T, 2012)
"Hyponatremia is a common problem in critical care patients and is associated with increased duration of hospital stay and increased morbidity and mortality."( Cirulli, J; Friedman, B, 2013)
"Acute hyponatremia is a more dramatic situation and needs rapid action when severe neurological symptoms are present."( Hensen, J, 2012)
"Hyponatremia is a common electrolyte disorder associated with increased morbidity and mortality, particularly in the elderly."( Abraham, WT; Bichet, DG; Chafekar, DS; Gross, PA; Hensen, J; Josiassen, RC; Orlandi, C, 2012)
"Hyponatremia is the most common electrolyte disorder in clinical practice."( Abraham, WT; Bichet, DG; Decaux, G; Josiassen, RC; Kopyt, N; Mannelli, M; Orlandi, C; Thacker, HP; Yagil, Y, 2012)
"Hyponatremia is the most common electrolyte disorder in the hospital setting and is defined as a serum sodium concentration less than 135 mmol/l."( Gross, P; Heinrich, S; Wagner, A, 2013)
"Hyponatremia is an independent predictor for worsening HF events after CRT implantation, which may be partly explained by elevated level of plasma arginine vasopressin."( Ako, J; Arao, K; Fujiwara, T; Ishikawa, SE; Momomura, S; Sakakura, K; Suga, C; Sugawara, Y; Wada, H, 2013)
"Hyponatremia is the most common electrolyte disorder."( Berl, T, 2013)
"Acute hyponatremia is defined as a reduction in the plasma sodium level in less than 48 h."( Aşçı, G; Çırpan, T; Demirci, MS; Peker, N; Tamer, AF; Turan, MN; Yaprak, M, 2013)
"Hyponatremia is a common electrolyte disorder in hospitalized patients."( Arici, M; Camsari, A; Gok Oguz, E; Horoz, M; Kiykim, A; Ozhan, O; Turgutalp, K; Yilmaz, A, 2013)
"Hyponatremia is related to cardiac tamponade in isolated case reports."( Chang, FK; Chiu, CH; Lee, YC, 2012)
"Hyponatremia is common in patients with cardiac tamponade."( Chang, FK; Chiu, CH; Lee, YC, 2012)
"Severe hyponatremia is a critical electrolyte abnormality in allogeneic stem cell transplantation (allo-SCT) recipients and >50% of cases of severe hyponatremia are caused by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH)."( Abe, D; Iseki, T; Kawaguchi, T; Kawajiri, C; Nagao, Y; Nakaseko, C; Ohwada, C; Sakai, S; Sakaida, E; Shimizu, N; Sugita, Y; Takeda, Y; Takeuchi, M; Tsukamoto, S; Yamazaki, A; Yokote, K, 2013)
"Hyponatremia is the most common electrolyte abnormality and it is associated with increased morbidity and mortality."( Melander, O; Öhlin, B; Olsson, K, 2013)
"Hypervolemic hyponatremia is often complicated with advanced heart failure together with increased excretion of sodium by diuretics."( Endo, M; Hatano, M; Hirata, Y; Imamura, T; Inaba, T; Kato, N; Kinugawa, K; Kyo, S; Maki, H; Nagai, R; Nishimura, T; Ono, M; Shiga, T; Yao, A, 2012)
"Hyponatremia is prevalent before liver transplantation and generally corrected immediately after transplantation."( Han, JS; Joo, KW; Kim, DK; Kim, YS; Lee, J; Lee, JW; Na, KY; Oh, KH; Oh, YK; Suh, KS, 2013)
"Hyponatremia is known to be a poor prognostic factor in patients hospitalized with heart failure (HF), however not well studied in Japan."( Aokage, T; Asai, K; Gheorghiade, M; Kajimoto, K; Minami, Y; Mizuno, K; Mizuno, M; Munakata, R; Sakata, Y; Sato, N; Takano, T; Yumino, D, 2013)
"Hyponatremia is a common disorder associated with higher mortality in hospitalized patients, but its impact in an ambulatory setting remains unclear."( Ayers, C; de Lemos, J; Gankam-Kengne, F; Khera, A; Maalouf, NM, 2013)
"Hyponatremia is the most common electrolyte disorder encountered in clinical practice and represents a clinical, social, and economic burden."( Peri, A, 2013)
"Hyponatremia is a common complication occurring in one third of patients after subarachnoid hemorrhage (SAH)."( Hironaka, Y; Matsuda, R; Motoyama, Y; Nakagawa, I; Nakase, H; Nishimura, F; Park, YS; Takeshima, Y; Yamada, S, 2013)
"Hyponatremia is the most common electrolyte disorder in clinical practice, and it is associated with adverse outcomes."( Schrier, RW; Shchekochikhin, D; Tkachenko, O, 2013)
"Hyponatremia is the most frequently encountered electrolyte abnormality among hospitalized patients and thiazide users."( Abukhalid, N; Al Ammari, M; Al Johani, N; Al Qahtani, M; Al Sayyari, A; Al Swaidan, L; Alshahrani, A; Alskaini, A; Binsalih, S; Theaby, A, 2013)
"Hyponatremia is a common but often mistreated clinical situation in the ICU."( Qiu, M; Qiu, Y, 2013)
"Dilutional hyponatremia is a serious adverse effect of desmopressin, a vasopressin analog that is widely prescribed to manage monosymptomatic enuresis."( Bianchetti, MG; Ceschi, A; Faré, PB; Lava, SA; Lucchini, B; Simonetti, GD, 2013)
"Hyponatremia is seen more often than expected in a clinical setting."( Bargman, JM; Dimitriadis, C; Oreopoulos, D; Pipili, C; Sekercioglu, N, 2014)
"The hyponatremia is consistent with adult reports."( Klinger, G; Merlob, P; Rolnitsky, A, 2013)
"We conclude that hyponatremia is a frequent finding in CAP and seems associated with the disease severity."( Jackowska, T; Wrotek, A, 2013)
"Hyponatremia is the most frequent eletrolyte imbalance in hospitalized geriatric patient."( Németh, A; Oláh, R; Steiner, T; Winkler, G, 2013)
"Exercise-associated hyponatremia is known to be a complex process resulting from the interplay of hydration, arginine vasopressin, and sodium balance."( Hew-Butler, TD; Hoffman, MD; Lewis, DP; Owen, BE; Rogers, IR; Stuempfle, KJ; Verbalis, JG, 2014)
"Hyponatremia is common and is associated with poor in-hospital outcomes in patients hospitalized with heart failure (HF)."( Goto, D; Hamaguchi, S; Ishimori, N; Kinugawa, S; Matsushima, S; Sakakibara, M; Tsuchihashi-Makaya, M; Tsutsui, H, 2014)
"Hyponatremia is a serious, but often overlooked, electrolyte imbalance that has been independently associated with a wide range of deleterious changes involving many different body systems."( Goldsmith, SR; Greenberg, A; Korzelius, C; Schrier, RW; Sterns, RH; Thompson, CJ; Verbalis, JG, 2013)
"Hyponatremia is a potential side-effect of antidepressants that was observed most frequently in connection with compounds acting on the serotonin system."( Bognár, Z; Gazdag, G; Vonyik, G, 2013)
"Although hyponatremia is known to be associated with osteoporosis and a high fracture risk, the mechanism through which bone loss ensues has remained unclear."( Colaianni, G; Colucci, S; Corcelli, M; Cuscito, C; Di Benedetto, A; Grano, M; Li, J; Lu, P; Moonga, SS; New, MI; Sun, L; Tamma, R; Yuen, T; Zaidi, M; Zallone, A, 2013)
"Hyponatremia is common after acute subarachnoid hemorrhage (SAH) but the etiology is unclear and there is a paucity of prospective data in the field."( Ball, SG; Behan, LA; Hannon, MJ; Javadpour, M; Javadpur, M; O'Brien, MM; Sherlock, M; Thompson, CJ; Tormey, W, 2014)
"Hyponatremia is the most common electrolyte disorder and is a negative prognostic factor in several kinds of cancer."( Goto, Y; Kikuchi, S; Kobayashi, N; Sakai, M; Sato, Y; Suzuki, H; Usui, S; Yamaoka, M, 2014)
"Hyponatremia is associated with increased mortality in chronic kidney disease with and without end-stage renal disease (ESRD)."( Akita, W; Kasagi, Y; Kusaka, K; Kuwahara, M; Mandai, S; Sasaki, S; Shikuma, S; Tanaka, T, 2013)
"Hyponatremia is the most common electrolyte disorder in clinical practice, and evidence to date indicates that severe hyponatremia is associated with increased morbidity and mortality."( Corona, G; Forti, G; Giuliani, C; Maggi, M; Norello, D; Parenti, G; Peri, A; Verbalis, JG, 2013)
"Hyponatremia is one of the most common adverse effects in patients treated with oxcarbazepine (OXC)."( Byun, JI; Chu, K; Jung, KH; Kang, BS; Kim, DW; Kim, YS; Lee, SK; Lee, ST; Yeom, JS, 2014)
"Hyponatremia is a known complication of neurosurgical procedures and is associated with higher morbidity among neurosurgical patients."( Belzer, JS; Bratton, SL; Presson, AP; Riva-Cambrin, J; Williams, CN, 2014)
"Hyponatremia is an independent predictor of complications during hospitalization in our real-world cohort, but was not associated with 90 days mortality or readmissions."( Aramburu Bodas, O; Arévalo Lorido, JC; Carretero Gómez, J; Ceresuela, LM; Formiga, F; Montero Pérez-Barquero, M; Trullás Vila, JC, 2013)
"Hyponatremia is the most frequent electrolyte disorder in hospitalized patients."( Giuliani, C; Peri, A, 2014)
"Hyponatremia is associated with an increased risk of mortality on the liver transplantation (LT) waiting list."( Benson, JT; Biggins, SW; Heimbach, JK; Kim, WR; Larson, JJ; Leise, MD; Rosen, CB; Therneau, TM; Yang, JD; Yun, BC, 2014)
"Hyponatremia is the most common electrolyte disorder and is associated with serious neurologic sequelae and increased mortality."( Elisaf, MS; Filippatos, TD; Liamis, G, 2014)
"In conclusion, hyponatremia is prevalent at a similar frequency of over 10% in ambulatory patients with HFpEF and HFrEF."( Ather, S; Bambhroliya, A; Bavishi, C; Bozkurt, B; Deswal, A; Jneid, H; Virani, SS, 2014)
"The rate of hyponatremia is higher in hospitalized cancer patients than in hospitalized patients without cancer and is associated with poor clinical outcomes."( Ali, N; George, M; Lahoti, A; Palla, S; Salahudeen, AK, 2014)
"Although hyponatremia is a prognostic factor in acute heart failure (AHF), its influence on the acute clinical course of heart failure is unknown."( Cao, DX; Elkayam, U; Lou, M; Ng, TM; Patel, KA; Prasad, M; Wong, YM, 2014)
"Hyponatremia is a common condition in hospitalized patients, with an incidence rate of about 30%."( Corciulo, R; Labellarte, C; Lattarulo, S; Madaro, A; Mancusi Materi, G; Pezzolla, A; Spinelli, S, 2014)
"Hyponatremia is the most common electrolyte disturbance encountered in the neurological and neurosurgical intensive care units, and can exacerbate existing neurological deficits."( Duława, J; Hawrot-Kawecka, A; Holecki, M; Kret, B; Lasek-Bal, A, 2014)
"Hyponatremia is a common electrolyte disorder that carries significant morbidity and mortality."( Couturier, BS; Decaux, G; Gankam Kengne, F; Soupart, A, 2015)
"DDAVP-associated hyponatremia is a known complication of DDAVP therapy."( Achinger, SG; Arieff, AI; Ayus, JC; Kalantar-Zadeh, K, 2014)
"Hyponatremia is a common electrolyte abnormality in a variety of medical conditions."( Chen, CY; Chen, KH; Hung, CC; Lee, CC; Weng, CM, 2014)
"Hyponatremia is a common and potentially serious complication of transsphenoidal surgery (TSS)."( Nagatani, T; Okumura, E; Takeuchi, K; Wakabayashi, T, 2014)
"Hyponatremia is reported in about 15% of small cell lung cancer (SCLC)."( Ardizzoni, A; Boni, L; Buti, S; Mattioni, R; Tiseo, M, 2014)
"Hyponatremia is an independent prognostic factor for patients with SCLC treated with topotecan in second-line setting."( Ardizzoni, A; Boni, L; Buti, S; Mattioni, R; Tiseo, M, 2014)
"Hyponatremia is a common electrolyte disorder occurring in patients with malignancy."( Bukała, A; Karczmarek-Borowska, B; Zielińska, K, 2014)
"Hyponatremia is the most common electrolyte disorder encountered in clinical practice."( Agarwal, M; Brewer, JM; Fülöp, T; Gharaibeh, KA, 2015)
"Hyponatremia is a risk factor of elevated mortality, repetitive hospitalizations, and worsening of kidney function in patients with decompensation of CHF."( Kopylov, FIu; Kozlovskaia, NL; Shchekochikhin, DIu; Syrkin, AL, 2014)
"Hyponatremia is a known complication in patients with heart failure (HF)."( Adams, KF; Lin, TE; Patterson, JH, 2014)
"Our data show that hyponatremia is associated with up to a doubling in the risk of hip and morphometric spine fractures, independent of BMD."( Arampatzis, S; Bauer, DC; Bucur, RC; Ensrud, K; Harrison, SL; Jamal, SA; Orwoll, ES, 2015)
"Hyponatremia is associated with an increased risk of mortality in patients with heart failure and in acute ST-segment elevation myocardial infarction (STEMI)."( Burkhardt, K; Heier, M; Kirchberger, I; Kling, E; Kuch, B; Meisinger, C; von Scheidt, W; Zirngibl, A, 2015)
"Hyponatremia is the most commonly occurring electrolyte disorder and is associated with increased morbidity and mortality—independent of the underlying disease."( Haas, CS, 2014)
"Hyponatremia is a common and associated with poor clinical outcome in cancer patients."( Ahn, SH; Kim, CM; Lee, YJ; Yoon, J, 2015)
"Hyponatremia is an independent prognostic factor in terminal cancer patients and careful clinical concern is needed."( Ahn, SH; Kim, CM; Lee, YJ; Yoon, J, 2015)
"Hyponatremia is a reported, though uncommon, complication of thiazide use."( Eilbert, WP; Sardar, GK, 2015)
"Hyponatremia is a well-known phenomenon in cancer patients."( Bortlicek, Z; Bruha, F; Fiala, O; Minarik, M; Mukensnabl, P; Pesek, M; Racek, J; Svaton, M, 2014)
"Hyponatremia is associated with elevated wait-list mortality among end-stage liver disease candidates for liver transplantation (LT)."( Goodrich, NP; Merion, RM; Schaubel, DE; Sharma, P, 2015)
"Hyponatremia is an electrolyte abnormality that occurs in infancy due to a variety of inherited and acquired disorders."( Greenberg, JH; Marsenic, O; Tufro, A, 2015)
"Hyponatremia is the most commonly encountered electrolyte abnormality."( Brewster, UC; Pazhayattil, GS; Rastegar, A, 2015)
"Hyponatremia is the most frequently occurring electrolyte abnormality and can lead to life-threatening complications."( Abreo, K; Buffington, MA, 2016)
"Postoperative hyponatremia is also common and may exacerbate neurological injury."( Bratton, SL; Presson, AP; Riva-Cambrin, J; Williams, CN, 2015)
"Euvolemic hyponatremia is most frequently caused by the syndrome of inappropriate antidiuretic hormone secretion (SIADH)."( Lindner, U; Schäffler, A, 2015)
"Hyponatremia is defined as a serum below 135 mmol/l and is the most frequent electrolytes disorder."( Berchtold, L; Martin, PY; Ponte, B, 2015)
"In general, hyponatremia is treated with fluid restriction (in the setting of euvolemia), isotonic saline (in hypovolemia), and diuresis (in hypervolemia)."( Barstow, CH; Braun, MM; Pyzocha, NJ, 2015)
"Hyponatremia is not infrequently associated with desmopressin use."( Choi, EY; Kim, GH; Kim, YT; Park, JS; Park, SY, 2015)
"Hyponatremia is frequently seen in heart failure patients and has a high mortality rate."( Acaban, MB; Arı, H; Kahraman, F, 2015)
"Hyponatremia is the most prevalent electrolyte imbalance, and may be present in up to 30% of hospitalized patients."( Tanındı, A; Töre, HF, 2015)
"Hyponatremia is common among inpatients and is associated with severe adverse outcomes such as osmotic demyelination syndrome."( Cavalcanti, RB; MacMillan, TE; Tang, T, 2015)
"Hyponatremia is highly prevalent among patients admitted to Departments of Internal Medicine and is associated with increased 30-day and 1-year mortality risk, regardless of underlying disease."( Christiansen, CF; Heide-Jørgensen, U; Holland-Bill, L; Jørgensen, JO; Ring, T; Sørensen, HT; Ulrichsen, SP, 2015)
"Hyponatremia is a common complication among cancer patients."( Hill, J; Passero, V; Shields, J, 2016)
"Hyponatremia is a well-known risk factor for poor outcomes in Western studies of heart failure (HF) patients."( Choi, DJ; Ge, J; Hwang, JJ; Kang, SM; Lin, SJ; Park, JJ; Wen, MS; Yoo, BS; Zhang, J, 2015)
"Hyponatremia is prevalent in acute stroke admissions and is independently associated with higher mortality in patients <75 years."( Bettencourt-Silva, JH; Bowles, KM; Clark, AB; Cumming, K; Metcalf, AK; Myint, PK; Potter, JF; Soiza, RL, 2015)
"Hyponatremia is a common electrolyte abnormality in advanced liver disease that results from the impaired ability of the kidney to excrete solute-free water that leads to "dilutional" hyponatremia-water retention disproportionate to the retention of sodium."( Ko, B; Sinha, VK, 2015)
"Hyponatremia is the most common clinical electrolyte disorder."( Arima, H; Fujisawa, H; Fukumoto, K; Hayashi, Y; Iwama, S; Izumida, H; Kiyota, A; Komatsu, Y; Mizoguchi, H; Murata, Y; Nakashima, K; Ochiai, H; Oiso, Y; Sugimura, Y; Takagi, H; Takagishi, Y; Takeuchi, H; Takeuchi, S, 2016)
"Hyponatremia is the most common disorder of body fluid and electrolyte balance in clinical practice."( Khanna, A; Kumar, A; Madariaga, H, 2015)
"Hyponatremia is a common disorder and hyponatremia in the outpatient setting is not extensively studied."( Ergun, I; Oguz, AK; Sayın, I; Tasdemir, V, 2015)
"Hyponatremia is prevalent among elderly, especially in women and with thiazide diuretics."( Ergun, I; Oguz, AK; Sayın, I; Tasdemir, V, 2015)
"Hyponatremia is one of the electrolyte abnormalities frequently encountered in cancer therapy."( Beppu, T; Fujikawa, T; Hatanaka, A; Okano, W; Saito, Y; Shirakura, S; Tokumaru, T; Yamada, M, 2015)
"Hyponatremia is a common electrolyte alteration which has the potential for significant morbidity and mortality."( Castro-Correia, C; Correia, F; Fernandes, A; Fontoura, M; Garcia, M; Mota, TC; Ribeiro, A, 2015)
"Hyponatremia is a frequent problem in clinical practice and is known to be associated with a variety of serious adverse outcomes."( Whelton, PK, 2016)
"Hyponatremia is relatively common in patients hospitalized with HF in China and hyponatremia on admission is associated with higher in-hospital mortality and all-cause death and HF death one year after discharge."( Huang, Y; Zhang, J; Zhang, R; Zhang, Y; Zhou, Q; Zou, C, 2015)
"Hyponatremia is the most common electrolyte disorder in hospitalized patients associated with increased morbidity and mortality."( Christopoulou, F; Elisaf, MS; Filippatos, TD; Liamis, G, 2016)
"Even mild chronic hyponatremia is associated with increased mortality, attention deficit, gait instability, osteoporosis, and fractures, but it is not known if the correction of mild hyponatremia improves outcomes."( Silver, SM; Sterns, RH, 2016)
"Hyponatremia is the most frequent electrolyte abnormality seen postoperatively in pediatric patients receiving maintenance fluid therapy."( Fläring, U; Nilsson, K; Sandström, K, 2016)
"On-admission hyponatremia is an independent predictor for long-term outcomes in patients hospitalized for AHF."( Chen, CH; Cheng, HM; Cheng, YL; Guo, CY; Hsu, PF; Huang, WM; Lu, DY; Sung, SH; Yu, WC, 2016)
"Hyponatremia is the most common electrolyte abnormality in clinical practice, and a differential diagnosis of the etiologic disorders is crucial because hyponatremia is associated with many different disease states including malignancies."( Hui Bae, E; Kwon Ma, S; Sun Kim, S; Wan Kim, S, 2016)
"Hyponatremia is a risk factor for mortality in hemodialysis (HD) patients."( Canaud, B; Carioni, P; Dekker, MJ; Konings, CJ; Kooman, JP; Kotanko, P; Leunissen, KM; Levin, NW; Maheshwari, V; Marcelli, D; Raimann, JG; Usvyat, LA; van der Sande, FM, 2016)
"In HD patients, hyponatremia is associated with malnutrition, inflammation and fluid overload."( Canaud, B; Carioni, P; Dekker, MJ; Konings, CJ; Kooman, JP; Kotanko, P; Leunissen, KM; Levin, NW; Maheshwari, V; Marcelli, D; Raimann, JG; Usvyat, LA; van der Sande, FM, 2016)
"Although hyponatremia is related to poorer outcomes in several clinical settings, its significance remains unresolved in kidney transplantation."( An, JN; Han, DJ; Han, M; Han, SS; Kim, YH; Kim, YS; Lee, JP; Lim, CS; Na, KY; Oh, YK; Park, JY; Park, S; Park, SK, 2016)
"Hyponatremia is often caused by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH)."( Fujiwara, H; Machida, S; Saga, Y; Sakamoto, Y; Takahashi, Y; Takei, Y, 2016)
"Hyponatremia is associated with cardiac tamponade especially for malignant pericardial effusion and for patients with cardiac chambers compression signs."( Jong, BH; Shyu, KG; Wei, CC, 2016)
"Hyponatremia is probably due to the antidiuretic properties of CBZ and OXC that are, at least partly, explained by stimulation of the vasopressin 2 receptor/aquaporin 2 pathway."( Berghuis, B; de Haan, GJ; Koeleman, BP; Lindhout, D; Sander, JW; van den Broek, MP, 2016)
"Hyponatremia is a well-known sequela of community-acquired pneumonia (CAP)."( Ben-Tov, A; Birger, A; Danino, D; Grinspan, ZM; Hausman-Kedem, M; Limor, R; Reif, S; Yerushalmi-Feler, A, 2018)
"Hyponatremia is the most common electrolyte disorder in hospitalized patients, being associated with increased morbidity and mortality in different clinical conditions."( Badenes, D; Chalela, R; Chillarón, JJ; Gea, J; González-García, JG; Mojal, S; Montoya-Rangel, C; Valera-Hernández, L, 2016)
"All levels of hyponatremia are associated with all-cause mortality in primary care patients and hyponatremia is linked to an increased risk of being diagnosed with any cancer, particularly pulmonary and head and neck cancers."( Faber, J; Gislason, GH; Madsen, JC; Selmer, C; Torp-Pedersen, C, 2016)
"Hyponatremia is one of the common electrolyte disorders associated with cisplatin (CDDP) administration."( Hattori, Y; Kawahara, T; Kondo, T; Kumano, Y; Maeda, Y; Miyoshi, Y; Mochizuki, T; Ohtaka, M; Teranishi, J; Uemura, H; Yumura, Y, 2016)
"Hyponatremia is common in patients with subarachnoid hemorrhage, but its effect on outcomes remains contentious."( Bales, J; Cho, S; Joffe, AM; Khandelwal, N; Korab, GA; Spiekerman, CF; Tran, TK, 2016)
"Classically, hyponatremia is associated with increased fluid volume in heart failure and is often a result of neuroendocrine dysfunction and poor cardiac output."( Bhat, G; Tatooles, A; Yost, G, 2018)
"Hyponatremia is a common electrolyte disorder that arises from disturbances in water metabolism."( Gross, P; Pusl, T, 2016)
"Background Hyponatremia is the most common electrolyte abnormality encountered in cirrhotic patients."( Bel Hadj, N; Ben Nejma, H; Bougassas, W; Cheikh, M; El Elj, R; Ennaifer, R; Romdhane, H, 2016)
"Hyponatremia is the commonest electrolyte disorder encountered in clinical practice."( Gankam Kengne, F, 2016)
"Hyponatremia is an ominous laboratory sign in the setting of neoplasia."( Janczar, S; Mlynarski, W; Zalewska-Szewczyk, B, 2017)
"Hyponatremia is one of the most common electrolyte disorders encountered in the elderly."( Hataya, Y; Komatsu, Y; Oba, A; Yamashita, T, 2017)
"Hyponatremia is a common electrolyte disorder and is associated with mortality."( Golestaneh, L; Kargoli, F; Neugarten, J; Raff, A; Southern, W, 2017)
"Chronic hyponatremia is caused by relative excess of free water, it occurs within a broad spectrum of diseases associated with hypervolemia (heart failure, liver cirrhosis), normovolemia and hypovolemia and it is a negative prognostic factor for patients with chronic heart failure and cirrhotic ascites."( Tesař, V, 2016)
"Hyponatremia is a common water balance disorder that often poses a diagnostic or therapeutic challenge."( Hoorn, EJ; Zietse, R, 2017)
"Hyponatremia is a common complication in neonatal polycystic kidney disease and is thought to be due to water retention."( Bockenhauer, D, 2017)
"Hyponatremia is a common electrolyte disorder in cancer patients and has been associated with poor prognosis."( Ahmad, F; Blais, JD; Chiodo, J; Czerwiec, FS; Glaser, LA; Gralla, RJ; Zhou, W, 2017)
"Hyponatremia is the most common electrolyte imbalance encountered in clinical practice, associated with increased mortality and length of hospital stay."( Ahn, S; Baek, SH; Chin, HJ; Jo, YH; Kim, K; Kim, S; Lee, A; Lee, H; Lee, JB; Na, KY; Oh, YK; Shin, J, 2017)
"Hyponatremia is a frequent and potentially life-threatening adverse side effect of thiazide diuretics."( Becker, I; Burst, V; Greenberg, A; Grundmann, F; Kubacki, T; Rudolf, D; Verbalis, J, 2017)
"Hyponatremia is prevalent in HF patients and has been suggested as a contributor to poor response to standard therapy."( Gustafsson, F; Vishram-Nielsen, JK, 2017)
"Hyponatremia is defined as a plasma sodium concentration less than 135 or 130 mEq/L (or mmol/L) and may be responsible for life threatening symptoms that can be observed in a variety of medical conditions."( Bou Abdallah, F; Capron, A; Palmiere, C; Scarpelli, MP; Schmit, G; Vanhaebost, J, 2018)
"Hyponatremia is the most common electrolyte disorder among hospitalized patients and it is sometimes considered as a poor outcome predictor."( De Sanctis, L; Einaudi, S; Matarazzo, P; Tessaris, D; Tuli, G, 2017)
"Hyponatremia is a common problem in people taking CBZ or OXC."( Berghuis, B; de Haan, GJ; Koeleman, BPC; Lindhout, D; Sander, JW; van der Palen, J, 2017)
"Etiologies of hyponatremia are classified into four categories."( Braun, MM; Mahowald, M, 2017)
"Hyponatremia is the most common electrolyte abnormality seen in hospitalized patients, with up to 30 % having a plasma sodium concentration below 135 mmol/l."( Arlt, A; Mönig, H, 2017)
"Hyponatremia is associated with bone demineralization."( El Alaoui, M; Grellier, J; Jaafar, A; Lebely, C; Martin, A; Tack, I; Vallet, M, 2017)
"Hyponatremia is the most common electrolyte disorder in clinical practice and associated with increased morbidity and mortality, independent of underlying disease."( Fenske, W, 2017)
"Objective Hyponatremia is frequently observed in patients with decompensated liver cirrhosis and it is also related to a poor prognosis."( Hashimoto, E; Ikarashi, Y; Kobayashi, M; Kodama, K; Kogiso, T; Taniai, M; Tokushige, K; Torii, N; Yamamoto, K, 2017)
"Hyponatremia is one of the most frequently encountered electrolyte disorder in small cell lung cancer (SCLC) patients."( Gong, WJ; Li, H; Liu, A; Liu, JN; Liu, Y; Sun, NH; Sun, P; Wang, SH, 2017)
"Thus, when hyponatremia is observed in patients with CSWS, they may be misdiagnosed as having the syndrome of inappropriate secretion of antidiuretic hormone (SIADH)."( Arieff, AI; Gabbai, R; Goldfine, ID, 2017)
"Hyponatremia is the most common electrolyte disorder, and is associated with high-morbimortality rates."( Calle-Pascual, A; Cuesta, M; De Luis, D; Fernández-Peña, S; Gómez-Hoyos, E; Matía, P; Ortolá, A; Pérez-Ferre, N; Rubio, MÁ; Runkle-De la Vega, I, 2018)
"Hyponatremia is the most common electrolyte disorder in hospitals."( Abudureyimu, A; Chen, J; Ma, J; Qian, Q; Shu, Z; Tian, Z; Zhuo, L, 2018)
"Hyponatremia is associated with the increased risk of early and late mortality in patients with cardiac disease."( Araki, M; Hayashida, K; Kagase, A; Kano, S; Kodama, A; Koyama, Y; Naganuma, T; Shimura, T; Shirai, S; Tada, N; Watanabe, Y; Yamamoto, M; Yamanaka, F, 2018)
"Objective Admission hyponatremia is related to poor outcomes in patients with heart failure (HF)."( Arévalo-Lorido, JC; Brasé, A; Chivite, D; Corbella, X; Formiga, F; Moreno-Gonzalez, R; Petit, I, 2018)
"Hyponatremia is a common electrolyte disorder and a prognostic marker for mortality."( Golestaneh, L; Kaskel, F; McGinn, AP; Neugarten, J, 2018)
"Hyponatremia is common in cancer patients and has a negative impact on outcomes and survival."( Antonuzzo, A; Berardi, R; Blasi, L; Buosi, R; Lorusso, V; Migliorino, MR; Montesarchio, V; Peri, A; Sabbatini, R; Zilembo, N, 2018)
"Hyponatremia is the most common electrolyte disorder."( Ioannou, P; Mavrikaki, V; Panagiotakis, S; Papakitsou, I; Stavroulaki, M, 2018)
"Hyponatremia is the most common electrolyte disorder among hospitalized patients."( Al Mawed, S; Chong, K; Pankratz, VS; Roumelioti, ME; Sandoval, M; Unruh, M, 2018)
"Hyponatremia is common among hospitalized patients and is significantly associated with in-hospital mortality, discharge to hospice or to a nursing facility."( Al Mawed, S; Chong, K; Pankratz, VS; Roumelioti, ME; Sandoval, M; Unruh, M, 2018)
"Objective Hyponatremia is closely associated with the pathophysiology of cirrhosis."( Abe, K; Fujita, M; Hayashi, M; Ohira, H; Okai, K; Takahashi, A, 2018)
"Hyponatremia is a common feature of acute illness and associated with increased mortality."( Amin, A; Amin, D; Baumgartner, A; Bernard, M; Christ-Crain, M; Eckart, A; Haubitz, S; Hausfater, P; Huber, A; Kutz, A; Mueller, B; Schuetz, P; Struja, T, 2018)
"Hyponatremia is associated with poor outcomes in cirrhosis independent of MELD."( Bajaj, JS; Biggins, SW; Fallon, M; Garcia-Tsao, G; Kamath, PS; Lai, JC; Maliakkal, B; OʼLeary, JG; Reddy, RK; Subramanian, RM; Tandon, P; Thacker, LR; Thuluvath, P; Vargas, HE; Wong, F, 2018)
"Hyponatremia is common among elderly patients."( Kochi, M; Kohagura, K; Naka, T; Ohya, Y, 2018)
"Hyponatremia is common and is a predictor of mortality in the near future among very elderly residents of a geriatric facility."( Kochi, M; Kohagura, K; Naka, T; Ohya, Y, 2018)
"Severe hyponatremia is rare when carbamazepine is used as monotherapy."( Palacios Argueta, PJ; Pineda, A; Sánchez Rosenberg, GF, 2018)
"Hyponatremia is the most common electrolyte abnormality found in hospitalized patients with acute heart failure (AHF) and is related to poor prognosis."( Nuti, R; Palazzuoli, A; Ruocco, G; Verbrugge, FH, 2018)
"The approach to hyponatremia is in a state of flux, especially in differentiating syndrome of inappropriate antidiuretic hormone secretion (SIADH) from cerebral-renal salt wasting (RSW) because of diametrically opposite therapeutic goals."( Imbriano, LJ; Maesaka, JK; Miyawaki, N, 2018)
"DISCUSSION Hyponatremia is not uncommon among community-living older patients, especially in patients taking medications potentially causing hyponatremia."( D'Ambrosio, G; Grattagliano, I; Mastronuzzi, T, 2018)
"Treatment of hyponatremia is highly challenging."( Cárdenas, A; Leise, M, 2018)
"Hyponatremia is a common adverse effect induced by cisplatin."( Fukuda, K; Kawakubo, H; Kitagawa, Y; Nakamura, R; Shimada, A; Suda, K; Takeuchi, H; Wada, N, 2018)
"Hyponatremia is classified as a serum sodium concentration of <135 mEq/L, and the prevalence, clinical impact and prognostic factor of hyponatremia in heart failure patients varies widely."( Abebe, TB; Abegaz, TM; Belachew, SA; Bhagavathula, AS; Erku, DA; Gebresillassie, BM; Gebreyohannes, EA; Tefera, YG, 2018)
"In conclusion, hyponatremia is one of the crucial factors in the clinical prognosis of heart failure patients."( Abebe, TB; Abegaz, TM; Belachew, SA; Bhagavathula, AS; Erku, DA; Gebresillassie, BM; Gebreyohannes, EA; Tefera, YG, 2018)
"Hyponatremia is the most common electrolyte disturbance in hospitalized patients."( Bernasconi, L; Christ-Crain, M; Mueller, B; Nigro, N; Sailer, CO; Winzeler, B, 2019)
"Hyponatremia is defined as serum sodium level <135 meq/L."( Moulick, ND; Pillai, KS; Trivedi, TH, 2018)
"Hyponatremia is associated with development of hepatic encephalopathy (HE), but the nature of the relationship between serum sodium and HE incidence is unknown."( Bossen, L; Ginès, P; Jepsen, P; Vilstrup, H; Watson, H, 2019)
"Presenting hyponatremia is highly efficient in differentiating hypertriglyceridemia from other etiologies of AP."( Abu Omar, Y; Agrawal, R; Attar, BM; Demetria, MV; Wang, Y, 2019)
"Hyponatremia is the most frequent electrolyte disorder in hospitalised patients."( Peri, A, 2019)
"Acquired hyponatremia is a life threatening event."( Bignoumba, PI; Boguikouma, JB; Dibambou, N; Iba-Ba, J; Kombila, JM; Kombila, UD; Mackanga, JR; Missounga, L; Mouloungui, EM; Moussavou, IM, 2019)
"Hypernatremia and hyponatremia are associated with worse outcomes and longer intensive care stays."( Anstey, JR; Harrois, A, 2019)
"Hyponatremia is defined as a serum sodium level of less than 135 mEq/L in a patient."( Bopeththa, BVKM; Medagedara, C; Niyaz, SMM, 2019)
"Acute hyponatremia is a medical emergency that confers high mortality, attributed primarily to cerebral edema."( Cuesta, M; Dineen, R; Garrahy, A; Hannon, AM; Sherlock, M; Thompson, CJ; Tormey, W, 2019)
"This hyponatremia is saline-responsive, but relapse can be frequently observed."( Decaux, G; Musch, W, 2019)
"Hyponatremia is the most common electrolyte disorder in the clinic practice and it is closely related to the prognosis of various diseases."( Chen, Z; Jia, Q; Liu, C, 2019)
"Hyponatremia is occasionally unmasked in psychiatric patients during hospitalization after routine blood and urinary tests, and correlates in most cases with an inappropriate secretion of antidiuretic hormone, mainly due to iatrogenic factors."( Catapano, F; Fabrazzo, M; Fuschillo, A; Perris, F, 2019)
"Hyponatremia is the most frequent electrolyte disorder found in clinical practice, particularly in hospitalized elderly patients, where it is associated with fractures, falls, hospital readmission, prolonged hospital stay and increased mortality."( Beker, BM; Bertini, V; Musso, CG; Nicoletti, C, 2019)
"Hyponatremia is a frequent feature seen in adrenal crisis; however, TTS cases preceded by low serum sodium associated with other diseases are also reported."( Elikowski, W; Greberska, W; Korol, L; Marchlewska, J; Małek-Elikowska, M; Słomczyński, M, 2019)
"Hyponatremia is seen commonly in patients with cancer and is associated with increased mortality and morbidity."( Kitchlu, A; Rosner, MH, 2019)
"In conclusion, hyponatremia is common at presentation among previously healthy infants with gastroenteritis, bronchiolitis or pyelonephritis."( Agostoni, C; Alberzoni, M; Bernardi, S; Bianchetti, MG; D'Angelo, EA; Fossali, EF; Mazzoni, MB; Milani, GP; Odone, L; Rocchi, A, 2019)
"Hyponatremia is a commonly encountered electrolyte disturbance seen in diverse clinical settings."( Balan, S; Murlidharan, P; N, AK; Patil, S; Pisharody, R, 2019)
"Hyponatremia is a commonly overlooked important extrapulmonary manifestation of bronchiolitis."( Mutanabbi, M; Shova, SS, 2019)
"Hyponatremia is also associated with increased risk of death if present during specific disease states in dogs."( Burton, AG; Hopper, K, 2019)
"Hyponatremia is the most common electrolyte disturbance amongst hospitalized patients."( van Walraven, C; Woodfine, JD, 2020)
"Hyponatremia is an independent prognostic factor of mortality in people with IS (p = 0."( Bartosik-Psujek, H; Braun, M; Czarnota, J; Gala-Błądzińska, A; Gargasz, K; Kaczorowski, R, 2019)
"Hyponatremia is more frequently observed in patients with HS than IS."( Bartosik-Psujek, H; Braun, M; Czarnota, J; Gala-Błądzińska, A; Gargasz, K; Kaczorowski, R, 2019)
"Hyponatremia is the most common electrolyte abnormality observed in clinical practice."( Ben-Zvi, E; Benchetrit, S; Cohen-Hagai, K; Eitan, M; Gur, E; Kitay-Cohen, Y; Pereg, D; Topaz, G, 2020)
"Hyponatremia is associated with higher mortality and ACS risk among patients with chest pain who were discharged from internal medicine wards following ACS-rule-out."( Ben-Zvi, E; Benchetrit, S; Cohen-Hagai, K; Eitan, M; Gur, E; Kitay-Cohen, Y; Pereg, D; Topaz, G, 2020)
"Hyponatremia is common in patients who received CD19+ CAR T-cells."( Brentjens, RJ; Buie, LW; Daley, RJ; Dixon, BN; Hsu, M; Latcha, S; Park, JH; Purdon, TJ, 2020)
"Hyponatremia is a common laboratory finding in premature and ill neonates."( de Bruin, C; Steggerda, SJ; van der Lee, D; Vlaardingerbroek, H, 2020)
"Hyponatremia is the most common electrolyte disorder encountered clinically."( Rondon-Berrios, H, 2020)
"Hyponatremia is not rare in cystic fibrosis and might be due to several mechanisms."( Kuznetsova, AA; Lava, SAG; Marina, AS; Milani, GP; Natochin, YV; Prokopenko, AV, 2020)
"The topic of hyponatremia is in a state of flux."( Imbriano, LJ; Maesaka, JK; Miyawaki, N, 2020)
"Hyponatremia is the most commonly observed electrolyte disturbance in clinical medicine."( de Leeuw, DC; Kooter, AJ, 2020)
"Hyponatremia is the most common electrolyte disorder in hospitalized patients with pneumonia."( Blum, CA; Cesana-Nigro, N; Christ-Crain, M; Mueller, B; Potasso, L; Sailer, CO; Schuetz, P, 2020)
"Hyponatremia is a frequent complication in patients with advanced cirrhosis."( Ginès, P; Solà, E, 2019)
"The etiology of hyponatremia is often multifactorial."( Greenberg, A; Lehrich, RW; Mohottige, D, 2019)
"Hyponatremia is a common complication after aneurysmal subarachnoid hemorrhage (aSAH)."( Bershad, E; Damani, R; Escamilla-Ocañas, CE; Venkatasubba Rao, CP, 2020)
"Hyponatremia is a common electrolyte disorder observed in a wide variety of malignancies and is associated with substantial morbidity and mortality."( Jhaveri, KD; Rondon-Berrios, H; Workeneh, BT, 2020)
"Hyponatremia is associated with poorer outcomes and diuretic response in patients hospitalized for heart failure."( Elkayam, U; Fong, MW; Grazette, LP; Han, EE; Kuo, A; Lou, M; Mehra, A; Ng, TMH; Upadhyay, RY; Yoon, AJ, 2020)
"Hyponatremia is the most common electrolyte disorder."( Logtenberg, SJJ; Tobé, TJM; van der Zalm, IJB, 2020)
"Hyponatremia is worrisome and awareness of medication-induced hyponatremia, especially due to proton pump inhibitors, is needed."( Logtenberg, SJJ; Tobé, TJM; van der Zalm, IJB, 2020)
"Hyponatremia is one of the most common water-electrolyte imbalances in the human organism."( Krajewska, M; Królicka, AL; Kruczkowska, A; Kusztal, MA, 2020)
"Hyponatremia is a rare medication adverse effect that should be kept in mind when treating these patients with either of these medications, and should especially be considered when combining them."( Azhar Munir, R; Chiu, CY; Khalid, A; Khanna, R; Sarwal, A; Widjaja, M, 2020)
"Hyponatremia is a common electrolyte disorder in patients with stroke, which leads to various fatal complications."( Inoue, T; Moteki, Y; Niimi, Y; Okada, Y; Sato, S; Shima, S; Takahashi, O, 2020)
"Hyponatremia is frequently seen in patients with ascites secondary to advanced cirrhosis and portal hypertension."( Alukal, JJ; John, S; Thuluvath, PJ, 2020)
"Drug-induced hyponatremia is common, with medications from many drug-classes implicated."( Calissendorff, J; Falhammar, H; Lindh, JD; Mannheimer, B; Skov, J, 2021)
"Hyponatremia is a common adverse effect of high-dose and moderate-dose of intravenous CY, but is rare in patients treated with low-dose (<15 mg/kg)."( Chen, J; Jin, Y; Li, C; Li, Z, 2020)
"Hyponatremia is common in cancer patients receiving ICIs."( Chute, DF; Faje, AT; Jhaveri, KD; Lee, M; Reynolds, KL; Rusibamayila, N; Seethapathy, H; Sise, ME; Strohbehn, I; Zubiri, L, 2021)
"Hyponatremia is a state of an osmole-free water excess compared to the amounts of solutes and clinical management of hyponatremic patients requires pathophysiology-oriented approaches to select appropriate treatments."( Kettritz, R, 2021)
"Hyponatremia is the most common electrolyte disorder in hospitalized patients and occurs in about 30% of patients with pneumonia."( Bartoloni, A; Berni, A; Corona, G; Fanelli, A; Fibbi, B; Lavorini, F; Maggi, M; Malandrino, D; Nozzoli, C; Parenti, G; Peri, A; Peris, A; Pieralli, F; Pini, R; Poggesi, L; Scocchera, G; Ungar, A, 2021)
"Hyponatremia is frequent in cancer patients, as many studies carried out in these patients have shown."( Araújo, V; Arede, A; Brandão, M; Costa, I; Ferraz Gonçalves, J; Freitas, S; Grilo, I; Martins, O; Prucha, B, 2022)
"Hyponatremia is common in cancer patients receiving palliative care but did not seem to influence survival."( Araújo, V; Arede, A; Brandão, M; Costa, I; Ferraz Gonçalves, J; Freitas, S; Grilo, I; Martins, O; Prucha, B, 2022)
"Hyponatremia is a prognostic marker for specific pathologies."( Akyuz, O; Celik, M; Gucun, M; Guner, A; Kahyaoglu, M; Yilmaz, Y, 2022)
"Hyponatremia is a common hydroelectrolytic disorder in pediatric patients with advanced cirrhosis."( Imbett-Yepez, S; Peña-Vélez, R; Ramírez-Mayans, J; Zárate-Mondragón, F, 2021)
"Hyponatremia is a common electrolyte disorder in patients with end-stage liver disease (ESLD) and is associated with increased mortality on the liver transplantation (LT) waiting list."( Bezinover, D; Saner, FH; Verbeek, TA, 2022)
"Hyponatremia is a common complication of diabetes."( Huang, L; Li, C; Shen, X; Wu, C; Yan, S; Zhang, Y; Zhao, F, 2021)
"Admission hyponatremia is associated with worse clinical outcome in stroke patients, but whether normalization of hyponatremia improves outcome is unknown."( Bonati, LH; Christ-Crain, M; De Marchis, GM; Dittrich, T; Gensicke, H; Polymeris, AA; Potasso, L; Refardt, J; Wagner, B; Wiencierz, A; Wright, PR, 2022)
"Hyponatremia is usually seen with sodium phosphate based solutions and is rare with polyethylene glycol."( Acharya, SP; Acharya, U; Karki, B; Pathak, R; Sunder Shrestha, P, 2020)
"Hyponatremia is associated with an increased risk of bone fragility and fractures."( Christ-Crain, M; Meier, C; Potasso, L; Refardt, J, 2021)
"Hyponatremia is a common condition of varying etiology among hospitalized patients and is associated with adverse outcomes."( Estilo, A; McCormick, L; Rahman, M, 2021)
"Hyponatremia is a discriminating predictor of complicated appendicitis in a paediatric population."( Lala, S; Upadhyay, V; Walsh, A; Wells, C, 2022)
"Hyponatremia is an independent prognostic factor for mortality; however, the reason for this remains unclear."( Ayus, JC; Formeck, CL; Joyce, EL; Kellum, JA; Moritz, ML; Siripong, N, 2022)
"Hyponatremia is known to be associated with adverse outcome in community-acquired pneumonia (CAP) and acute exacerbation of chronic obstructive pulmonary disease (AECOPD)."( Exadaktylos, AK; Funk, GC; Gygli, R; Herschmann, S; Lindner, G; Ravioli, S, 2022)
"TMP/SMX-induced hyponatremia is a rare and serious adverse reaction."( Fan, Z; He, Y; Lei, H; Li, Z; Liu, X; Wang, C; Zeng, J, 2022)
"Predialytic hyponatremia is associated with poor outcome in hemodialysis patients."( Canaud, B; Harlos, J; Maierhofer, A, 2023)
"Hyponatremia is defined as serum sodium concentration less than 135meq/l."( Bhushan, D; Roy, R, 2022)
"Symptomatology of hyponatremia is subtle and is often interpreted as age-related in the geriatric patients."( Dhar, M; Kapoor, M; Pathania, M, 2022)
"Hyponatremia is common and prognostically important in hospitalized patients with heart failure with reduced ejection fraction, but its prevalence and importance in ambulatory patients are uncertain."( Bengtsson, O; Boulton, DW; Docherty, KF; Greasley, PJ; Inzucchi, SE; Jhund, PS; Kosiborod, MN; Køber, L; Langkilde, AM; Martinez, FA; McMurray, JJV; Petrie, MC; Ponikowski, P; Sabatine, MS; Sjöstrand, M; Solomon, SD; Yeoh, SE, 2022)
"Hyponatremia is a new marker of perforated appendicitis and therefore, serum sodium level measurement should be considered in patients with a clinical presentation consistent with appendicitis if complications are suspected."( Buluş, H; Öztürk, B; Öztürk, D; Turhan, VB; Ünsal, A, 2022)
"Hyponatremia is a well-established marker of adverse outcomes in chronic heart failure (HF) but not well studied in patients with left ventricular assist device (LVAD)."( Desai, S; Duran, A; Eiswirth, C; Krim, SR; Shariati, F; Sleem, A; Tutor, A; Ventura, HO; Wever-Pinzon, J, 2023)
"Hyponatremia is regarded as the most common electrolyte imbalance among hospitalised patients."( Ekpe, L; Emin, E; Kingsley, O; Lawrence, O, 2022)
"Hyponatremia is a water-electrolyte balance disorder diagnosed in about 30% of patients after subarachnoid hemorrhage (SAH)."( Aleksandrowicz, M; Kozniewska, E, 2022)
"Hyponatremia is the most frequent electrolytic disorder in hospitalized patients, and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH), the most frequent cause of hiponatremia with clinically normal extracellular volume."( Molina, A; Piñeiro, G; Poch, E, 2022)
"Hyponatremia is a common disorder most often related to free water excess relying on overstimulated or inappropriate AVP secretion."( Arnoux, G; Feraille, E; Martin, PY; Olivier, V; Sassi, A, 2022)
"Hyponatremia is a noted adverse event, but incidence and risk factors remain undefined."( Bradford, CV; Johnson, PN; Miller, JL; Neely, SB; Ranallo, CD, 2023)
"Hyponatremia is a common electrolyte abnormality that has been associated with poor outcomes in several conditions including acute myocardial infarction (AMI)."( Angeloni, N; Bhuta, K; Chaudhuri, D; Cordova Sanchez, A; Murphy, R; Shmorgon, G, 2022)
"As chronic hyponatremia is frequently associated with cirrhosis, patients undergoing liver transplantation are at an increased risk for developing this condition."( Caja, GON; Couto, CF; Ferreira, CA; Ferreira, GSA; Figueira, AVF; Moreira, ML; Murta, MCB; Trevizoli, NC; Watanabe, ALC, 2022)
"Hyponatremia is the most common electrolyte disorder in COVID 19 infection."( Alagöz, G; Çakır, B; Özkan Aksoy, N; Özmen, S, 2023)
"Hyponatremia is a common disorder in childhood."( Agostoni, C; Bianchetti, MG; Cantoni, B; Corsello, A; Faré, PB; Malandrini, S; Meani, F; Milani, GP, 2022)
"Hyponatremia is the most common electrolyte disorder and it affects approximately 5% of adults and 35% of hospitalized patients."( Adrogué, HJ; Madias, NE; Tucker, BM, 2022)
"Mild chronic hyponatremia is associated with cognitive impairment, gait disturbances, and increased rates of falls and fractures."( Adrogué, HJ; Madias, NE; Tucker, BM, 2022)
"Hyponatremia is one of the most common electrolyte abnormalities."( Imai, N; Shibagaki, Y; Sumi, H, 2022)
"Hyponatremia is common in horses with bacterial pleuropneumonia, but no further characterization of this abnormality has been reported."( Austin, S; Barger, A; Foreman, JH; Migliorisi, A; Wilkins, P, 2022)
"Hyponatremia is the most common electrolyte disorder in lung cancer, and it particularly occurs in small cell lung cancer (SCLC) patients."( Erturk, K; Ozturk, A; Tas, F, 2023)
"Hyponatremia is a frequent condition in hospitalized patients and is associated with significant morbidity and mortality."( Grosjean, A; Marti, C; Thieffry, C, 2022)
"Hyponatremia is the most prevalent electrolyte disorder in the outpatient and inpatient settings."( Barajas Galindo, DE; de la Vega, IR; Fernández Martínez, A; Ferrer García, JC; Gómez Hoyos, E; Ortolá Buigues, A; Ropero-Luis, G; Ruiz-Sánchez, JG; Serrano Gotarredona, J, 2023)
"Hyponatremia is the most prevalent electrolyte disorder in the outpatient and inpatient settings."( Barajas Galindo, DE; de la Vega, IR; Fernández Martínez, A; Ferrer García, JC; Gómez Hoyos, E; Ortolá Buigues, A; Ropero-Luis, G; Ruiz-Sánchez, JG; Serrano Gotarredona, J, 2023)
"Hyponatremia is the most prevalent electrolyte disorder in the outpatient and inpatient settings."( Barajas Galindo, DE; de la Vega, IR; Fernández Martínez, A; Ferrer García, JC; Gómez Hoyos, E; Ortolá Buigues, A; Ropero-Luis, G; Ruiz-Sánchez, JG; Serrano Gotarredona, J, 2023)
"Hyponatremia is the most frequent electrolytic disorder in clinical practice."( Anceschi, C; Brogi, M; Fanelli, A; Fibbi, B; Lanzilao, L; Maggi, M; Marroncini, G; Naldi, L; Peri, A, 2023)
"Hyponatremia is the most frequent electrolytic disorder in clinical practice."( Anceschi, C; Brogi, M; Fanelli, A; Fibbi, B; Lanzilao, L; Maggi, M; Marroncini, G; Naldi, L; Peri, A, 2023)
"Hyponatremia is the most frequent electrolytic disorder in clinical practice."( Anceschi, C; Brogi, M; Fanelli, A; Fibbi, B; Lanzilao, L; Maggi, M; Marroncini, G; Naldi, L; Peri, A, 2023)
"Hyponatremia is a complication that has been reported in literature during bowel preparation."( Chang, CC; Chiang, TH; Fang, KC; Tan, JH, 2022)
"Hyponatremia is a complication that has been reported in literature during bowel preparation."( Chang, CC; Chiang, TH; Fang, KC; Tan, JH, 2022)
"Hyponatremia is the most frequent electrolyte disorder in hospitalized patients with increased mortality and morbidity."( Eckelt, F; Federbusch, M; Fenske, W; Fries, C; Isermann, B; Kaiser, T; Schmidt, M; Sicker, T, 2023)
"Correcting hyponatremia is also complicated, especially in the setting of chronic hyponatremia."( Borkan, SC; Kamel, MH; Upadhyay, A, 2023)
"Hyponatremia is one of the common electrolyte abnormalities in intensive care unit settings."( Gupta, SK; Parajuli, S; Shakya, YL; Shakya, YM; Tiwari, S, 2022)
"Hyponatremia is one of the most common problems encountered in clinical practice and one of the least-understood because accurate diagnosis and management require some familiarity with water homeostasis physiology, making the topic seemingly complex."( Christ-Crain, M; Meena, P; Rondon-Berrios, H; Workeneh, BT, 2023)
"Hyponatremia is the most common electrolyte disorder in clinical practice, which may lead to life-threatening complications."( Huang, Y; Luo, T; Tang, H; Xu, C; Yang, X; Zhang, P, 2023)
"Hyponatremia is associated with worse outcomes in patients with chronic heart failure (HF) and reduced ejection fraction (HFrEF)."( Deis, T; Gustafsson, F; Larsson, JE; Rask, KA; Rossing, K, 2023)
"Hyponatremia is a common electrolyte abnormality in arthroplasty patients."( Baker, CM; Goh, GS; Khan, IA; Parvizi, J; Sherman, MB; Tarabichi, S, 2023)
"Hyponatremia is a common electrolyte disorder in elderly critically ill patients, and it may be associated with poor outcomes, higher morbidity, and mortality."( Chen, J; Fan, S; Ma, J; Zheng, W, 2023)
"Hyponatremia is associated with increased risk for osteoporosis."( Christ-Crain, M; Meier, C; Monnerat, S; Potasso, L; Refardt, J, 2023)
"Hyponatremia is a common electrolyte disorder in patients with chronic kidney disease."( Fujii, M; Inaguma, D; Kato, J; Okamoto, N; Sasakawa, Y; Tatematsu, Y, 2023)
"Hyponatremia is primarily a water balance disorder associated with high morbidity and mortality."( Baek, SH; Kim, S; Ryu, JY, 2023)
"Mild hyponatremia is frequently encountered in the pediatric emergency department (PED)."( Amaddeo, A; Andrade, S; Barbi, E; Cozzi, G; Magni, E; Pintaldi, S; Pizzolon, C; Zago, A, 2023)
"Iatrogenic hyponatremia is a common complication following intravenous maintenance fluid therapy (IV-MFT) in hospitalized children."( Abdelaziz, A; Abdelwahab, OA; Albakri, K; Amer, BE; Amin, AM; Hamouda, N; Mohamed, MA; Soliman, Y; Zedan, EM, 2024)
"Hyponatremia is the most common electrolyte imbalance seen in clinical practice and a common laboratory findings in children with community acquired pneumonia."( Ahmed, E; Ahmed, F; Ali, MA; Amin, SE; Dhar, SK; Roy, AK; Sarker, MR; Yesmin, A, 2023)
"Hyponatremia is one of the most common electrolyte disorders in emergency departments and hospitalized patients."( Joannidis, M; Klein, SJ; Köglberger, P; Perschinka, F, 2023)
"To prove that hyponatremia is associated with LZD rather than infection, we compared the incidence and risk of developing hyponatremia between patients receiving LZD and those receiving vancomycin (VCM)."( Hashimoto, T; Hiramatsu, K; Itoh, H; Iwao, M; Morinaga, Y; Tanaka, R; Tatsuta, R, 2023)
"Hyponatremia is considered mild when the sodium concentration is 130 to 134 mEq per L, moderate when 125 to 129 mEq per L, and severe when less than 125 mEq per L."( Miller, NE; Rushlow, D; Stacey, SK, 2023)

Context

ExcerptReference
"Severe hyponatremia has been observed in three children with sickle cell disease, and mild hyponatremia was noted during 36% of random hospitalizations for sickle crisis secondary to vasoocclusion or infection."( Finberg, L; Kochen, JA; Radel, EG, 1976)
"Hyponatremia has been recognized in foals with renal failure, ruptured urinary bladder, and iatrogenic water overload."( Carlson, GP; Lakritz, J; Madigan, J, 1992)
"Hyponatremia has been recognized as a complication in adults with acquired immunodeficiency syndrome (AIDS)."( al-Mousily, F; Neiberger, R; Paryani, S; Sleasman, J; Tolaymat, A, 1995)
"Hyponatremia has been reported to occur in approximately 5% of carbamazepine-treated patients who otherwise do well on that agent."( Brewerton, TD; Jackson, CW, 1994)
"Hyponatremia has been reported in up to one third of patients with intracranial disease and has frequently been associated with tuberculous meningitis, often complicated by hydrocephalus."( Bhoola, KD; Buck, R; Gouws, E; Kemp, M; Narotam, PK; van Dellen, JR, 1994)
"Severe hyponatremia has been described after elective surgery with subsequent permanent brain damage."( Boehnert, M; Buchfelder, M; Fahlbusch, R; Gross, P; Henig, A; Hensen, J, 1998)
"Hyponatremia has been reported with selective serotonin-reuptake inhibitors (SSRIs)."( Karki, SD; Masood, GR; Patterson, WR, 1998)
"The hyponatremia has traditionally been attributed to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH); however, in our patients the treatment has been resuscitation with normal saline as opposed to fluid restriction (the accepted treatment of SIADH), thus placing the diagnosis of SIADH in question."( Bradley, JP; Levine, JP; McCarthy, JG; Stelnicki, E; Weiner, HL, 2001)
"Hyponatremia has been reported in adults treated with DDAVP for Von Willebrand's disease and hemophilia and in children treated for enuresis, but as yet few cases of hyponatremia developing in enuretic adults treated with DDAVP have been reported."( Klutke, C; Shindel, A; Tobin, G, 2002)
"Hyponatremia has been recognized as an important postoperative metabolic complication after central nervous system (CNS) operations in children."( Byeon, JH; Huh, EJ; Lee, SJ, 2004)
"Hyponatremia has emerged as an important cause of race-related death and life-threatening illness among marathon runners."( Almond, CS; Binstadt, BA; Duncan, CN; Fortescue, EB; Greenes, DS; Mannix, RC; Newburger, JW; Olson, DP; Salerno, AE; Shin, AY; Wypij, D, 2005)
"Transient hyponatremia has been attributed to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH), but the details of hyponatremia have not been clarified."( Hizuka, N; Hori, T; Kawamata, T; Sata, A; Takano, K, 2006)
"Mild hyponatremia has traditionally been considered benign, but it may be associated with gait and attention deficits and an increased risk of falls that may result in fracture."( Eustace, JA; Kinsella, S; Molloy, MG; Moran, S; Sullivan, MO, 2010)
"Because hyponatremia has not previously been associated with cocaine, we sought to uncover a plausible explanation that might be contributing to this new finding."( Friend, K; Milone, MC; Perrone, J, 2012)
"The causes of hyponatremia have to be carefully examined."( Hensen, J, 2012)
"In addition, hyponatremia has been associated with mortality in long-term hemodialysis patients without residual function in whom the underlying disease cannot be responsible for hyponatremia."( Hoorn, EJ; Zietse, R, 2013)
"Hyponatremia has long been associated with worsened clinical outcomes in patients with cirrhosis and those awaiting liver transplant."( Saab, S; Sharma, N; Yu, C, 2013)
"Hyponatremia has significant prognostic implications in patients with heart, failure."( Alirhayim, Z; Almahmoud, MF; Ambulgekar, N; El-Refai, M; Hassan, S; Khalid, F; Mittal, C; Qureshi, W; Shah, B; Tashman, R, 2013)
"Hyponatremia has a complex, non-linear relationship with brain Glx and mI, cognition and HRQOL."( Ahluwalia, V; Bajaj, JS; Bouneva, I; Fuchs, M; Gilles, H; Heuman, DM; Kraft, KA; Luketic, V; Puri, P; Sanyal, AJ; Sterling, RK; Stravitz, RT; Thacker, L; Wade, JB, 2013)
"Hyponatremia has been associated with poor survival in many solid tumors and more recently found to be of prognostic and predictive value in metastatic renal cell cancer (mRCC) patients treated with immunotherapy."( Agarwal, N; Choueiri, TK; Donskov, F; Heng, DY; Kollmannsberger, C; Lee, JL; Mackenzie, MJ; McDermott, DF; North, SA; Pal, SK; Rha, SY; Rini, BI; Schutz, FA; Sircar, M; Srinivas, S; Tan, MH; Vaishampayan, U; Wood, LA; Xie, W; Yuasa, T, 2014)
"The presence of hyponatremia has been perceived to increase the risk of adverse events on initiation of treatment with angiotensin-converting enzyme inhibition in heart failure patients."( Balling, L; Gustafsson, F; Kober, L; Schou, M; Torp-Pedersen, C, 2013)
"In particular, hyponatremia has been shown to increase gait instability, falls, and fracture risk."( Hannon, MJ; Verbalis, JG, 2014)
"Hyponatremia has been reported from patients with severe neurological disease, and the syndrome of inappropriate secretion of antidiuretic hormone and cerebral salt wasting syndrome are the two main etiologies of hyponatremia after brain injury."( Bae, JH; Kim, DH; Kim, JM; Kwon, OS; Park, KY; Shin, DW; Youn, YC, 2014)
"Hyponatremia has complex pathophysiology, is frequent and has potentially severe clinical manifestations, and its treatment is associated with high risks."( Agaba, EI; Rondon-Berrios, H; Tzamaloukas, AH, 2014)
"The management of hyponatremia has evolved in recent years, particularly with the introduction of tolvaptan for hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH)."( Aylwin, S; Burst, V; Peri, A; Runkle, I; Thatcher, N, 2015)
"Hyponatremia has been associated with an increased mortality risk in the general population."( Bakker, SJ; Bilo, HJ; Groenier, KH; Kema, IP; Kleefstra, N; Kootstra-Ros, JE; Landman, GW; Logtenberg, SJ; Navis, G; Riphagen, IJ; Struck, J; van Hateren, KJ, 2015)
"Hyponatremia has been identified as a relevant factor for cognitive impairment but has not been investigated in patients receiving peritoneal dialysis (PD)."( Dong, J; Duan, LP; Hao, L; Liao, JL; Liu, GL; Pi, HC; Ren, YP; Wang, Q; Xiong, ZY; Xu, R; Zheng, ZX, 2015)
"Hyponatremia has been shown to be a prognostic factor in heart failure (HF) with preserved ejection fraction (HFpEF)."( Akiyama, E; Fujisue, K; Hirata, Y; Jinnouchi, H; Kurokawa, H; Kusaka, H; Maeda, H; Matsubara, J; Matsui, K; Matsuzawa, Y; Ogawa, H; Sugamura, K; Sugiyama, S; Yamamoto, E, 2016)
"Background Hyponatremia has been known as an important predictor of clinical outcomes in patients with heart failure (HF)."( Ball, PA; Morrissey, H; Saepudin, S, 2016)
"Hyponatremia has been associated with increased all-cause mortality in hospitalized individuals."( Faber, J; Gislason, GH; Madsen, JC; Selmer, C; Torp-Pedersen, C, 2016)
"Once the type of hyponatremia has been diagnosed, the next step is to decide which of the known etiologies of hyponatremia applies."( Gross, P; Pusl, T, 2016)
"Cases of fatal hyponatremia have been reported in both clinical and forensic literature in situations of water intoxication due to psychogenic polydipsia, amphetamine derivative drug intake, high-endurance exercise, iatrogenic causes, and exceptional cases of child abuse by forced water intoxication."( Bou Abdallah, F; Capron, A; Palmiere, C; Scarpelli, MP; Schmit, G; Vanhaebost, J, 2018)
"Moreover, hyponatremia has been demonstrated to be an indicator of poor prognosis in a variety of conditions."( Arlt, A; Mönig, H, 2017)
"Chronic mild hyponatremia has been associated with bone demineralization of unknown mechanisms."( El Alaoui, M; Grellier, J; Jaafar, A; Lebely, C; Martin, A; Tack, I; Vallet, M, 2017)
"Hyponatremia has been shown to have a predictive and negative prognostic indication in multiple cancer types, but the role of glioblastoma patients' serum sodium at the time of diagnosis in predicting glioblastoma patient survival has not been determined."( Bourcier, AJ; Langan, ST; Liao, J; Mrowczynski, OD; Rizk, EB; Specht, CS, 2018)
"Hyponatremia has been shown to worsen the outcome in acute-on-chronic liver failure patients thus validating findings in animal models."( Hamdi, T, 2018)
"Chronic hyponatremia has been associated with both neurologic deficits and increased risk of gait abnormalities leading to falls and resultant bone fractures."( Adams, AL; Bhandari, S; Jacobsen, SJ; Kalantar-Zadeh, K; Kamat, S; Krasa, H; Li, BH; Rhee, CM; Sim, JJ; Sundar, S, 2019)
"Hyponatremia has been identified as a predictor of necrotizing soft tissue infections and gangrenous cholecystitis."( Kaji, A; Keeley, JA; Kim, DY; Neville, A; Putnam, B, 2019)
"The presence of hyponatremia has been independently associated with worse outcomes in this patient population."( Davila, CD; Udelson, JE, 2019)
"Hyponatremia has been associated with a worse outcome in several pathologic conditions The main objective of this study was to determine whether serum sodium alterations may be independent predictors of the outcome of hospitalized COVID-19 patients."( Bartoloni, A; Berni, A; Corona, G; Fanelli, A; Fibbi, B; Lavorini, F; Maggi, M; Malandrino, D; Nozzoli, C; Parenti, G; Peri, A; Peris, A; Pieralli, F; Pini, R; Poggesi, L; Scocchera, G; Ungar, A, 2021)
"Chronic hyponatremia has been reported to be associated with low solute intake and low creatinine excretion (reflecting likely sarcopenia)."( Decaux, G, 2022)
"Hyponatremia has been associated with an increased risk of mortality."( Bhasin-Chhabra, B; Koratala, A; Veitla, V; Weinberg, S, 2022)
"Acute hyponatremia has an onset within 48 hours, commonly resulting in severe symptoms, while chronic hyponatremia develops over 48 hours and usually is pauci-symptomatic."( Christ-Crain, M; Meena, P; Rondon-Berrios, H; Workeneh, BT, 2023)

Actions

ExcerptReference
"However, whether hyponatremia affects the short-term mortality in chronic peritoneal dialysis (CPD) patients remains unclear."( Chen, CY; Chen, KH; Hung, CC; Lee, CC; Weng, CM, 2014)
"Hyponatremia affects approximately 5% of adults and 35% of patients who are hospitalized."( Adrogué, HJ; Madias, NE; Tucker, BM, 2022)

Treatment

ExcerptReference
"The main goals of treatment in hyponatremia are to manage the underlying disease and, if necessary, to increase serum sodium concentration and plasma osmolality."( DiBartola, SP, 1989)
"Special treatment for hyponatremia was not given in 30 of the 58 cases (control group)."( Morinaga, K; Ohkawara, S; Tabuse, H, 1989)
"Reported successes in the treatment of hyponatremia due to SIADH by administration of urea and normal saline led to the authors' routine use of this therapy for hyponatremic neurosurgical patients."( Harbaugh, RE; Reeder, RF, 1989)
"The pathophysiology, diagnosis, and treatment of hyponatremia are discussed."( Cadnapaphornchai, P; Rossi, NF, 1987)
"Demeclocycline has been used in the treatment of hyponatremia of various etiologies including one case of carbamazepine-induced hyponatremia."( Brewerton, TD; Jackson, CW, 1994)
"The current treatment of hyponatremia is unsatisfactory and can be associated with significant morbidity."( Kitiyakara, C; Wilcox, CS, 1997)
"We report a case of successfully treated hyponatremia using continuous venovenous hemodialysis with a specially prepared dialysate containing a lower than usual sodium concentration."( Bender, FH, 1998)
"The traditional treatment for hyponatremia used to be water restriction."( Gross, P; Palm, C; Reimann, D, 2000)
"Inadequate treatment of severe hyponatremia (< 120 mEq/l) can be associated with severe neurological damage."( Decaux, G, 2001)
"Inadequate treatment of severe hyponatremia (<120 mEq/L) can be associated with severe neurological damage."( Decaux, G; Soupart, A, 2003)
"A major new approach to treatment of hyponatremia is the development of aquaretics: AVP-receptor antagonists that provide a targeted therapeutic approach to correcting the many kinds of hyponatremia caused by excess AVP levels."( Miller, M, 2006)
"The optimal treatment of hyponatremia is controversial, but appropriate treatment must be determined according to the osmolality and volume status of the patient."( Diringer, MN; Zazulia, AR, 2006)
"More efficient and specific treatments of hyponatremia are needed."( Gross, P; Herbrig, K; Palm, C; Pistrosch, F, 2006)
"Conventional treatments for hyponatremia (e."( McFarlane, S; Rai, A; Sowers, JR; Whaley-Connell, A, 2006)
"Many current treatments for hyponatremia are limited by poor compliance, inconsistent or delayed response, or risk of adverse effects."( Miller, M, 2007)
"A major new approach in the treatment of hyponatremia is the development of AVP receptor antagonists that directly inhibit the effect of increased AVP which results in the excretion of electrolyte free water."( Hussain, SM; Marcus, RJ; Sureshkumar, KK, 2007)
"Conventional treatment of hyponatremia in CHF is based largely on water restriction, which is neither effective nor well tolerated."( Goldsmith, SR, 2009)
"For the treatment of hyponatremia, tolvaptan was associated with significantly increased serum sodium concentrations compared with placebo on treatment days 4 (3."( Hutchinson, DJ; Nemerovski, C, 2010)
"Conventional treatment of hyponatremia in CHF is largely based on water restriction, which is neither effective nor well-tolerated."( Goldsmith, SR, 2010)
"Early treatment of hyponatremia might prevent DIND in patients after SAH."( Kurokawa, S; Nakagawa, I; Nakase, H, 2010)
"The authors review the treatment of hyponatremia in order to provide clinicians with a sound approach in a variety of settings in which severity, symptoms, and underlying disease states influence therapy."( Freda, BJ; Ho, W; Vaidya, C, 2010)
"We wanted to report the treatment of hyponatremia with urea in these patients."( Andres, C; Decaux, G; Gankam Kengne, F; Soupart, A, 2010)
"Definitive treatment of hyponatremia should be directed toward its etiology."( Overgaard-Steensen, C, 2011)
"A major advance in our ability to treat hyponatremia was the introduction and approval of aquaretics (vaptans)."( Elhassan, EA; Schrier, RW, 2011)
"Vaptans are also useful for treating euvolemic hyponatremia associated with the syndrome of inappropriate antidiuretic hormone (SIADH), at least when it is chronic and/or minimally symptomatic."( Robertson, GL, 2011)
"Failure to adequately investigate and treat hyponatremia may also be associated with adverse outcomes."( Deitelzweig, SB; McCormick, L, 2011)
"Short-term use of VRAs in treating hyponatremia was successful at raising [Na(+)](serum)."( Almarzouqi, L; Balk, EM; Borgi, L; Jaber, BL; Madias, NE; Seabra, VF, 2011)
"Use of online formulas to treat hyponatremia is a common practice."( Chan, G; Sandhu, G; Zouain, E, 2012)
"The rationale for treating the hyponatremia, even when apparently asymptomatic, is discussed, with attention to cognitive function, gait, and bone structure disturbances that increase the risk for fractures."( Berl, T, 2013)
"Conventional treatments of hyponatremia present some pitfalls, such as suboptimal efficacy, risk of overly rapid correction, and adverse effects."( Peri, A, 2013)
"Demeclocycline is currently used to treat hyponatremia in patients with the syndrome of inappropriate antidiuretic hormone secretion (SIADH)."( Deen, PM; Fenton, RA; Hadrup, N; Kortenoeven, ML; Sinke, AP; Trimpert, C; Wetzels, JF, 2013)
"Appropriate treatment of hyponatremia may reduce the risk of death, hospital resource utilization, and economic burden."( Han, E; Kang, HJ; Kim, HL; Lee, EK; Lee, MY; Park, SY, 2014)
"We report the approach to the treatment of hyponatremia and its unique challenges in infancy."( Greenberg, JH; Marsenic, O; Tufro, A, 2015)
"Its chemosensitivity mandates prompt treatment."( Bentayeb, H; Cotrel, R; Dayen, C; Douadi, Y; Garoute, C; Iacob, E; Lecuyer, E; Plouvier, N; Suguenot, R, 2015)
"Thus, tolvaptan could be used for treatment of hyponatremia in patients with NSIAD who carry the I130N-V2R mutation."( Balla, A; Erdélyi, LS; Groß, U; Hunyady, L; Mann, WA; Morris-Rosendahl, DJ; Nagel, M; Várnai, P, 2015)
"Tolvaptan is an oral medication used to treat SIADH-related hyponatremia patients that needs to be initiated at hospital so patients can have their serum sodium monitored."( Camps Herrero, C; Carcereny, E; De Las Peñas, R; Escobar Álvarez, Y; Henao, F; López López, R; Ponce, S; Rodríguez, CA; Virizuela, JA, 2016)
"On the other hand, inappropriate treatment of hyponatremia (under- or mainly overtreatment) may also lead to devastating consequences."( Christopoulou, F; Elisaf, MS; Filippatos, TD; Liamis, G, 2016)
"Moreover, issues concerning the optimal treatment for hyponatremia during CHF are addressed and discussed."( Cantatrione, C; De Vecchis, R; Mazzei, D, 2017)
"The role of vaptans in the treatment of hyponatremia should be defined even better, in Europe vaptans can be used to treat the syndrome of inadequate antidiuretic hormone secretion (SIADH)."( Tesař, V, 2016)
"The incidence of treatment-induced hyponatremia was significantly higher in the ultrafiltration group than those receiving conventional treatment (P=0."( Grodin, JL; Kim, YH; Kitai, T; Tang, WH, 2017)
"Discharge hyponatremia but not treatment-induced hyponatremia was associated with worse clinical outcomes."( Grodin, JL; Kim, YH; Kitai, T; Tang, WH, 2017)
"This review discusses the diagnosis and treatment of hyponatremia, comparing the two guidelines and highlighting recent developments."( Hoorn, EJ; Zietse, R, 2017)
"Tolvaptan (TLV) is indicated to treat hyponatremia due to syndrome of inappropriate diuretic hormone (SIADH) in Europe."( Bricmont, P; Dandurand, A; Shoaf, SE, 2017)
"Although tolvaptan has been used to treat hyponatremia, the effect of its long-term use in elderly patients was unknown."( Fei, YH; Han, XB; Liu, YH; Xu, HT, 2017)
"Both the diagnosis and treatment of hyponatremia are challenging."( Antonuzzo, A; Berardi, R; Blasi, L; Buosi, R; Lorusso, V; Migliorino, MR; Montesarchio, V; Peri, A; Sabbatini, R; Zilembo, N, 2018)
"Although tolvaptan treatment improves hyponatremia, only few studies have investigated whether tolvaptan actually benefits the survival of cirrhotic patients."( Ding, HG; Han, T; Li, Y; Liebe, R; Ma, H; Wang, S; Weng, H; Xie, W; Zhang, X, 2018)
"LT is the only definitive treatment for hyponatremia in ESLD."( Bezinover, D; Saner, FH; Stine, JG; Verbeek, TA, 2020)
"In the treatment of hyponatremia in cancer patients, TpST was found to have more positive effects on blood sodium levels, length of hospital stay, hospital complications, and hyponatremia symptoms compared to ST."( Basal, FB; Bilgetekin, I; Demirci, U; Erturk, I; Karacin, C; Karadurmus, N; Oksuzoglu, B, 2021)
"Incidence and treatment for hyponatremia was examined."( Bilello, JF; Davis, JW; Dirks, RC; Edmonds, NS; McCullough, KA, 2020)
"Hypertonic saline has been used for the treatment of hyponatremia for nearly a century."( Rondon-Berrios, H; Sterns, RH, 2022)
"Tolvaptan was correctly used to treat only hyponatremia caused by SIADH in nearly all of the 252 patients studied."( Estilo, A; McCormick, L; Rahman, M, 2021)
"Emergency treatment of hyponatremia should be guided by presence of symptoms and focus on distinguishing between acute and chronic hyponatremia."( Haidinger, M; Lindner, G; Ravioli, S; Schwarz, C, 2022)
"The aim of initial treatment of severe hyponatremia is to rapidly increase serum sodium to reduce the complications of cerebral edema."( Bech, AP; de Boer, H; Haverkort, DA; Massop, K, 2023)
"Preclinical studies in untreated hyponatremia suggest osteoclast upregulation, whereas a clinical study showed improved osteoblast function after hyponatremia normalization in hospitalized patients with syndrome of inappropriate antidiuresis (SIAD)."( Christ-Crain, M; Meier, C; Monnerat, S; Potasso, L; Refardt, J, 2023)

Research

Studies (5,912)

TimeframeStudies, This Condition (%)All Conditions %
pre-19901935 (32.73)23.3326
1990's749 (12.67)12.5806
2000's1097 (18.56)18.1394
2010's1554 (26.29)28.8240
2020's577 (9.76)9.53
DrugIndicatedRelationship StrengthStudiesTrials
acetoacetic acid0low10
gamma-aminobutyric acid0low80
aminolevulinic acid0low10
5-hydroxytryptophan0low30
ethylene glycol0low10
acetone0low10
adenine0medium11
ammonium hydroxide0medium201
betaine0low10
bromide0low30
1-butanol0medium11
carbamates0medium11
carbamyl phosphate0low10
carnitine0low10
choline0medium31
citric acid, anhydrous0medium81
chlorine0medium2177
hydrochloric acid0low40
salicylic acid0low10
3-hydroxybutyric acid0low10
bupropion0medium51
creatine0medium142
lactic acid0low50
ethanolamine0low10
formaldehyde0low50
glycine0medium643
glycerol0low50
hydrogen carbonate0medium641
dalteparin0low10
histamine0low20
iodine0medium311
methanol0low10
inositol0medium121
melatonin0low10
nickel0low10
niacinamide0low40
oxalic acid0low10
porphobilinogen0low80
pyrazinamide0low40
succinic acid0low10
taurine0low90
thiamine0low20
toluene0low20
uracil0low10
uric acid0medium853
urea0medium1357
vanillin0low10
vanilmandelic acid0low20
mandelic acid0low10
1-anilino-8-naphthalenesulfonate0low10
3,4-methylenedioxyamphetamine0low30
n-methyl-3,4-methylenedioxyamphetamine0medium471
homovanillic acid0low10
phenytoin0low190
hydroxyindoleacetic acid0low10
5-methoxytryptamine0low10
acetaminophen0low60
acetazolamide0medium81
amantadine0low10
diatrizoic acid0low20
aminoglutethimide0low10
p-aminohippuric acid0low20
theophylline0low40
amiodarone0low110
amitriptyline0low70
amlodipine0low20
amoxapine0low20
antipyrine0low10
aspirin0low60
baclofen0low20
bendroflumethiazide0medium161
benserazide0low10
biperiden0low10
bisacodyl0medium31
bromazepam0low10
bromhexine0low10
bumetanide0low20
bupivacaine0low30
buspirone0low10
busulfan0low10
caffeine0low50
camphor, (+-)-isomer0low10
carbamazepine0medium1113
carvedilol0low10
celecoxib0medium11
chloral hydrate0low10
chloroquine0low30
chlorothiazide0medium201
chlorpromazine0low60
chlorpropamide0medium331
chlorthalidone0medium191
cimetidine0low10
ciprofloxacin0low10
citalopram0low320
clofibrate0low30
clomipramine0low60
clonazepam0low30
clonidine0low50
dantrolene0low20
desipramine0low10
nordazepam0low10
amphetamine0low10
diazepam0medium71
diazoxide0low30
diclofenac0medium21
dimercaprol0low10
diphenhydramine0low20
valproic acid0low140
doxepin0low10
doxylamine0low10
droperidol0low10
enflurane0low10
estazolam0low10
ethacrynic acid0low280
ether0low10
etodolac0low10
felbamate0low10
fenofibrate0low10
fentanyl0low20
flecainide0low30
fluconazole0low30
flucytosine0low10
fluphenazine0low30
fluorouracil0medium72
fluoxetine0medium291
foscarnet0low30
furosemide0medium14617
gabapentin0low10
gentamicin0low60
glyphosate0low10
guanethidine0low10
guanfacine0low10
haloperidol0low120
halothane0medium31
hydralazine0low30
hydrochlorothiazide0medium772
hydroflumethiazide0low20
hydroxyurea0low20
ibuprofen0medium92
lidocaine0low10
ifosfamide0medium61
imipramine0low80
amrinone0low10
indapamide0low150
indomethacin0low130
iofetamine0low10
iohexol0low30
iodipamide0low10
isoflurane0low10
isoniazid0low40
2-propanol0low20
isoproterenol0medium41
ketamine0low30
ketoconazole0low20
labetalol0low20
lamotrigine0low40
lansoprazole0low30
lofepramine0low30
lorazepam0low90
losartan0low20
loxapine0low10
edaravone0low10
mechlorethamine0low10
meperidine0low20
metaproterenol0low10
metformin0low10
methyclothiazide0low20
methyl salicylate0low10
methylphenidate0low30
metoclopramide0low50
metolazone0low30
metyrapone0low100
mianserin0low100
midazolam0medium11
midodrine0medium11
mirtazapine0low110
mitotane0low10
modafinil0low10
muscimol0low10
ethylmaleimide0low10
apnea0low110
nafamostat0low10
nefazodone0low10
nicardipine0low20
nifedipine0low10
nimodipine0low10
nortriptyline0low20
ns 16190low10
omeprazole0low130
oxonic acid0medium54
oxidopamine0low10
oxprenolol0low20
oxybutynin0low20
aminosalicylic acid0low10
pantoprazole0low50
papaverine0low10
pentobarbital0low10
pentoxifylline0low10
perphenazine0low20
phenobarbital0low70
phenoxybenzamine0low20
piracetam0low60
pirenzepine0low10
potassium chloride0medium301
prazosin0low40
probenecid0low10
procaine0low50
promethazine0low20
propafenone0low10
propranolol0low100
rabeprazole0low10
risperidone0medium81
sennoside a&b0low10
sevoflurane0low20
sibutramine0low20
sk&f 860020medium11
succinylcholine0medium21
sulfamethoxazole0low10
sulfinpyrazone0low10
tegafur0medium54
thalidomide0medium32
thioridazine0low20
thiothixene0low10
ticlopidine0low20
tolazamide0low20
tolbutamide0low80
tranexamic acid0low20
trazodone0low40
triamterene0low120
triazolam0low10
trichlormethiazide0low10
trifluoperazine0low30
trihexyphenidyl0low10
trimethadione0low10
trimethoprim0low70
trimipramine0low10
urethane0low10
vigabatrin0low10
mitomycin0medium21
corticosterone0low260
prednisolone0low170
reserpine0low30
cephaloridine0medium11
phentolamine0low20
sorbitol0medium121
dichloroisoproterenol0low10
hydroxyproline0low10
thyroxine0medium531
dibenzylchlorethamine0low20
spironolactone0medium524
aldosterone0medium2434
penicillamine0low10
prednisone0low220
tetrahydrocortisone0low10
paramethasone0low10
androsterone0low20
etiocholanolone0low10
dehydroepiandrosterone0low50
pilocarpine0low20
pentylenetetrazole0low10
triiodothyronine0medium141
biguanides0low20
alanine0low20
serine0low30
chloramphenicol0low20
aspartic acid0medium81
glutamine0low80
lysine0low30
sucrose0low60
tubocurarine0low10
apomorphine0low10
cephalothin0medium11
galactose0low10
carbostyril0low40
levodopa0low130
edetic acid0low20
methoxamine0low10
cloxacillin0low10
leucine0low80
androstenedione0low20
methionine0low10
desoxycorticosterone0low340
colchicine0low80
oxacillin0low10
barbituric acid0low10
triamcinolone diacetate0low10
17-alpha-hydroxyprogesterone0low60
chlorisondamine0low10
ampicillin0medium31
mannitol0medium781
cytarabine0low20
histidine0low10
valine0low20
tryptophan0low20
isoleucine0low10
arginine0low120
tromethamine0low40
methylprednisolone0medium161
n-vinyl-2-pyrrolidinone0low10
thymol0low30
quinoxalines0low20
xanthenes0low10
cyclohexanol0low170
pyrroles0medium527
thiophenes0low80
phenformin0low30
framycetin0low30
1-naphthylamine0low80
pregnenolone0low60
nafcillin0low10
quinazolines0medium61
isoxazoles0low10
oxazoles0low10
thiazoles0medium51
pyrazines0medium122
calcium gluconate0low10
ephedrine0medium11
hydrazine0low30
evans blue0low10
aminophylline0low30
betamethasone0low10
perflubron0low10
bicuculline0low10
kainic acid0low10
phenylpropanolamine0low30
alpha-aminopyridine0low10
copper gluconate0medium71
methamphetamine0low20
malondialdehyde0low10
lithium carbonate0low100
18-hydroxycorticosterone0low20
doxylamine succinate0low10
acetylcysteine0low30
clopamide0low10
dehydroepiandrosterone sulfate0low20
methoxytryptophol0low10
lormetazepam0low10
deoxycytidine0medium62
canrenone0low10
ethambutol0low30
vancomycin0low20
glycyrrhizic acid0low10
d-alpha tocopherol0low10
metylperon0medium11
s,n,n'-tripropylthiocarbamate0low10
amiloride0medium311
pimozide0low20
fluorescein0low10
flupenthixol0low10
sabinene0low10
tranylcypromine0low10
streptomycin0low10
carbonates0low60
carbenicillin0low10
metanephrine0low20
iodinated glycerol0low30
trimethaphan0low10
molindone0low10
mercury0low20
cadmium0low10
chromium0low10
gadolinium0low40
helium0low10
magnesium sulfate0low40
mercuric chloride0low30
phosphoric acid, trisodium salt0low40
camptothecin0medium32
bromine0low30
barium sulfate0low20
tricalcium phosphate0medium11
silver nitrate0low40
chlorine0low140
deuterium oxide0low20
calcium pyrophosphate0low10
vasotocin0low10
trolamine salicylate0low40
ammonium chloride0low20
xipamide0low30
levamisole0low10
lisuride0low20
daunorubicin0low10
bromocriptine0low20
phenyl acetate0medium41
triamcinolone0low30
fludrocortisone0medium842
4-methoxyamphetamine0low20
transferrin0low10
normeperidine0low10
calcium oxalate0medium21
glutamic acid0low70
cefazolin0low20
azides0low10
amoxicillin0low10
timolol0low10
tramadol0low110
oxcarbazepine0medium403
paclitaxel0medium74
etoposide0low60
dobutamine0medium21
ribavirin0low20
methyldopa0low50
diltiazem0low10
pirfenidone0low10
vindesine0low20
epirubicin0low20
lorcainide0low10
paroxetine0medium372
captopril0medium261
cefoperazone0low30
colforsin0low10
fomesafen0low40
lovastatin0low10
atomoxetine hydrochloride0low10
itraconazole0low10
fosphenytoin0low10
n 0437, (-)-isomer0low10
clopidogrel0low30
topotecan0low10
gemcitabine0medium51
aripiprazole0low50
remifentanil0low10
mazapertine succinate0low10
duloxetine hydrochloride0low180
irinotecan0medium32
valsartan0low20
ziprasidone0low30
3-iodobenzylguanidine0low10
relcovaptan0low20
capecitabine0medium11
cathinone0low20
venlafaxine hydrochloride0low200
hydrochlorothiazide-triamterene0low20
glucose, (beta-d)-isomer0medium51
chloroquine diphosphate0low10
18-hydroxydeoxycorticosterone0low10
oseltamivir0low10
n-acetylaspartic acid0medium31
cephalosporin c0low10
milnacipran0low10
goralatide0medium11
telmisartan0low10
triazoles0low60
fluorodeoxyglucose f180low10
sertraline0low170
picosulfate sodium0medium61
zoledronic acid0medium11
artemether0low10
voriconazole0low50
olaquindox0low10
terlipressin0medium211
7-hydroxystaurosporine0medium11
methotrimeprazine0low10
oxazolidin-2-one0low10
rivastigmine0low10
rosiglitazone0low10
clarithromycin0low20
coenzyme a0low10
nicotine0low50
fibrinogen0low40
mci 90380low10
lopinavir0low20
droxidopa0low10
pregnanetriol0low50
carbidopa, levodopa drug combination0low40
amiloride, hydrochlorothiazide drug combination0low120
perindopril0medium11
hypotaurine0low10
3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide0low10
11-hydroxyandrostenedione0low10
benzamil0low20
ecteinascidin 7430low10
opc 212680low20
mozavaptan0medium202
pramipexole0low20
imatinib mesylate0low10
gefitinib0low10
ro 8-05760low10
blonanserin0low10
methotrexate0low20
reboxetine0low40
tamsulosin0low10
sulbactam0low20
aspartame0low10
pomalidomide0low10
proline0medium121
docetaxel anhydrous0medium72
ezetimibe0low10
moxifloxacin0low20
naproxen0low20
canertinib dihydrochloride0medium11
lubiprostone0low10
satavaptan0medium265
varenicline0low10
argipressin,beta-mercapto-beta,beta-cyclopentamethylenepropionic acid(1)-val(4)-0low10
angiotensin ii0low630
sb 2035800medium11
erlotinib hydrochloride0low20
eslicarbazepine acetate0medium102
137 l0low10
darunavir0low10
sorafenib0low40
telmisartan, hydrochlorothiazide drug combination0low10
estradiol 3-benzoate0low10
cortisone0low270
fludrocortisone acetate0low80
sorbinil0low10
trimethoprim, sulfamethoxazole drug combination0low170
bortezomib0medium62
ritonavir0low20
dihydropyridines0low10
carboplatin0medium102
lithium chloride0low50
glycogen0low60
bradykinin0low10
amylopectin0low10
oxytocin0medium584
7-dehydrocholesterol0low10
inositol 1,4,5-trisphosphate0low10
ouabain0low10
puromycin0low10
pentostatin0low10
cortodoxone0low30
digitoxin0low50
rocuronium0low10
linezolid0low110
indican0low10
teprotide0low30
arachidonic acid0low10
tacrolimus0low80
cocaine0low50
clindamycin0low10
fosfomycin0low10
zithromax0low10
diethylstilbestrol0low10
imidazolidines0low10
neomycin c0low10
melphalan0low10
enkephalin, leucine0low10
sodium bicarbonate0low50
potassium bicarbonate0low10
dipyrone0low10
isomethyleugenol0low10
picibanil0low10
lypressin0medium201
arginine vasopressin0medium28816
s 10330low10
canrenoic acid0low10
propylthiouracil0low10
benztropine0low20
sulindac0low10
enclomiphene0low10
1,3-dimethylthiourea0low10
thiourea0low10
indigo carmine0low10
D-fructopyranose0low50
unithiol0low10
digoxin0low130
nadp0low10
ethionamide0low10
thiopental0low20
pica0low20
lithium0low310
quinine0low30
((5,6-dichloro-2,3,9,9a-tetrahydro-3-oxo-9a-propyl-1h-fluoren-7-yl)oxy)acetic acid0low10
dasatinib0low10
alpha-chymotrypsin0low10
17-ketosteroids0low170
icodextrin0low10
bilirubin0low150
dinoprostone0low110
dinoprost0low10
vitamin k semiquinone radical0low10
alprostadil0low10
amphotericin b0low30
humulene0low10
oleuropein0low10
maytansine0low10
misoprostol0low10
dothiepin hydrochloride0low10
thromboxane b20low10
codeine0low20
phenylephrine hydrochloride0low10
levetiracetam0low90
naloxone0low20
topiramate0low30
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin0low10
morphine0low20
atosiban0low10
clobetasol0low10
deamino arginine vasopressin0medium2228
fluticasone0low10
fluvoxamine0low30
bosutinib0low10
su 112480low40
lead0low10
aluminum0low10
naltrexone0low30
lisinopril0low50
benazepril0low10
ramipril0low10
sulfur0low10
enalapril0low180
fumarates0low30
cysteine0low10
phosphorus0low130
norbinaltorphimine0low10
trandolapril0medium22
pregabalin0low10
aliskiren0low30
magnesium citrate0medium51
4,4'-diisothiocyanostilbene-2,2'-disulfonic acid0low20
proguanil0low10
monorden0low10
saralasin0low80
selenium0low10
radium0low10
oxalates0low20
(3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid0low10
pregnanediol0low20
lumefantrine0low10
n-(3-iodopropen-1-yl)-2-carbomethoxy-3-(4-chlorophenyl)tropane0low10
moducrin0low10
everolimus0medium11
beta-escin0low60
s-nitroso-n-acetylpenicillamine0low20
vilazodone hydrochloride0low10
panobinostat0medium11
staurosporine0medium11
phosphocreatine0medium61
s 17430low50
desvenlafaxine succinate0low20
niravoline0medium11
ezetimibe, simvastatin drug combination0medium11
vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine-0low10
paliperidone palmitate0low10
rivaroxaban0low10
eslicarbazepine0low10
dapagliflozin0low10
cediranib0medium11
g(m1) ganglioside0low10
bibw 29920low10
binimetinib0low10
ipragliflozin0low10
acebutolol0low20
lactulose0medium21
cariprazine0medium11
nystatin a10low10
carfilzomib0medium11
lisdexamfetamine dimesylate0low10
trametinib0low10
losartan potassium0low50
deoxycortone pivalate0low10
dextrothyroxine0low10
pituitrin0medium82511
virginiamycin0low10
acid phosphatase0low10
nad0low10
dianhydrogalactitol0low10
cytochrome c-t0low10
cosyntropin0low60
cholecystokinin0low10
atrial natriuretic factor0medium832
adrenocorticotropin zinc0low10
gastrins0low10
glucagon0low50
beta-endorphin0low10
angiotensinogen0low10
c-peptide0low20
natriuretic peptide, c-type0low10
carbetocin0low10
mesna0medium11
ru 283180low10
ro13-99040low40
sodium ethylxanthate0low20
cortisol succinate, sodium salt0low20
quinupristin-dalfopristin0low10
gdc 04490medium11
pci 327650medium11
quetiapine fumarate0low50
cardiovascular agents0medium61
trelstar0low10
tolterodine tartrate0low30
piperidines0medium61
methylone0low10
abt-1990medium11
methylcellulose0low10
natriuretic peptide, brain0medium494
heme0low50
ascorbic acid0medium81
tetracycline0low10
minocycline0low60
salicylates0low40
piroxicam0low10
mobic0low20
warfarin0low30
demeclocycline0medium553
s 1 (combination)0medium43
epidermal growth factor0low10
calca protein, human0low10
transforming growth factor beta0low10
selinexor0low20
osimertinib0low20
angiotensin i0low30
adrenomedullin0low10
vitamin b 120low20
cyclosporine0low70
muramidase0low10
exudates0low20
technetium tc 99m dimercaptosuccinic acid0low10
acyclovir0low60
levoleucovorin0medium11
cyclic gmp0medium11
deoxyguanosine0low10
guanine0low10
rifampin0low40
clozapine0medium201
dacarbazine0low20
ganciclovir0low10
olanzapine0low80
allopurinol0low10
pemetrexed0low10
aprepitant0low10
nintedanib0low10
8-hydroxy-2'-deoxyguanosine0low10
heme arginate0low30
cholestyramine resin0low10
eye0low10
carbidopa0low60
metallothionein0low10
preproenkephalin0low10
leptin0low10
pyrimidinones0low20

Protein Targets (3,160)

ProteinPotency MeasurementsInhibition MeasurementsActivation MeasurementsDrugs
Cytochrome P450 2C9 066172
Chain B, pheromone binding protein0011
Chain A, pheromone binding protein0011
Chain A, JmjC domain-containing histone demethylation protein 3A340034
Chain A, RNA-directed RNA polymerase NS50101
acid sphingomyelinase6006
thioredoxin reductase12200122
USP1 protein, partial830083
TDP1 protein19000190
vitamin D3 receptor isoform VDRA660066
importin subunit beta-1 isoform 1200020
flap endonuclease 1440044
serine/threonine-protein kinase PLK1120012
snurportin-1200020
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1260026
GTP-binding nuclear protein Ran isoform 1110011
DNA polymerase eta isoform 1120012
DNA polymerase iota isoform a (long)450045
urokinase-type plasminogen activator precursor250025
plasminogen precursor250025
urokinase plasminogen activator surface receptor precursor250025
geminin18200182
DNA polymerase kappa isoform 1460046
fibroblast growth factor 22 isoform 1 precursor0001
Mitogen-activated protein kinase 13041115
Beta-lactamase0606
Transthyretin02410
Fatty acid-binding protein, intestinal0527
Fatty acid-binding protein, adipocyte0224
Cyclin-A20202
Cannabinoid receptor 10112
Cyclin-dependent kinase 2071724
Choline O-acetyltransferase0202
Mitogen-activated protein kinase 12041115
Guanine nucleotide-binding protein G140014
Fatty acid-binding protein 50112
Fatty acid-binding protein 50022
Mitogen-activated protein kinase 11041620
Mitogen-activated protein kinase 140101929
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE930093
aldehyde dehydrogenase 1 family, member A110300103
glucocorticoid receptor [Homo sapiens]15500155
farnesoid X nuclear receptor860086
estrogen nuclear receptor alpha24900249
Voltage-dependent calcium channel gamma-2 subunit770077
Cellular tumor antigen p5312900129
Glutamate receptor 2784286
Choline O-acetyltransferase 0204
Chain A, HADH2 protein520052
Chain B, HADH2 protein520052
RAR-related orphan receptor gamma14200142
GLI family zinc finger 316200162
AR protein20400204
thyroid stimulating hormone receptor860086
estrogen receptor 2 (ER beta)840084
nuclear receptor subfamily 1, group I, member 311200112
progesterone receptor10300103
retinoic acid nuclear receptor alpha variant 114000140
estrogen-related nuclear receptor alpha16900169
pregnane X nuclear receptor13100131
aryl hydrocarbon receptor690069
thyroid stimulating hormone receptor580058
activating transcription factor 6530053
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a590059
v-jun sarcoma virus 17 oncogene homolog (avian)730073
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1350035
thyroid hormone receptor beta isoform 214500145
nuclear factor erythroid 2-related factor 2 isoform 114900149
cytochrome P450 3A4 isoform 1890089
Gamma-aminobutyric acid receptor subunit pi89195114
Gamma-aminobutyric acid receptor subunit beta-189195114
Gamma-aminobutyric acid receptor subunit delta89195114
Gamma-aminobutyric acid receptor subunit gamma-289197116
Gamma-aminobutyric acid receptor subunit alpha-589195114
Gamma-aminobutyric acid receptor subunit alpha-389195114
Gamma-aminobutyric acid receptor subunit gamma-189195114
Gamma-aminobutyric acid receptor subunit alpha-289195114
Gamma-aminobutyric acid receptor subunit alpha-489195114
Gamma-aminobutyric acid receptor subunit gamma-389195114
Gamma-aminobutyric acid receptor subunit alpha-689195114
Gamma-aminobutyric acid receptor subunit alpha-189217118
Gamma-aminobutyric acid receptor subunit beta-389195114
Gamma-aminobutyric acid receptor subunit beta-289197116
Kelch-like ECH-associated protein 10011
GABA theta subunit89195114
Gamma-aminobutyric acid receptor subunit epsilon89195114
Histone acetyltransferase KAT80101
hypoxia-inducible factor 1 alpha subunit470047
retinoid X nuclear receptor alpha11100111
Lysine-specific demethylase 6B0101
Lysine-specific demethylase 4B0101
Heat shock protein HSP 90-alpha05510
Heat shock protein HSP 90-beta0449
Cholesteryl ester transfer protein0112
5-hydroxytryptamine receptor 1A074782
Lysine-specific demethylase 5A0202
Endoplasmin0011
Hypoxia-inducible factor 1-alpha0213
Endothelial PAS domain-containing protein 10112
Lysine-specific demethylase 4C0101
acetylcholinesterase690069
pregnane X receptor190019
SMAD family member 2390039
SMAD family member 3390039
Microtubule-associated protein tau810081
G830083
vitamin D (1,25- dihydroxyvitamin D3) receptor990099
arylsulfatase A770077
euchromatic histone-lysine N-methyltransferase 217700177
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a970097
nuclear receptor subfamily 1, group I, member 2220022
chromobox protein homolog 112300123
survival motor neuron protein isoform d560056
histone acetyltransferase KAT2A isoform 1600060
lamin isoform A-delta1016700167
Interferon beta12500125
HLA class I histocompatibility antigen, B alpha chain 830083
Glucocorticoid receptor022330
Sex hormone-binding globulin001212
Glycine receptor subunit alpha-1022022
Corticosteroid-binding globulin012012
Adenosine receptor A3030131
Replicase polyprotein 1ab0211334
Androgen receptor025026
Alpha-1B adrenergic receptor068775
Glycine receptor subunit beta022022
Glycine receptor subunit alpha-2022022
Glycine receptor subunit alpha-3022022
Mitogen-activated protein kinase 3 031518
Alpha-1A adrenergic receptor074882
Sodium-dependent dopamine transporter 075580
TAR DNA-binding protein 43350035
Inositol hexakisphosphate kinase 1830083
cytochrome P450 2C9, partial830083
ATP-dependent phosphofructokinase880088
peroxisome proliferator-activated receptor delta880088
Histone H2A.x490049
thyroid hormone receptor beta isoform a450045
heat shock protein beta-1460046
Protein skinhead-10101
Monocarboxylate transporter 20202
Solute carrier family 22 member 200909
Solute carrier family 22 member 609010
D(2) dopamine receptor0651286
D(4) dopamine receptor032442
D(3) dopamine receptor073686
D(2) dopamine receptor043650
dopamine D1 receptor170017
GLS protein900090
Thrombopoietin270027
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)390039
cytochrome P450 2D6 isoform 1510051
cytochrome P450 2C19 precursor390039
ras-related protein Rab-9A260026
lethal factor (plasmid)430043
POU domain, class 2, transcription factor 10004
Spike glycoprotein100412116
5-hydroxytryptamine receptor 2C040546
5-hydroxytryptamine receptor 2A047552
Sodium-dependent noradrenaline transporter 091899
Sodium-dependent dopamine transporter034236
5-hydroxytryptamine receptor 1B054458
5-hydroxytryptamine receptor 1D020424
5-hydroxytryptamine receptor 1F020424
5-hydroxytryptamine receptor 2B036642
5-hydroxytryptamine receptor 609413
Sodium-dependent serotonin transporter09110101
Sodium-dependent serotonin transporter034439
5-hydroxytryptamine receptor 7 019423
5-hydroxytryptamine receptor 5A09413
5-hydroxytryptamine receptor 5B09413
5-hydroxytryptamine receptor 3A013417
5-hydroxytryptamine receptor 4 010415
5-hydroxytryptamine receptor 3B013417
NFKB1 protein, partial400040
nonstructural protein 1260026
bromodomain adjacent to zinc finger domain 2B300030
5-hydroxytryptamine receptor 1A0321345
5-hydroxytryptamine receptor 1D0408
5-hydroxytryptamine receptor 1B0516
5-hydroxytryptamine receptor 2A081589
5-hydroxytryptamine receptor 2C079483
Cholecystokinin receptor type A0415
Gastrin/cholecystokinin type B receptor0101
5-hydroxytryptamine receptor 7023124
5-hydroxytryptamine receptor 6060163
Fatty-acid amide hydrolase 10808
5-hydroxytryptamine receptor 40303
Transient receptor potential cation channel subfamily M member 80101
Transporter025228
Vitamin D3 receptor0001
Serine/threonine-protein kinase Chk1041620
3-phosphoinositide-dependent protein kinase 1021012
Cyclin-dependent kinase 1031417
Cyclin-dependent kinase 4041519
G1/S-specific cyclin-D10303
Chain A, Avidin0022
Chain A, Avidin0022
Chain B, Avidin0022
EWS/FLI fusion protein12000120
Apoptosis regulator Bcl-20325
Bcl-2-like protein 10303
Induced myeloid leukemia cell differentiation protein Mcl-10202
Aspartyl/asparaginyl beta-hydroxylase0101
Bcl-2-related protein A10101
Bcl-2-like protein 20101
Bcl2-associated agonist of cell death 0101
peroxisome proliferator activated receptor gamma10000100
cytochrome P450 2C9 precursor360036
potassium voltage-gated channel subfamily H member 2 isoform d790079
ubiquitin carboxyl-terminal hydrolase 2 isoform a240024
histone-lysine N-methyltransferase 2A isoform 2 precursor180018
ATP-binding cassette sub-family C member 301730173
Multidrug resistance-associated protein 401740180
Bile salt export pump02500250
Mitogen-activated protein kinase 1031518
Histamine H2 receptor599378
Disintegrin and metalloproteinase domain-containing protein 17190019
ATAD5 protein, partial670067
Smad3420042
peripheral myelin protein 22950095
Solute carrier family 22 member 6027029
Carbonic anhydrase 12022237
UDP-glucuronosyltransferase 1A90309
Bile salt export pump034034
Cytochrome P450 2B10001
Cytochrome P450 1A10001
Carbonic anhydrase 1047270
Carbonic anhydrase 2053680
Myoglobin0101
Cytochrome P450 1A10214
Cytochrome P450 1A2022126
Prostaglandin G/H synthase 1016017
Carbonic anhydrase 3019227
Cytochrome P450 3A4061375
Cytochrome P450 2D6050155
Polyunsaturated fatty acid lipoxygenase ALOX15015015
Sulfotransferase 1A1 0002
UDP-glucuronosyltransferase 1-608011
Arachidonate 5-lipoxygenase-activating protein0303
UDP-glucuronosyltransferase 1A1 013018
Carbonic anhydrase 4033247
Prostaglandin G/H synthase 1021022
Carbonic anhydrase 6021235
Carbonic anhydrase 5A, mitochondrial026342
Prostaglandin G/H synthase 20211337
Carbonic anhydrase 7021235
Nuclear receptor ROR-gamma301132
Cytochrome P450 2J2040041
Carbonic anhydrase 9033350
Canalicular multispecific organic anion transporter 101650167
Carbonic anhydrase 15015020
Carbonic anhydrase 13015027
Carbonic anhydrase 14020235
Carbonic anhydrase 5B, mitochondrial022237
toxin B0001
Chain A, TYROSYL-DNA PHOSPHODIESTERASE510051
Chain A, CARBONIC ANHYDRASE II0011
Chain A, CARBONIC ANHYDRASE II0011
Chain A, CARBONIC ANHYDRASE II0011
Chain A, Carbonic Anhydrase Ii0011
Chain A, Carbonic Anhydrase Ii0011
Chain A, Beta-lactamase490049
Chain A, Endochitinase0101
Chain A, Endochitinase0101
Chain A, Endochitinase0101
Chain A, Class Iii Chitinase Chia10101
Chain A, Carbonic anhydrase 130101
Chain A, Carbonic anhydrase II0101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase0101
Chain B, Carbonic anhydrase0101
Chain A, Carbonic anhydrase 20101
Carbonic anhydrase 0003
Carbonic anhydrase 0505
GALC protein240024
cytochrome P450 family 3 subfamily A polypeptide 414100141
Carbonic anhydrase 0404
Carbonic anhydrase 0404
Carbonic anhydrase0404
Bloom syndrome protein isoform 1640064
muscleblind-like protein 1 isoform 1230023
Carbonic anhydrase0202
Prolyl endopeptidase0202
Carbonic anhydrase-related protein 110103
Glycogen phosphorylase, muscle form0404
Renin0707
Carbonic anhydrase 20202
Cathepsin B0101
Steryl-sulfatase0102
Polyunsaturated fatty acid 5-lipoxygenase0404
Cytochrome P450 2C8015017
Cytochrome P450 2A609211
Translocator protein06310
Cytochrome P450 2B608213
Carbonic anhydrase 5A, mitochondrial0202
Adenosine receptor A1113019
Serum paraoxonase/arylesterase 10808
Dipeptidyl peptidase 40304
Endochitinase0101
Adenosine receptor A2a012221
Delta-type opioid receptor023432
Cytochrome P450 2C19034039
Delta-type opioid receptor019425
Mu-type opioid receptor022531
Carbonic anhydrase010014
Kappa-type opioid receptor012218
Carbonic anhydrase0101
D(1A) dopamine receptor252027
Corticosteroid 11-beta-dehydrogenase isozyme 10314
Carbonic anhydrase0308
Cholinesterase0516
Carbonic anhydrase 0303
Mu-type opioid receptor025432
Beta-carbonic anhydrase 10404
Carbonic anhydrase 20303
Glutamate receptor ionotropic, NMDA 2B017427
Squalene synthase0303
Neuronal acetylcholine receptor subunit alpha-707311
Carbonic anhydrase0202
Carbonic anhydrase, alpha family 0505
Carbonic anhydrase 0308
Carbonic anhydrase 30101
Carbonic anhydrase04010
Carbonic anhydrase04010
Carbonic anhydrase 0404
Sigma intracellular receptor 2012012
Delta carbonic anhydrase0404
Sigma non-opioid intracellular receptor 1013215
Renin0202
Carbonic anhydrase 0308
Endochitinase A10101
Multidrug resistance-associated protein 10202
Carbonic anhydrase 1308213
Carbonic anhydrase 407011
Acidic mammalian chitinase0101
Carbonic anhydrase 70101
Carbonic anhydrase 0202
Carbonic anhydrase 0101
Carbonic anhydrase 2, isoform A 0101
Monocarboxylate transporter 40001
Chain A, 2-oxoglutarate Oxygenase660066
Chain A, ATP-DEPENDENT DNA HELICASE Q1140014
15-lipoxygenase, partial320032
phosphopantetheinyl transferase690069
regulator of G-protein signaling 4730073
D(1A) dopamine receptor530053
muscarinic acetylcholine receptor M1630063
Histone deacetylase 3011112
Histone deacetylase 4010010
Histone deacetylase 1013114
Histone deacetylase 7010010
Histone deacetylase 2012113
Polyamine deacetylase HDAC10010010
Histone deacetylase 11 010010
Ataxin-2890089
Histone deacetylase 8012012
Histone deacetylase 6013114
Histone deacetylase 9010010
Histone deacetylase 5010010
cytochrome P450 2D610600106
Urotensin-2 receptor0303
Urotensin-2 receptor0202
Chain E, Purine nucleoside phosphorylase0101
Chain A, Ferritin light chain330033
Thymidine kinase 0202
hemoglobin subunit beta4004
atrial natriuretic peptide receptor 1 precursor180018
Solute carrier family 22 member 1 048058
Purine nucleoside phosphorylase0303
Thymidine kinase, cytosolic0204
POU domain, class 2, transcription factor 20002
Purine nucleoside phosphorylase0033
Solute carrier family 22 member 6019026
Thymidine kinase 0101
Solute carrier family 22 member 8015022
Thymidine kinase0202
Chain A, MTA/SAH nucleosidase0101
Chain A, Ribosome-inactivating protein alpha-trichosanthin0011
Chain A, Ricin A chain0011
Chain A, Ribosome-inactivating protein 30011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
nuclear factor erythroid 2-related factor 2 isoform 2440044
tumor susceptibility gene 101 protein1001
Xanthine dehydrogenase/oxidase0303
Protein mono-ADP-ribosyltransferase PARP150303
Leucine-rich repeat serine/threonine-protein kinase 2031013
ATPase family AAA domain-containing protein 5520052
Alanine racemase, biosynthetic0001
Glutamate receptor ionotropic, NMDA 1 016526
Proton-coupled amino acid transporter 1011012
Adenosine deaminase0001
Mineralocorticoid receptor 05410
Mineralocorticoid receptor0101
Solute carrier organic anion transporter family member 1A106010
Fumarate hydratase530053
polyprotein530053
Pepsin A0101
Renin-1 0101
Renin 0101
Cathepsin D 0202
Renin 0101
Protease 07513
interleukin 8240024
IDH1530053
transcriptional regulator ERG isoform 3140014
Polyphenol oxidase 208011
Hypoxanthine-guanine phosphoribosyltransferase0002
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase 0101
Adenosine receptor A2a016523
Nuclear receptor ROR-gamma0101
Xanthine dehydrogenase/oxidase0315
Shiga toxin subunit A0202
Histamine H3 receptor0206
Botulinum neurotoxin type A 0202
Neutrophil cytosol factor 10202
Nitric oxide synthase, endothelial0101
Nitric oxide synthase, brain0102
Nitric oxide synthase, brain 0103
Nitric oxide synthase, inducible0115
Phosphatidylinositol 4-kinase alpha0101
Tyrosine-protein kinase 0011
Phosphatidylinositol 4-kinase type 2-beta0101
Phosphatidylinositol 4-kinase type 2-alpha0101
Phosphatidylinositol 4-kinase beta011011
Thromboxane-A synthase 010010
Prostaglandin E2 receptor EP3 subtype0303
Prostaglandin E2 receptor EP4 subtype0314
Prostaglandin E2 receptor EP1 subtype0303
Prostacyclin receptor0426
Nuclear receptor subfamily 4 group A member 20033
Solute carrier organic anion transporter family member 2A10207
Nuclear receptor subfamily 4 group A member 20011
Nuclear receptor subfamily 4 group A member 20011
Prostaglandin E2 receptor EP2 subtype0314
Solute carrier organic anion transporter family member 2A10105
Solute carrier organic anion transporter family member 2B10202
Solute carrier organic anion transporter family member 3A10001
signal transducer and activator of transcription 6, interleukin-4 induced2002
putative alpha-glucosidase3003
Solute carrier family 22 member 2021028
Glutamate receptor ionotropic, NMDA 2D0415
Glutamate receptor ionotropic, NMDA 3B0415
Matrix protein 20112
Matrix protein 20123
Glutamate receptor ionotropic, NMDA 2A 014423
Glutamate receptor ionotropic, NMDA 2C014423
Glutamate receptor ionotropic, NMDA 10516
Glutamate receptor ionotropic, NMDA 2A0516
Glutamate receptor ionotropic, NMDA 2B0517
Glutamate receptor ionotropic, NMDA 2C0415
Glutamate receptor ionotropic, NMDA 2D014423
Solute carrier family 22 member 1020026
Glutamate receptor ionotropic, NMDA 3A0415
Glutamate receptor ionotropic, NMDA 3B014423
Multidrug and toxin extrusion protein 1025025
Solute carrier family 22 member 2018021
Glutamate receptor ionotropic, NMDA 3A014423
Chain U, UROKINASE-TYPE PLASMINOGEN ACTIVATOR0101
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR0101
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR0101
glucocerebrosidase250025
alpha-galactosidase170017
lysosomal alpha-glucosidase preproprotein160016
huntingtin isoform 2220022
Membrane primary amine oxidase 0202
Prothrombin07312
Coagulation factor X0606
Plasminogen0617
Urokinase-type plasminogen activator0404
Tissue-type plasminogen activator0404
Cationic trypsin0303
Coagulation factor XI0101
Plasma kallikrein0106
Vitamin K-dependent protein C0101
Urokinase-type plasminogen activator0303
Trypsin-10303
Trypsin-20202
Sodium/hydrogen exchanger 10101
Amine oxidase [flavin-containing] A014015
Sodium/hydrogen exchanger 10303
Sodium/hydrogen exchanger 30202
Trypsin-30202
Amiloride-sensitive sodium channel subunit alpha0202
5-hydroxytryptamine receptor 7023023
Sodium/hydrogen exchanger 20202
Acid-sensing ion channel 10202
Potassium voltage-gated channel subfamily H member 201000102
Sodium channel protein type 5 subunit alpha027027
Sodium/hydrogen exchanger 50202
Acid-sensing ion channel 30101
Sodium/hydrogen exchanger0101
peripheral myelin protein 22 isoform 1440044
Sterol O-acyltransferase 10101
Cholesterol side-chain cleavage enzyme, mitochondrial 0112
Triosephosphate isomerase0101
Steroid 17-alpha-hydroxylase/17,20 lyase0505
Cholesterol side-chain cleavage enzyme, mitochondrial0101
Aromatase013019
Ribosyldihydronicotinamide dehydrogenase [quinone]061420
Aromatase0213
Cytochrome P450 11B2, mitochondrial0101
Gamma-aminobutyric acid receptor subunit rho-10145
Glutamate receptor 10426
Glutamate receptor 20426
Glutamate receptor 30224
Glutamate receptor ionotropic, kainate 30505
Solute carrier family 15 member 1012012
Glutamate receptor 40415
Solute carrier family 15 member 10606
Solute carrier family 15 member 20808
thioredoxin glutathione reductase230023
microphthalmia-associated transcription factor isoform 90101
Tyrosine-protein phosphatase non-receptor type 10417
PPM1D protein400040
caspase 7, apoptosis-related cysteine protease310031
caspase-3310031
cellular tumor antigen p53 isoform a250025
mitogen-activated protein kinase 1420042
serine/threonine-protein kinase mTOR isoform 1360036
nuclear receptor ROR-gamma isoform 1620062
Polyunsaturated fatty acid lipoxygenase ALOX15B320032
Voltage-dependent L-type calcium channel subunit alpha-1C012012
Solute carrier organic anion transporter family member 1A407012
Voltage-dependent L-type calcium channel subunit alpha-1F026026
5-hydroxytryptamine receptor 4070272
Lysine-specific demethylase PHF20101
Thyroid hormone receptor alpha0101
Receptor tyrosine-protein kinase erbB-20171330
Integrin beta-3193123
Tyrosine-protein kinase Fyn0171532
ATP-dependent translocase ABCB1015015
Aldo-keto reductase family 1 member B1070070
Muscarinic acetylcholine receptor M2052458
Muscarinic acetylcholine receptor M4051153
ATP-dependent translocase ABCB1054575
Integrin alpha-IIb192122
Beta-1 adrenergic receptor022426
Muscarinic acetylcholine receptor M5050051
Alpha-2A adrenergic receptor078586
Thyroid hormone receptor alpha0336
Thyroid hormone receptor beta0336
Muscarinic acetylcholine receptor M1057666
Beta-3 adrenergic receptor020424
Lethal factor0202
Alpha-2B adrenergic receptor075482
Thyroid hormone receptor beta0303
Muscarinic acetylcholine receptor M3053256
ATP-dependent translocase ABCB1016016
Substance-K receptor020020
D(1A) dopamine receptor050560
Carnitine O-palmitoyltransferase 2, mitochondrial0202
Histamine H2 receptor038442
Endothelin-1 receptor0516
B2 bradykinin receptor0417
Melanocortin receptor 40404
C-8 sterol isomerase0505
Melanocortin receptor 5010010
Mu-type opioid receptor0341353
Sodium channel protein type 1 subunit alpha010010
Sodium channel protein type 4 subunit alpha013016
Squalene synthase0101
Delta-type opioid receptor030743
Kappa-type opioid receptor031745
5-hydroxytryptamine receptor 2B081283
C-C chemokine receptor type 20505
Melanocortin receptor 30404
Carnitine O-palmitoyltransferase 1, liver isoform0202
C-C chemokine receptor type 40202
Sodium channel protein type 7 subunit alpha0808
Voltage-dependent L-type calcium channel subunit alpha-1D 026026
Voltage-dependent L-type calcium channel subunit alpha-1S026026
Voltage-dependent L-type calcium channel subunit alpha-1C034035
Squalene monooxygenase0101
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase0505
Sodium channel protein type 9 subunit alpha014014
Lysine-specific demethylase 7A0101
Carnitine O-palmitoyltransferase 1, muscle isoform0101
Sodium channel protein type 2 subunit alpha011011
Sigma non-opioid intracellular receptor 1067269
NAD-dependent protein deacetylase sirtuin-3, mitochondrial0314
Sodium channel protein type 3 subunit alpha012012
Sodium channel protein type 11 subunit alpha0808
Histone lysine demethylase PHF80101
Sodium channel protein type 8 subunit alpha0808
Sodium channel protein type 10 subunit alpha0909
atrial natriuretic peptide receptor 2 precursor220022
Albumin001616
High affinity nerve growth factor receptor021719
Muscarinic acetylcholine receptor M1020324
Muscarinic acetylcholine receptor M3017321
Muscarinic acetylcholine receptor M4018322
Muscarinic acetylcholine receptor M5018322
Muscarinic acetylcholine receptor M2018322
Angiotensin-converting enzyme047048
Alpha-2C adrenergic receptor073480
D(1B) dopamine receptor011015
UDP-glucuronosyltransferase 1A406014
Alpha-1D adrenergic receptor064775
Histamine H1 receptor015217
Histamine H1 receptor051660
UDP-glucuronosyltransferase 1A30007
Voltage-dependent N-type calcium channel subunit alpha-1B0909
Nuclear receptor subfamily 3 group C member 3 037037
Histamine H3 receptor010212
NEDD8-activating enzyme E1 regulatory subunit isoform a0101
NEDD8-conjugating enzyme Ubc120101
Potassium channel subfamily K member 20111122
Alpha-2B adrenergic receptor032840
Voltage-dependent L-type calcium channel subunit alpha-1C0909
Alpha-2C adrenergic receptor031839
Alpha-2A adrenergic receptor031839
Alpha-1A adrenergic receptor0221038
Alpha-1B adrenergic receptor015827
Potassium channel subfamily K member 2 0202
endonuclease IV290029
isocitrate dehydrogenase 1, partial5005
67.9K protein450045
M-phase phosphoprotein 8360036
transient receptor potential cation channel subfamily V member 15005
neuropeptide S receptor isoform A280028
Sulfotransferase 1A10101
Inositol monophosphatase 1320032
Sulfotransferase 2A10101
Histamine H4 receptor08513
Beta-lactamase 0002
Beta-lactamase 0002
Beta-lactamase 0002
Beta-lactamase 0104
apical membrane antigen 1, AMA1160016
Beta-lactamase 0002
Beta-lactamase SHV-10002
Beta-lactamase SHV-10104
Beta-lactamase0104
B2 metallo-beta-lactamase 0004
Solute carrier family 15 member 20606
Beta-lactamase 0002
Beta-lactamase 0002
Beta-lactamase 0002
Beta-lactamase 0002
Solute carrier family 22 member 30505
Phenylethanolamine N-methyltransferase0203
Substance-P receptor0101
Cytochrome P450 2A50202
Beta-2 adrenergic receptor06513
Sigma non-opioid intracellular receptor 1013316
Chain A, Cruzipain270027
tumor necrosis factor5005
Aurora kinase B041519
Broad substrate specificity ATP-binding cassette transporter ABCG2031135
Chain A, Mutant Al2 6e7p9g0011
Beta-lactamase 0003
Beta-lactamase 0003
Beta-lactamase 0002
Metallo-beta-lactamase type 20114
Metallo-beta-lactamase VIM-11 0002
Metallo-beta-lactamase VIM-20002
Beta-lactamase 0103
Metallo-beta-lactamase0002
Beta-lactamase 0003
DNA polymerase beta120012
60 kDa heat shock protein, mitochondrial0808
Beta-lactamase OXA-70003
10 kDa heat shock protein, mitochondrial0808
Angiopoietin-1 receptor041115
Beta-lactamase 0103
Beta-lactamase 0103
Beta-lactamase 0103
Thiosulfate sulfurtransferase0808
Metallo-beta-lactamase VIM-130103
Efflux transporter 0104
Beta-lactamase 0002
Beta-lactamase Toho-10003
Beta-lactamase 0104
Class D beta-lactamase0104
60 kDa chaperonin 0808
Metallo-beta-lactamase0002
Beta-lactamase 0103
Beta-lactamase 0001
10 kDa chaperonin 0808
Metallo-b-lactamase 0006
Carbapenem-hydrolyzing beta-lactamase KPC0104
Beta-lactamase class B VIM-2 0118
Beta-lactamase VIM-1 0103
Chain A, Putative fructose-1,6-bisphosphate aldolase270027
MPI protein0101
hypothetical protein, conserved5005
polyunsaturated fatty acid lipoxygenase ALOX12100010
perilipin-50404
perilipin-10404
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a0404
caspase-1 isoform alpha precursor7007
cGMP-dependent 3',5'-cyclic phosphodiesterase0404
Aurora kinase A041519
Rap guanine nucleotide exchange factor 3160016
cAMP-specific 3',5'-cyclic phosphodiesterase 4A010010
Dual specificity protein kinase TTK011314
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A0303
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B0303
cAMP-specific 3',5'-cyclic phosphodiesterase 4B0808
cAMP-specific 3',5'-cyclic phosphodiesterase 4C0505
cAMP-specific 3',5'-cyclic phosphodiesterase 4D010010
cGMP-inhibited 3',5'-cyclic phosphodiesterase B0707
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C0505
cGMP-inhibited 3',5'-cyclic phosphodiesterase A0808
Inner centromere protein0101
Caspase-7180018
caspase-3180018
nuclear factor NF-kappa-B p105 subunit isoform 17007
Beta-glucuronidase0303
Cholinesterase0718
Gastrin/cholecystokinin type B receptor1204
Testosterone 17-beta-dehydrogenase 30202
Alpha-synuclein114015
Chain A, retinol dehydratase0101
Glucose-6-phosphate 1-dehydrogenase0808
G-protein coupled bile acid receptor 10044
Atrial natriuretic peptide receptor 30202
Type-1A angiotensin II receptor 07512
Type-1 angiotensin II receptor0011
Type-1B angiotensin II receptor0819
Type-1 angiotensin II receptor010620
Type-2 angiotensin II receptor011112
Type-2 angiotensin II receptor0707
Nicotinate phosphoribosyltransferase0505
Luciferase530053
Tryptophan 5-hydroxylase 10707
D027027
D(3) dopamine receptor025126
D(2) dopamine receptor010010
Alpha-1D adrenergic receptor044752
D(1B) dopamine receptor017017
D(4) dopamine receptor019120
E3 ubiquitin-protein ligase Mdm20202
D0202
D0909
Substance-P receptor0314
Neuromedin-K receptor0101
cGMP-dependent protein kinase 1 001616
Substance-P receptor0101
Chain A, ADIPOCYTE LIPID-BINDING PROTEIN0011
Chain A, SERUM ALBUMIN0011
Chain A, SERUM ALBUMIN0011
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)160016
lethal(3)malignant brain tumor-like protein 1 isoform I5005
DNA dC->dU-editing enzyme APOBEC-3G isoform 14004
Fatty-acid amide hydrolase 10101
Prostaglandin G/H synthase 1 09011
Trypsin0101
Coagulation factor VII0303
60 kDa chaperonin0505
Tissue factor0404
Calmodulin 0146
Prostaglandin G/H synthase 2011012
Lanosterol 14-alpha demethylase011213
Solute carrier organic anion transporter family member 1B3021026
Cytosolic phospholipase A2 gamma0202
Transient receptor potential cation channel subfamily V member 20202
Solute carrier organic anion transporter family member 1B1022027
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN0022
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN0022
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN0022
Nitric oxide synthase, endothelial0002
Nitric oxide synthase, inducible0102
Cationic amino acid transporter 30202
Vasopressin V2 receptor015420
Oxytocin receptor09514
Vasopressin V1a receptor0639
Vasopressin V1a receptor025530
Vasopressin V1b receptor0549
Vasopressin V2 receptor0011
Vasopressin V1b receptor0416
Translocator protein0203
Oxytocin receptor0628
Vasopressin V2 receptor 09211
5-hydroxytryptamine receptor 3E0718
mu-type opioid receptor isoform MOR-10044
5-hydroxytryptamine receptor 2A0044
5-hydroxytryptamine receptor 3A0213
5-hydroxytryptamine receptor 3B0718
Neuronal acetylcholine receptor subunit alpha-4610320
Neuronal acetylcholine receptor subunit beta-2610320
Histamine H1 receptor06412
5-hydroxytryptamine receptor 3A011112
3-hydroxy-3-methylglutaryl-coenzyme A reductase 0606
5-hydroxytryptamine receptor 3D0718
Multidrug and toxin extrusion protein 2012012
5-hydroxytryptamine receptor 3C0718
Chain A, Hyaluronidase, phage associated0101
Pancreatic alpha-amylase0202
Albumin0202
Urease0304
Prolyl 4-hydroxylase subunit alpha-10001
Tyrosinase0202
Hyaluronate lyase0101
Prolyl hydroxylase EGLN20001
Egl nine homolog 10113
Prolyl hydroxylase EGLN30001
Hypoxia-inducible factor 1-alpha inhibitor0001
Solute carrier family 23 member 10101
Metabotropic glutamate receptor 60135
Excitatory amino acid transporter 40202
Glutamate transporter homolog0011
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase0202
Excitatory amino acid transporter 10304
Excitatory amino acid transporter 20304
Excitatory amino acid transporter 30304
Metabotropic glutamate receptor 10124
Metabotropic glutamate receptor 20124
Carbonic anhydrase-like protein, putative0007
Chain A, Phospholipase A2 isoform 30011
GTP-binding protein (rab7)0033
ras protein, partial0033
Rac1 protein0033
cell division cycle 42 (GTP binding protein, 25kDa), partial0033
Prostaglandin-H2 D-isomerase0202
Prostaglandin G/H synthase 2 0708
Epidermal growth factor receptor0321952
Fatty acid-binding protein, liver08210
Myeloperoxidase0909
Seed linoleate 13S-lipoxygenase-10303
Glutathione hydrolase 1 proenzyme0101
Substance-P receptor0404
4-aminobutyrate aminotransferase, mitochondrial0303
Ras-related protein Rab-2A0033
Rho-associated protein kinase 20202
glp-1 receptor, partial400040
Atrial natriuretic peptide receptor 10112
Atrial natriuretic peptide receptor 1 0011
Gamma-aminobutyric acid type B receptor subunit 20325
Gamma-aminobutyric acid type B receptor subunit 20303
Gamma-aminobutyric acid type B receptor subunit 10325
Gamma-aminobutyric acid type B receptor subunit 10202
Angiotensin-converting enzyme 016118
Liver carboxylesterase 10108
Angiotensin-converting enzyme0909
Zinc finger protein mex-50011
POsterior Segregation0022
Genome polyprotein0101
Hexokinase-20101
NPC intracellular cholesterol transporter 1 precursor190019
Spike glycoprotein041216
Replicase polyprotein 1ab051217
Transmembrane protease serine 2041216
Procathepsin L061218
Replicase polyprotein 1a061218
Replicase polyprotein 1ab051217
Replicase polyprotein 1ab0111223
Angiotensin-converting enzyme 2 071219
Gamma-aminobutyric acid receptor subunit alpha-1016622
Gamma-aminobutyric acid receptor subunit gamma-2015520
Gamma-aminobutyric acid receptor subunit beta-3016420
Chain A, Betaine ABC transporter permease and substrate binding protein0011
Chain A, Osmoprotection protein (ProX)0011
Chain A, Glycine betaine/carnitine/choline-binding protein0022
Chain A, Glycine betaine/carnitine/choline-binding protein0022
Chain A, Glycine betaine/carnitine/choline-binding protein0022
Chain A, Glycine betaine/carnitine/choline-binding protein0022
galanin receptor type 30101
ORF730022
Leukotriene C4 synthase001010
Bone morphogenetic protein receptor type-1B001515
Membrane-associated progesterone receptor component 10099
Cell division cycle 7-related protein kinase001111
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform051015
Serine/threonine-protein kinase PLK4021517
Serine/threonine-protein kinase 25001010
ATP-dependent RNA helicase DDX3X001414
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta001010
Pyridoxal kinase001414
Citron Rho-interacting kinase011516
Serine/threonine-protein kinase RIO3001010
Dual specificity mitogen-activated protein kinase kinase 7001010
Inhibitor of nuclear factor kappa-B kinase subunit beta011012
Peripheral plasma membrane protein CASK001010
Cyclin-G-associated kinase021517
Serine/threonine-protein kinase DCLK1001010
Inhibitor of nuclear factor kappa-B kinase subunit alpha011011
Muscle, skeletal receptor tyrosine-protein kinase001010
Ephrin type-B receptor 6001515
Peroxisomal acyl-coenzyme A oxidase 3001414
Mitogen-activated protein kinase kinase kinase 13001010
Death-associated protein kinase 3001010
Mitogen-activated protein kinase kinase kinase 7001010
Receptor-interacting serine/threonine-protein kinase 2041519
Mitotic checkpoint serine/threonine-protein kinase BUB1001414
NUAK family SNF1-like kinase 1011011
Dynamin-like 120 kDa protein, mitochondrial001414
Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma001010
Tyrosine-protein kinase JAK2021113
Rho-associated protein kinase 2001515
Serine/threonine-protein kinase ULK1001515
Serine/threonine-protein kinase/endoribonuclease IRE1001515
Ribosomal protein S6 kinase alpha-5001515
U5 small nuclear ribonucleoprotein 200 kDa helicase001414
Ribosomal protein S6 kinase alpha-4001515
Serine/threonine-protein kinase 16001515
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma001010
Serine/threonine-protein kinase PAK 3001010
Cyclin-dependent kinase-like 5001212
Serine/threonine-protein kinase 17B001010
Serine/threonine-protein kinase 10011516
Serine/threonine-protein kinase D3011516
Cyclin-dependent kinase 14001010
Structural maintenance of chromosomes protein 2001414
Mitogen-activated protein kinase kinase kinase 6001515
Serine/threonine-protein kinase OSR1001010
Mitogen-activated protein kinase kinase kinase kinase 4001515
Serine/threonine-protein kinase LATS1001515
Serine/threonine-protein kinase PAK 4021517
Serine/threonine-protein kinase Chk2011011
Tyrosine-protein kinase ABL10141935
RAF proto-oncogene serine/threonine-protein kinase061016
Guanine nucleotide-binding protein G(i) subunit alpha-2001010
ADP/ATP translocase 2001414
Cytochrome P450 2E10303
Protein kinase C beta type011415
Insulin receptor081523
Tyrosine-protein kinase Lck0141529
Glycogen phosphorylase, liver form001414
Tyrosine-protein kinase Fes/Fps011516
Macrophage colony-stimulating factor 1 receptor061016
Adenine phosphoribosyltransferase001111
Tyrosine-protein kinase Yes031518
Tyrosine-protein kinase Lyn051520
Proto-oncogene tyrosine-protein kinase receptor Ret071522
Insulin-like growth factor 1 receptor051520
Signal recognition particle receptor subunit alpha001313
Cytochrome c1, heme protein, mitochondrial001414
Hepatocyte growth factor receptor031417
Tyrosine-protein kinase HCK081523
Proto-oncogene tyrosine-protein kinase ROS001010
Platelet-derived growth factor receptor beta0121527
Tyrosine-protein kinase Fgr021315
Wee1-like protein kinase 2001010
Uncharacterized serine/threonine-protein kinase SBK3001010
Serine/threonine-protein kinase A-Raf011415
Mast/stem cell growth factor receptor Kit091221
Glycogen phosphorylase, brain form001414
Breakpoint cluster region protein071726
Serine/threonine-protein kinase pim-1011516
Fibroblast growth factor receptor 1081523
DNA topoisomerase 2-alpha041428
ADP/ATP translocase 3001414
Inosine-5'-monophosphate dehydrogenase 2001414
Proto-oncogene tyrosine-protein kinase Src0161531
cAMP-dependent protein kinase type II-alpha regulatory subunit001414
Insulin receptor-related protein001010
Serine/threonine-protein kinase B-raf051621
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform001515
Platelet-derived growth factor receptor alpha0111122
Tyrosine-protein kinase Fer011516
Protein kinase C alpha type021416
cAMP-dependent protein kinase catalytic subunit alpha011516
Vascular endothelial growth factor receptor 1 071017
General transcription and DNA repair factor IIH helicase subunit XPD001414
Interferon-induced, double-stranded RNA-activated protein kinase001010
Casein kinase II subunit alpha'001515
Ras-related protein Rab-6A001414
Serine/threonine-protein kinase MAK001010
Cyclin-dependent kinase 11B001010
Ephrin type-A receptor 1001515
Fibroblast growth factor receptor 2021012
Receptor tyrosine-protein kinase erbB-3041014
Multifunctional protein ADE2001414
Fibroblast growth factor receptor 4021012
Fibroblast growth factor receptor 3021012
cAMP-dependent protein kinase catalytic subunit gamma011314
cAMP-dependent protein kinase catalytic subunit beta011516
Ferrochelatase, mitochondrial001414
Ribosomal protein S6 kinase beta-1001515
Tyrosine-protein kinase JAK1021517
Protein kinase C eta type011011
Beta-adrenergic receptor kinase 1011718
Probable ATP-dependent RNA helicase DDX6001414
Activin receptor type-2A001010
MAP/microtubule affinity-regulating kinase 3001515
Deoxycytidine kinase001418
Ephrin type-A receptor 2051520
Ephrin type-A receptor 3001010
Ephrin type-A receptor 8001010
Ephrin type-B receptor 2031518
Leukocyte tyrosine kinase receptor001010
Non-receptor tyrosine-protein kinase TYK2001515
Phosphatidylethanolamine-binding protein 1001212
Wee1-like protein kinase001515
Heme oxygenase 2001414
Tyrosine-protein kinase receptor UFO021012
Mitogen-activated protein kinase 4001010
S-adenosylmethionine synthase isoform type-2001414
DnaJ homolog subfamily A member 1001414
RAC-alpha serine/threonine-protein kinase021517
RAC-beta serine/threonine-protein kinase011516
G protein-coupled receptor kinase 4001010
DNA replication licensing factor MCM4001414
Myosin-10001111
Tyrosine-protein kinase receptor Tie-1001010
Vascular endothelial growth factor receptor 3061016
Vascular endothelial growth factor receptor 20111123
Dual specificity mitogen-activated protein kinase kinase 2041519
Receptor-type tyrosine-protein kinase FLT3081524
Bone morphogenetic protein receptor type-1A001515
Activin receptor type-1B001515
TGF-beta receptor type-1011516
Serine/threonine-protein kinase receptor R3001212
TGF-beta receptor type-2001414
Electron transfer flavoprotein subunit beta001010
Tyrosine-protein kinase CSK031518
Glycine--tRNA ligase001414
Protein kinase C iota type011516
Exosome RNA helicase MTR4001414
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform041014
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform051015
Serine/threonine-protein kinase mTOR091120
Megakaryocyte-associated tyrosine-protein kinase001010
Tyrosine-protein kinase Tec031518
Tyrosine-protein kinase TXK031114
Tyrosine-protein kinase ABL2011516
Tyrosine-protein kinase FRK021517
Tyrosine-protein kinase ZAP-70001010
Tyrosine-protein kinase SYK041519
26S proteasome regulatory subunit 6B021416
Mitogen-activated protein kinase 8001616
Mitogen-activated protein kinase 9011617
Dual specificity mitogen-activated protein kinase kinase 4001212
Dual specificity mitogen-activated protein kinase kinase 3001515
Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha101314
Casein kinase I isoform alpha051419
Casein kinase I isoform delta021517
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform 071017
MAP kinase-activated protein kinase 2011516
Cyclin-dependent kinase 8011011
Elongation factor Tu, mitochondrial001414
Choline-phosphate cytidylyltransferase A001010
Cysteine--tRNA ligase, cytoplasmic001212
Casein kinase I isoform epsilon021517
Very long-chain specific acyl-CoA dehydrogenase, mitochondrial001414
Dual specificity protein kinase CLK1001515
Dual specificity protein kinase CLK2001515
Dual specificity protein kinase CLK3001313
Glycogen synthase kinase-3 alpha001515
Glycogen synthase kinase-3 beta021618
Cyclin-dependent kinase 7001515
Cyclin-dependent kinase 9001515
Ras-related protein Rab-27A001414
Tyrosine-protein kinase Blk031114
Interleukin-1 receptor-associated kinase 1001515
Ribosomal protein S6 kinase alpha-3021517
Cytoplasmic tyrosine-protein kinase BMX031114
cAMP-dependent protein kinase catalytic subunit PRKX001111
Serine/threonine-protein kinase Nek2011516
Serine/threonine-protein kinase Nek3001515
Serine/threonine-protein kinase Nek4001010
Tyrosine-protein kinase JAK3021113
Dual specificity mitogen-activated protein kinase kinase 6011516
Serine/threonine-protein kinase PLK1041418
Death-associated protein kinase 1001010
Dipeptidyl peptidase 10202
LIM domain kinase 1011516
LIM domain kinase 2011516
Mitogen-activated protein kinase 10021618
Tyrosine--tRNA ligase, cytoplasmic001313
5'-AMP-activated protein kinase subunit gamma-1001415
5'-AMP-activated protein kinase catalytic subunit alpha-2011012
Ephrin type-B receptor 3001515
Ephrin type-A receptor 5001515
Ephrin type-B receptor 4051520
Ephrin type-B receptor 1001010
Ephrin type-A receptor 4001515
Adenylate kinase 2, mitochondrial001414
Adenosine kinase001414
Hormonally up-regulated neu tumor-associated kinase001010
Serine/threonine-protein kinase SIK1021012
Receptor-interacting serine/threonine-protein kinase 4001010
Ras-related protein Rab-10001313
Cell division control protein 2 homolog001010
Actin-related protein 3001414
Actin-related protein 2001414
Calcium-dependent protein kinase 1001010
GTP-binding nuclear protein Ran001414
Casein kinase II subunit alpha001010
Phosphatidylinositol 5-phosphate 4-kinase type-2 beta001010
SRSF protein kinase 2001010
Casein kinase I isoform gamma-2001515
Mitogen-activated protein kinase kinase kinase 9001010
Serine/threonine-protein kinase PknB001010
Cyclin-dependent kinase 3001515
Cyclin-dependent kinase-like 1001010
Cyclin-dependent kinase 6011415
Cyclin-dependent-like kinase 5 001515
Cyclin-dependent kinase 16001515
Cyclin-dependent kinase 17001515
Protein kinase C epsilon type011011
Dual specificity mitogen-activated protein kinase kinase 1051520
Mitogen-activated protein kinase kinase kinase 10001010
DNA topoisomerase 2-beta021524
Protein kinase C theta type011516
Activin receptor type-1001515
Macrophage-stimulating protein receptor001515
Focal adhesion kinase 1031518
Protein kinase C zeta type021012
Protein kinase C delta type021517
Tyrosine-protein kinase BTK051621
Tyrosine-protein kinase receptor TYRO3001010
Cyclin-dependent kinase 18001111
Activated CDC42 kinase 1021517
Epithelial discoidin domain-containing receptor 1051520
Tyrosine-protein kinase ITK/TSK021113
Myotonin-protein kinase011011
Mitogen-activated protein kinase kinase kinase kinase 2011516
Mitogen-activated protein kinase kinase kinase 12001010
Tyrosine-protein kinase Mer021214
Serine/threonine-protein kinase 4011516
5'-AMP-activated protein kinase catalytic subunit alpha-1011517
Serine/threonine-protein kinase PAK 1001010
Dual specificity mitogen-activated protein kinase kinase 5001515
Mitogen-activated protein kinase 7001515
Serine/threonine-protein kinase PAK 2001515
Serine/threonine-protein kinase 3001515
Mitogen-activated protein kinase kinase kinase 1001515
cGMP-dependent protein kinase 2001010
Integrin-linked protein kinase001414
Rho-associated protein kinase 1001515
Non-receptor tyrosine-protein kinase TNK1001515
Serine/threonine-protein kinase PRP4 homolog001010
Receptor-interacting serine/threonine-protein kinase 1011011
Calcium/calmodulin-dependent protein kinase type II subunit beta001010
Calcium/calmodulin-dependent protein kinase type II subunit gamma011516
Calcium/calmodulin-dependent protein kinase type II subunit delta001515
Dual specificity tyrosine-phosphorylation-regulated kinase 1A001515
Activin receptor type-2B001515
Bone morphogenetic protein receptor type-2001515
Protein-tyrosine kinase 6021517
Cyclin-dependent kinase 13001515
Calcium/calmodulin-dependent protein kinase type 1001010
Inhibitor of nuclear factor kappa-B kinase subunit epsilon001515
Protein-tyrosine kinase 2-beta011516
Maternal embryonic leucine zipper kinase021517
Chromodomain-helicase-DNA-binding protein 4001414
Peroxisomal acyl-coenzyme A oxidase 1001212
Serine/threonine-protein kinase D1011011
Serine/threonine-protein kinase 38001212
Receptor tyrosine-protein kinase erbB-4051116
Ribosomal protein S6 kinase alpha-2001010
Ephrin type-A receptor 7001515
Delta(24)-sterol reductase001414
Ribosomal protein S6 kinase alpha-1031518
Dual specificity testis-specific protein kinase 1001313
Myosin light chain kinase, smooth muscle011516
Serine/threonine-protein kinase STK11001515
Rhodopsin kinase GRK1011011
NT-3 growth factor receptor001010
Serine/threonine-protein kinase N1001515
Serine/threonine-protein kinase N2001515
Calcium/calmodulin-dependent protein kinase type IV001515
Mitogen-activated protein kinase kinase kinase 11001515
BDNF/NT-3 growth factors receptor011011
MAP kinase-activated protein kinase 30077
Mitogen-activated protein kinase 6001010
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform001010
Discoidin domain-containing receptor 2051520
AP2-associated protein kinase 1011516
Myosin light chain kinase 3001515
Uncharacterized aarF domain-containing protein kinase 50088
Serine/threonine-protein kinase SBK1001010
Mitogen-activated protein kinase kinase kinase 19001010
Putative heat shock protein HSP 90-beta 2001414
Serine/threonine-protein kinase TNNI3K011011
Rab-like protein 30099
Serine/threonine-protein kinase MRCK alpha001515
Serine/threonine-protein kinase MRCK gamma001515
Acyl-CoA dehydrogenase family member 10001212
Serine/threonine-protein kinase Nek5001010
Serine/threonine-protein kinase N3001212
Serine/threonine-protein kinase ULK3001515
Dual serine/threonine and tyrosine protein kinase001010
Mitogen-activated protein kinase kinase kinase 15001010
Uncharacterized protein FLJ45252001414
Acyl-CoA dehydrogenase family member 11001313
Serine/threonine-protein kinase/endoribonuclease IRE2001313
Serine/threonine-protein kinase MARK2001515
ATP-dependent RNA helicase DHX30001212
Serine/threonine-protein kinase TAO1001515
STE20-related kinase adapter protein alpha001414
Myosin-14001414
AarF domain-containing protein kinase 1001414
Serine/threonine-protein kinase tousled-like 2001010
Serine/threonine-protein kinase 32C001010
Serine/threonine-protein kinase pim-3001010
ATP-dependent RNA helicase DDX42001212
Serine/threonine-protein kinase VRK2001010
Myosin light chain kinase family member 4001010
Homeodomain-interacting protein kinase 1011011
Calcium/calmodulin-dependent protein kinase type 1D011011
Mitogen-activated protein kinase kinase kinase kinase 3001515
Cyclin-dependent kinase-like 3001010
MAP kinase-activated protein kinase 5001414
Serine/threonine-protein kinase BRSK2001010
Serine/threonine-protein kinase NIM1001010
Eukaryotic peptide chain release factor GTP-binding subunit ERF3B0066
Serine/threonine-protein kinase ULK2001010
Misshapen-like kinase 1011314
Serine/threonine-protein kinase DCLK2001010
Calcium/calmodulin-dependent protein kinase kinase 1001010
Casein kinase I isoform alpha-like001010
Homeodomain-interacting protein kinase 4011011
Myosin-IIIa001010
Ankyrin repeat and protein kinase domain-containing protein 1001010
Serine/threonine-protein kinase Nek11001010
Atypical kinase COQ8A, mitochondrial001515
Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma001515
Mitogen-activated protein kinase 15001515
Serine/threonine-protein kinase Nek9001515
Serine/threonine-protein kinase BRSK1001010
Serine/threonine-protein kinase 35001010
Serine/threonine-protein kinase Nek7001313
Rhodopsin kinase GRK7001010
Serine/threonine-protein kinase 32A001010
Myosin-IIIb001010
ATP-dependent RNA helicase DDX1001414
Dual specificity tyrosine-phosphorylation-regulated kinase 2001010
Cyclin-dependent kinase-like 2001010
Mitogen-activated protein kinase kinase kinase kinase 1001515
Serine/threonine-protein kinase Sgk3001010
Atypical kinase COQ8B, mitochondrial001010
MAP/microtubule affinity-regulating kinase 4001515
Calcium/calmodulin-dependent protein kinase type 1G001212
Serine/threonine-protein kinase Nek1001515
Cyclin-dependent kinase 15001010
PAS domain-containing serine/threonine-protein kinase001212
Calcium/calmodulin-dependent protein kinase kinase 2001515
EKC/KEOPS complex subunit TP53RK001414
SRSF protein kinase 1001010
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase041519
Mitogen-activated protein kinase kinase kinase 5001515
Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha001010
Mitogen-activated protein kinase kinase kinase 3001515
Eukaryotic translation initiation factor 2-alpha kinase 1001515
Serine/threonine-protein kinase RIO1001010
MAP kinase-interacting serine/threonine-protein kinase 1001010
Serine/threonine-protein kinase RIO2001010
Cyclin-dependent kinase 19011011
Transient receptor potential cation channel subfamily M member 6001010
Testis-specific serine/threonine-protein kinase 1001010
Serine/threonine-protein kinase 33001010
Nucleolar GTP-binding protein 1001414
Serine/threonine-protein kinase D2001515
Serine/threonine-protein kinase DCLK3001010
NUAK family SNF1-like kinase 2001515
RNA cytidine acetyltransferase001414
Serine/threonine-protein kinase SIK2011516
Myosin light chain kinase 2, skeletal/cardiac muscle001010
STE20-like serine/threonine-protein kinase 001515
Serine/threonine-protein kinase TAO3001515
Homeodomain-interacting protein kinase 2011011
Tyrosine-protein kinase Srms001010
Homeodomain-interacting protein kinase 3011011
Serine/threonine-protein kinase PLK3021012
dCTP pyrophosphatase 1001414
Dual specificity protein kinase CLK4001515
MAP kinase-interacting serine/threonine-protein kinase 2011011
Serine/threonine-protein kinase Nek6001010
Casein kinase I isoform gamma-1001515
Serine/threonine-protein kinase PAK 6011213
SNF-related serine/threonine-protein kinase001010
Serine/threonine-protein kinase LATS2001010
Serine/threonine-protein kinase 36011011
Phenylalanine--tRNA ligase beta subunit001414
BMP-2-inducible protein kinase001515
Obg-like ATPase 1001313
Midasin001414
Interleukin-1 receptor-associated kinase 4011516
Serine/threonine-protein kinase 32B001010
Mitogen-activated protein kinase kinase kinase 20001515
Cyclin-dependent kinase 12001414
Serine/threonine-protein kinase PLK2021012
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13001414
Serine/threonine-protein kinase MARK1001010
Serine/threonine-protein kinase pim-2001212
Serine/threonine-protein kinase PAK 5011011
Serine/threonine-protein kinase 26001515
eIF-2-alpha kinase GCN2001010
Serine/threonine-protein kinase NLK011516
Serine/threonine-protein kinase 17A001010
STE20/SPS1-related proline-alanine-rich protein kinase001010
Ephrin type-A receptor 6001010
5'-AMP-activated protein kinase subunit gamma-2001415
Serine/threonine-protein kinase TBK1021517
Septin-9001414
Death-associated protein kinase 2001010
Ribosomal protein S6 kinase alpha-6001515
TRAF2 and NCK-interacting protein kinase011516
Serine/threonine-protein kinase tousled-like 1001010
Serine/threonine-protein kinase TAO2001515
Long-chain-fatty-acid--CoA ligase 5001010
ALK tyrosine kinase receptor031114
SRSF protein kinase 3001010
Serine/threonine-protein kinase ICK001414
Cyclin-dependent kinase 11A001010
Aurora kinase C001010
Calcium/calmodulin-dependent protein kinase type II subunit alpha001010
RAC-gamma serine/threonine-protein kinase011516
Serine/threonine-protein kinase 38-like001111
Microtubule-associated serine/threonine-protein kinase 1001010
Serine/threonine-protein kinase SIK3011516
Mitogen-activated protein kinase kinase kinase 2001515
Thyroid hormone receptor-associated protein 3001313
Dual specificity tyrosine-phosphorylation-regulated kinase 1B001212
Mitogen-activated protein kinase kinase kinase kinase 5011516
Receptor-interacting serine/threonine-protein kinase 3011415
Serine/threonine-protein kinase MRCK beta001515
Interleukin-1 receptor-associated kinase 3001515
Serine/threonine-protein kinase 24011314
Casein kinase I isoform gamma-3001515
Mitogen-activated protein kinase kinase kinase 4001515
Gamma-aminobutyric acid receptor subunit pi014014
Gamma-aminobutyric acid receptor subunit delta014014
Gamma-aminobutyric acid receptor subunit beta-1014216
Gamma-aminobutyric acid receptor subunit alpha-5015520
Gamma-aminobutyric acid receptor subunit alpha-3015318
Gamma-aminobutyric acid receptor subunit alpha-2015419
Gamma-aminobutyric acid receptor subunit beta-2014418
Gamma-aminobutyric acid receptor subunit alpha-4014216
Gamma-aminobutyric acid receptor subunit epsilon014014
Gamma-aminobutyric acid receptor subunit alpha-6015217
Gamma-aminobutyric acid receptor subunit gamma-1014014
Gamma-aminobutyric acid receptor subunit gamma-3014014
Gamma-aminobutyric acid receptor subunit theta014014
Caspase-75005
Eukaryotic translation initiation factor 5B0099
UMP-CMP kinase 0099
ATP-dependent 6-phosphofructokinase, platelet type001313
Serine/threonine-protein kinase ATR0268
Structural maintenance of chromosomes protein 1A001313
Cyclin-dependent kinase 100044
Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial001212
Mcl-10303
G-protein coupled receptor 35 isoform a0101
G-protein coupled receptor 550101
Aryl hydrocarbon receptor0011
Chain H, Proteasome component PUP10101
Chain I, Proteasome component PUP30101
Chain K, Proteasome component PRE20101
Chain L, Proteasome component C50101
Chain K, Proteasome component PRE20101
Chain L, Proteasome component C50101
Proteasome subunit beta type-110203
26S proteasome non-ATPase regulatory subunit 110202
26S proteasome non-ATPase regulatory subunit 120202
26S proteasome non-ATPase regulatory subunit 140202
Proteasome subunit alpha type-70203
26S proteasome non-ATPase regulatory subunit 30202
Chymotrypsinogen A0505
Cathepsin B0202
Neutrophil elastase0303
Cathepsin G0404
Lysosomal protective protein0202
Chymotrypsinogen B0101
26S proteasome regulatory subunit 6A0202
Nuclear factor NF-kappa-B p105 subunit0102
Proteasome subunit beta type-10204
Chymase0101
Proteasome subunit alpha type-10203
Proteasome subunit alpha type-20203
Proteasome subunit alpha type-30203
Proteasome subunit alpha type-40203
Proteasome subunit beta type-80203
Proteasome subunit beta type-80101
Proteasome subunit beta type-90203
Proteasome subunit alpha type-50203
Proteasome subunit beta type-40203
Proteasome subunit beta type-60203
Proteasome subunit beta type-50305
26S proteasome regulatory subunit 70202
Lon protease homolog, mitochondrial0101
Proteasome subunit beta type-100203
26S proteasome non-ATPase regulatory subunit 80202
Proteasome subunit beta type-30203
Proteasome subunit beta type-20204
26S proteasome non-ATPase regulatory subunit 70202
26S proteasome non-ATPase regulatory subunit 40202
26S proteasome complex subunit SEM10202
Proteasome subunit alpha type-60236
26S proteasome regulatory subunit 40202
26S proteasome regulatory subunit 80202
26S proteasome regulatory subunit 10B0202
Nuclear factor NF-kappa-B p100 subunit 0101
Transcription factor p650202
26S proteasome non-ATPase regulatory subunit 20202
26S proteasome non-ATPase regulatory subunit 60202
Proteasomal ubiquitin receptor ADRM10202
ATP-dependent Clp protease proteolytic subunit0112
NACHT, LRR and PYD domains-containing protein 3 0202
Proteasome subunit alpha-type 80203
Proteasome subunit beta type-70203
26S proteasome non-ATPase regulatory subunit 10202
26S proteasome non-ATPase regulatory subunit 130202
Nucleophosmin0101
Glycogen phosphorylase, muscle form0101
Tyrosine-protein kinase Blk0202
Platelet-derived growth factor receptor alpha0101
Sodium- and chloride-dependent GABA transporter 10606
G protein-coupled receptor kinase 6001212
Synaptic vesicular amine transporter0404
Platelet-derived growth factor receptor beta0101
Dual specificity testis-specific protein kinase 20088
Isoleucine--tRNA ligase, mitochondrial0099
B2 bradykinin receptor0101
B1 bradykinin receptor0101
Olfactory receptor 51E20033
Genome polyprotein 0112
Solute carrier family 12 member 20101
Potassium channel subfamily K member 30303
Potassium channel subfamily K member 30101
Potassium channel subfamily K member 90101
Acetylcholine receptor subunit alpha0527
Acetylcholine receptor subunit gamma0527
Integrin alpha-50101
Acetylcholine receptor subunit beta0527
UDP-glucuronosyltransferase 2B708019
Neuronal acetylcholine receptor subunit beta-20629
Neuronal acetylcholine receptor subunit beta-40528
Neuronal acetylcholine receptor subunit alpha-30527
UDP-glucuronosyltransferase 2B10 0606
Neuronal acetylcholine receptor subunit alpha-70527
Neuronal acetylcholine receptor subunit alpha-40528
Acetylcholine receptor subunit delta0527
Beta-2 adrenergic receptor09111
Beta-1 adrenergic receptor09213
Beta-3 adrenergic receptor0617
Alpha-2A adrenergic receptor0303
5-hydroxytryptamine receptor 2A0101
Lysosomal alpha-glucosidase0101
Matrix metalloproteinase-90606
Chain A, Glycogen Phosphorylase0101
Chain A, Glycogen phosphorylase, liver form0022
Chain A, glycogen phosphorylase, liver form0022
Chain A, Glycogen phosphorylase, liver form0022
Chain A, Glycogen phosphorylase, liver form0022
Chain A, Chitinase0101
Glycogen phosphorylase, liver form0101
Glycogen phosphorylase, muscle form0101
Acetylcholinesterase020020
Amine oxidase [flavin-containing] B014015
Adenosine receptor A30303
Adenosine receptor A2b0305
Adenosine receptor A2b0316
Adenosine receptor A1015221
Vasopressin V2 receptor0204
Adenosine receptor A2a0202
Adenosine receptor A10303
DNA-dependent protein kinase catalytic subunit0707
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B0101
Adenylate cyclase type 10114
Chitotriosidase-10415
Serine-protein kinase ATM0202
Adenosine receptor A2b0103
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C0101
Palmitoleoyl-protein carboxylesterase NOTUM0235
Endochitinase B10415
Muscarinic acetylcholine receptor0214
Phosphodiesterase 0101
Guanine deaminase0203
DNA topoisomerase 0101
eukaryotic translation initiation factor 2-alpha kinase 3 isoform 1 precursor0011
relaxin receptor 1 isoform 13003
Telomerase reverse transcriptase0101
Type-2 restriction enzyme ScaI0101
Deoxyribonuclease-2-alpha0101
Tyrosyl-DNA phosphodiesterase 20101
Deoxyribonuclease-10101
Type-2 restriction enzyme PstI0101
Type-2 restriction enzyme EcoRI0101
DNA ligase0202
Heterogeneous nuclear ribonucleoprotein A10011
DNA topoisomerase 104314
Type-2 restriction enzyme BamHI0101
Somatostatin receptor type 10101
Somatostatin receptor type 20101
Somatostatin receptor type 40101
Somatostatin receptor type 30101
Somatostatin receptor type 50101
Type-2 restriction enzyme HindIII0101
Ribonuclease pancreatic0101
DNA topoisomerase 10203
DNA topoisomerase 10101
Integrase 0404
DNA topoisomerase type IB small subunit 0011
Tyrosyl-DNA phosphodiesterase 10303
Vpr9009
Chain A, angiotensin converting enzyme0101
Chain A, angiotensin converting enzyme0101
Neprilysin0101
Neprilysin0202
Leukotriene A-4 hydrolase0314
EEF1AKMT4-ECE2 readthrough transcript protein0101
Leukotriene A-4 hydrolase0101
Thymidine phosphorylase0011
Endothelin-converting enzyme 10101
Succinyl-diaminopimelate desuccinylase0404
Beta-lactamase TEM0406
Beta-lactamase 0304
Beta-lactamase 0303
Major prion protein0066
Sodium channel protein type 1 subunit alpha0505
Sodium channel protein type 2 subunit alpha0808
Sodium channel protein type 3 subunit alpha0505
Frizzled-80011
P2X purinoceptor 40404
Dihydroxyacetone phosphate acyltransferase0003
Oxytocin receptor0022
Chain A, serum paraoxonase0101
Poly [ADP-ribose] polymerase tankyrase-20123
Proteasome subunit beta type-20101
Proteasome subunit beta type-10101
Glutathione S-transferase omega-10404
Solute carrier family 22 member 50001
Solute carrier family 22 member 50102
Solute carrier family 22 member 160001
Solute carrier family 22 member 210001
Solute carrier family 22 member 50001
short transient receptor potential channel 6 isoform 10022
Toll-like receptor 40202
Amyloid-beta precursor protein2709
Beta-2 adrenergic receptor017624
Potassium channel subfamily K member 100101
Cytochrome P450 1B10404
tyrosine-protein kinase Yes110011
Solute carrier family 22 member 1108013
Solute carrier family 22 member 809011
Glutathione reductase, mitochondrial0808
Glutathione peroxidase 10101
Microsomal glutathione S-transferase 10101
Solute carrier family 22 member 706010
Solute carrier family 22 member 70508
Chain A, Carbonic anhydrase II0101
thyrotropin-releasing hormone receptor7007
interferon gamma precursor0003
prostaglandin E2 receptor EP2 subtype1002
Prostaglandin E synthase0303
cGMP-specific 3',5'-cyclic phosphodiesterase0606
Cytochrome c oxidase subunit 10101
Cytochrome c oxidase subunit 20101
Catechol O-methyltransferase0101
Cytochrome c oxidase subunit 20303
Quinolone resistance protein NorA0607
Calpain-2 catalytic subunit0101
Prostaglandin G/H synthase 10303
Cruzipain0303
Indoleamine 2,3-dioxygenase 10505
Bifunctional epoxide hydrolase 20404
Prostaglandin G/H synthase 2 0608
Prostaglandin G/H synthase 20506
Prostaglandin G/H synthase 1 0608
Prostaglandin G/H synthase 10101
Cyclooxygenase-2 0101
Rap guanine nucleotide exchange factor 4100010
P2Y purinoceptor 120303
Beta-lactamase 0001
Beta-lactamase 0103
Beta-lactamase0001
Nuclear receptor subfamily 1 group I member 2011112
Beta-lactamase0103
Beta-lactamase0103
Beta-lactamase OXA-100001
Beta-lactamase0001
Beta-lactamase0001
Beta-lactamase 0001
Beta-lactamase 0103
Beta-lactamase 0001
Beta-lactamase 0001
Beta-lactamase IMP-1 0001
Beta-lactamase 0001
Beta-lactamase 0001
Beta-lactamase 0001
Beta-lactamase 0203
WRN3003
Beta-lactamase 0102
DNA (cytosine-5)-methyltransferase 1 isoform b0101
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 10101
Solute carrier family 22 member 80506
Beta-lactamase OXA-10102
Metallo-beta-lactamase VIM-20001
Beta-lactamase 0102
phosphoglycerate kinase4004
streptokinase A precursor0066
30S ribosomal protein S60607
30S ribosomal protein S70607
50S ribosomal protein L150607
50S ribosomal protein L100607
50S ribosomal protein L110607
50S ribosomal protein L7/L120607
50S ribosomal protein L190607
50S ribosomal protein L10607
50S ribosomal protein L200607
50S ribosomal protein L270607
50S ribosomal protein L280607
50S ribosomal protein L290607
50S ribosomal protein L310607
50S ribosomal protein L31 type B0607
50S ribosomal protein L320607
50S ribosomal protein L330607
50S ribosomal protein L340607
50S ribosomal protein L350607
50S ribosomal protein L360607
30S ribosomal protein S100607
30S ribosomal protein S110607
30S ribosomal protein S120607
30S ribosomal protein S130607
30S ribosomal protein S160607
30S ribosomal protein S180607
30S ribosomal protein S190607
30S ribosomal protein S200607
30S ribosomal protein S20607
30S ribosomal protein S30607
30S ribosomal protein S40607
30S ribosomal protein S50607
30S ribosomal protein S80607
30S ribosomal protein S90607
50S ribosomal protein L130607
50S ribosomal protein L140607
50S ribosomal protein L160607
50S ribosomal protein L230607
30S ribosomal protein S150607
50S ribosomal protein L170607
50S ribosomal protein L210607
50S ribosomal protein L300607
50S ribosomal protein L60607
30S ribosomal protein S140607
30S ribosomal protein S170607
30S ribosomal protein S10607
50S ribosomal protein L180607
50S ribosomal protein L20607
50S ribosomal protein L30607
50S ribosomal protein L240607
50S ribosomal protein L40607
50S ribosomal protein L220607
50S ribosomal protein L50607
30S ribosomal protein S210607
50S ribosomal protein L250607
50S ribosomal protein L36 20607
Methionine--tRNA ligase, mitochondrial0011
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase0101
glucose-6-phosphate 1-dehydrogenase isoform b0101
Dihydrofolate reductase 0404
Riboflavin-binding protein0011
Histidine-rich protein PFHRP-II0203
Spike glycoprotein0101
DNA ligase 10101
Beta-secretase 10303
Calcium-dependent protein kinase 10011
MO15-related protein kinase Pfmrk 0101
DNA ligase A0101
Sigma intracellular receptor 20303
Phosphoethanolamine N-methyltransferase0101
Cysteine proteinase falcipain 2a 0101
Cysteine proteinase falcipain 2a 0101
NADPH oxidase 10404
Snq2p0008
Adenylate cyclase type 1 0404
histone deacetylase 9 isoform 39009
Transient receptor potential cation channel subfamily V member 10202
Albumin0131534
Sarcoplasmic/endoplasmic reticulum calcium ATPase 10404
Major prion protein0011
Cys-loop ligand-gated ion channel0101
Calmodulin-10426
Sphingomyelin phosphodiesterase0202
Adenylate cyclase type 30404
Adenylate cyclase type 20415
Adenylate cyclase type 40404
Trypanothione reductase010010
Pleiotropic ABC efflux transporter of multiple drugs08016
Adenylate cyclase type 80404
Gastrin/cholecystokinin type B receptor0303
Aldehyde oxidase 10101
Adenylate cyclase type 60404
Adenylate cyclase type 50404
Aldehyde oxidase0507
Adenylyl cyclase 7 0404
cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 70001
Chain A, Acetylcholinesterase0022
Chain A, Acetylcholinesterase0022
Chain A, Acetylcholinesterase0022
Chain A, Acetylcholinesterase0022
Chain A, Acetylcholinesterase0022
Chain A, Acetylcholinesterase0022
Chain A, Acetylcholinesterase0022
Chain A, Putative Glycine Betaine-binding Abc Transporter Protein0011
Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN0011
Chain A, Choline-binding protein0011
Solute carrier family 22 member 10304
Solute carrier family 22 member 20303
Neuronal acetylcholine receptor subunit alpha-30539
Neuronal acetylcholine receptor subunit alpha-20427
Neuronal acetylcholine receptor subunit beta-30337
Neuronal acetylcholine receptor subunit beta-40539
Neuronal acetylcholine receptor subunit alpha-50326
Sodium- and chloride-dependent creatine transporter 10101
Neuronal acetylcholine receptor subunit alpha-60337
Neuronal acetylcholine receptor subunit alpha-90326
High affinity choline transporter 10101
Neuronal acetylcholine receptor subunit alpha-100326
Potassium-transporting ATPase alpha chain 10202
Potassium-transporting ATPase subunit beta0202
Solute carrier family 22 member 40202
DNA gyrase subunit B0101
DNA gyrase subunit A0101
DNA gyrase subunit B0203
DNA gyrase subunit A0407
DNA gyrase subunit B0407
DNA topoisomerase 4 subunit A0101
DNA topoisomerase 4 subunit B0102
DNA topoisomerase 4 subunit A0203
DNA gyrase subunit A0203
Multidrug resistance protein MdtK0011
DNA gyrase subunit B0405
DNA gyrase subunit A0405
Enoyl-[acyl-carrier-protein] reductase [NADH]0207
DNA topoisomerase 4 subunit A0101
DNA topoisomerase 4 subunit B0101
Sodium-dependent noradrenaline transporter0404
Aldo-keto reductase family 1 member B10707
Sodium-dependent serotonin transporter0404
Sodium-dependent dopamine transporter0606
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase0011
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase0011
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase0011
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase0011
hepatocyte nuclear factor 4-alpha isoform 20101
Beta-lactamase0101
3-dehydroquinate dehydratase0011
ATP-citrate synthase 0203
Ribonuclease T0001
Cell death-related nuclease 40001
3-dehydroquinate dehydratase0011
Prolyl 4-hydroxylase0303
Alpha-ketoglutarate-dependent dioxygenase FTO0202
Protein-arginine deiminase type-4010010
Peroxisome proliferator-activated receptor alpha0145
Peroxisome proliferator-activated receptor gamma051218
Peroxisome proliferator-activated receptor gamma0044
Peroxisome proliferator-activated receptor alpha1449
Trypanothione reductase0101
Envelope glycoprotein0044
2,3-bisphosphoglycerate-independent phosphoglycerate mutase3003
Gamma-aminobutyric acid receptor subunit alpha-10304
Gamma-aminobutyric acid receptor subunit beta-10304
Gamma-aminobutyric acid receptor subunit alpha-20304
Gamma-aminobutyric acid receptor subunit alpha-30304
Gamma-aminobutyric acid receptor subunit alpha-40304
Gamma-aminobutyric acid receptor subunit gamma-20304
Translocator protein0202
Translocator protein0404
Cholecystokinin receptor type A1304
Beta-1 adrenergic receptor 03510
Alpha-1B adrenergic receptor 0011
Solute carrier family 22 member 3014015
Alpha-1A adrenergic receptor0314
Alpha-2B adrenergic receptor0102
Alpha-2C adrenergic receptor0102
Alpha-2A adrenergic receptor0102
Nischarin0202
Nischarin0303
parathyroid hormone/parathyroid hormone-related peptide receptor precursor160016
P2Y purinoceptor 120202
Endothelin receptor type B0202
5-hydroxytryptamine receptor 3A0505
Endothelin receptor type B0202
5-hydroxytryptamine receptor 2C 0404
5-hydroxytryptamine receptor 2A0303
5-hydroxytryptamine receptor 5A0303
D(2) dopamine receptor0202
D(3) dopamine receptor0202
D(2) dopamine receptor0303
5-hydroxytryptamine receptor 2B0303
Transporter0707
Cholecystokinin receptor type A0303
5-hydroxytryptamine receptor 1A0303
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION0011
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION0011
Chain H, Fab M82G2, Heavy chain0011
Chain L, Fab M82G2, Light chain0011
Chain H, Fab M82g2, Heavy Chain0011
Chain L, Fab M82g2, Light Chain0011
Fatty acid-binding protein, heart0101
Muscarinic acetylcholine receptor M20101
Lysosomal Pro-X carboxypeptidase0101
Leukotriene B4 receptor 10102
Leukotriene B4 receptor 20113
Cytochrome P450 2D10303
Cytochrome P450 2D260404
Cytochrome P450 2D30404
Kappa-type opioid receptor09213
Mu-type opioid receptor011217
Cytochrome P450 2D40404
Mas-related G-protein coupled receptor member X20022
Histone acetyltransferase p3000101
Histone acetyltransferase KAT2B0101
Histone acetyltransferase KAT50101
N-alpha-acetyltransferase 500011
PAX80003
nuclear receptor subfamily 0 group B member 10202
steroidogenic factor 10202
Tubulin alpha-1A chain0225
Tubulin beta chain0224
Tubulin beta-4A chain0338
Tubulin beta chain0338
Tubulin alpha-3C chain0338
Tubulin alpha-1B chain0338
Tubulin alpha-4A chain0338
Tubulin beta-4B chain0338
Vesicular acetylcholine transporter0101
Tubulin beta-3 chain0439
Tubulin beta-2A chain0338
Tubulin polymerization-promoting protein0011
Tubulin beta-8 chain0338
Tubulin beta-2B chain0316
Tubulin alpha-3E chain0338
Tubulin alpha-1A chain0338
Similar to alpha-tubulin isoform 1 0215
Similar to alpha-tubulin isoform 1 0204
CREB-binding protein2002
Tubulin alpha-1C chain0338
Tubulin beta-6 chain0338
Tubulin beta-2B chain0338
Tubulin beta-1 chain0338
relaxin receptor 2 isoform 11001
Solute carrier family 2, facilitated glucose transporter member 10011
Adenylate cyclase type 80011
Relaxin receptor 10011
Nuclear receptor subfamily 1 group I member 20033
Potassium voltage-gated channel subfamily A member 10314
Sodium- and chloride-dependent creatine transporter 10101
Phosphodiesterase 0303
Multidrug resistance-associated protein 50102
LMP1 [Human herpesvirus 4]0003
nuclear receptor coactivator 1 isoform 1 [Homo sapiens]0303
transactivating tegument protein VP16 [Human herpesvirus 1]0303
nuclear receptor coactivator 3 isoform a0303
Thymidine kinase 2, mitochondrial0101
Thymidine kinase0101
Thymidylate synthase0405
Thymidine kinase0101
Probable deoxycytidylate deaminase0002
Cytidine deaminase0104
Enoyl-[acyl-carrier-protein] reductase [NADH] 0101
Deoxynucleoside kinase0101
Glutathione S-transferase P0202
Alpha-tocopherol transfer protein0011
Isocitrate lyase0202
Sodium/glucose cotransporter 10235
Sodium/glucose cotransporter 20336
Sodium/glucose cotransporter 20011
Sodium/myo-inositol cotransporter 20202
Solute carrier family 5 member 40101
Chain A, Pol Polyprotein0101
Chain A, Pol Polyprotein0101
Chain B, Pol Polyprotein0101
Chain A, Pol Polyprotein0101
Chain B, Pol Polyprotein0101
Chain A, HIV-1 Protease0101
Chain B, HIV-1 Protease0101
Chain A, protease0101
Chain B, protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, Protease (Retropepsin)0011
Chain B, Protease (Retropepsin)0011
Chain A, Protease (Retropepsin)0011
Chain B, Protease (Retropepsin)0011
Chain A, HIV-1 Protease0101
Chain B, HIV-1 Protease0101
Chain A, HIV-1 Protease0101
Chain B, HIV-1 Protease0101
Chain A, HIV-1 Protease0101
Chain B, HIV-1 Protease0101
Chain A, HIV-1 Protease0101
Chain B, HIV-1 Protease0101
Chain A, HIV-1 Protease0101
Chain B, HIV-1 Protease0101
Chain A, HIV-1 Protease0101
Chain B, HIV-1 Protease0101
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0101
Chain B, Protease0101
Chain A, HIV-1 protease0011
Chain B, HIV-1 protease0011
Chain A, HIV-1 protease0011
Chain B, HIV-1 protease0011
Chain A, HIV-1 Protease0011
Chain B, HIV-1 Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0101
Chain B, Protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, HIV-1 protease0101
Chain B, HIV-1 protease0101
Chain A, HIV-1 protease0101
Chain B, HIV-1 protease0101
Chain A, HIV-1 protease0101
Chain B, HIV-1 protease0101
Chain A, Protease0011
Chain B, Protease0011
Chain A, Pol polyprotein0101
Chain B, Pol polyprotein0101
Gag-Pol polyprotein0303
Gag-Pol polyprotein0213
Potassium voltage-gated channel subfamily E member 10808
Potassium voltage-gated channel subfamily KQT member 10808
Protease 09316
Gag-Pol polyprotein0101
Potassium voltage-gated channel subfamily D member 30505
Tyrosine-protein kinase ABL10202
Proto-oncogene tyrosine-protein kinase Src0224
Neuronal proto-oncogene tyrosine-protein kinase Src 0001
Proto-oncogene tyrosine-protein kinase LCK 0202
Myosin light chain kinase, smooth muscle0055
Tubulin alpha-1A chain0055
Myelin transcription factor 10101
Breakpoint cluster region protein0101
Protein cereblon06313
NF-kappa-B essential modulator0101
Chain A, Breast cancer type 1 susceptibility protein1001
runt-related transcription factor 1 isoform AML1b2002
core-binding factor subunit beta isoform 22002
NADH-ubiquinone oxidoreductase chain 40001
72 kDa type IV collagenase0404
Carbonyl reductase [NADPH] 10204
Glutamate receptor 124210
Glutamate receptor 324210
Glutamate receptor 424210
Platelet-activating factor receptor1002
Multidrug resistance-associated protein 1 0307
Reverse transcriptase/RNaseH 0224
Beta-glucuronidase0101
Glucose-6-phosphate 1-dehydrogenase 0101
NPC1-like intracellular cholesterol transporter 10112
Solute carrier organic anion transporter family member 1A50005
Solute carrier organic anion transporter family member 1A20105
Solute carrier organic anion transporter family member 1A30206
ATP-binding cassette sub-family C member 110002
Solute carrier organic anion transporter family member 1A10001
Solute carrier organic anion transporter family member 1B20103
hexokinase-4 isoform 14004
glucokinase regulatory protein4004
Thymidine kinase 2 0101
AAA family ATPase 0002
AAA family ATPase 0001
Sterol O-acyltransferase 10101
Histamine H3 receptor0101
Gamma-aminobutyric acid 0415
Alpha-1-acid glycoprotein 10002
Gamma-aminobutyric acid receptor subunit alpha-60415
Gamma-aminobutyric acid receptor subunit gamma-20415
Gamma-aminobutyric acid receptor subunit delta0415
Gamma-aminobutyric acid receptor subunit alpha-20415
Gamma-aminobutyric acid receptor subunit alpha-30415
Gamma-aminobutyric acid receptor subunit gamma-30415
Gamma-aminobutyric acid receptor subunit beta-10415
Gamma-aminobutyric acid receptor subunit alpha-10415
Gamma-aminobutyric acid receptor subunit beta-30415
Gamma-aminobutyric acid receptor subunit alpha-50415
Gamma-aminobutyric acid receptor subunit pi0415
Sphingosine-1-phosphate lyase 10101
Gamma-aminobutyric acid receptor subunit alpha-40415
Gamma-aminobutyric acid receptor subunit theta0415
Gamma-aminobutyric acid receptor subunit gamma-10415
Nicotinamide phosphoribosyltransferase0011
ATP-binding cassette sub-family C member 80314
ATP-sensitive inward rectifier potassium channel 110415
Beta-2 adrenergic receptor 0224
Aldo-keto reductase family 1 member B100305
Transient receptor potential cation channel subfamily A member 10044
Dihydrofolate reductase015016
Interleukin-80202
Calcium/calmodulin-dependent protein kinase type II subunit alpha0101
Aldo-keto reductase family 1 member B10708
C-X-C chemokine receptor type 10101
Sodium- and chloride-dependent GABA transporter 20505
Sodium- and chloride-dependent GABA transporter 30505
Sodium- and chloride-dependent betaine transporter0505
UDP-glucuronosyltransferase 1A70203
UDP-glucuronosyltransferase 1A100202
high affinity choline transporter 1 isoform a0101
Estrogen receptor010212
Estrogen-related receptor gamma0011
UDP-glucose 4-epimerase0202
Estrogen receptor beta0527
Cysteinyl leukotriene receptor 10202
STAT3, partial0303
signal transducer and activator of transcription 1-alpha/beta isoform alpha0303
Sodium/potassium-transporting ATPase subunit alpha-1 0809
Sodium/potassium-transporting ATPase subunit beta-10809
Sodium/potassium-transporting ATPase subunit alpha-30607
Sodium/potassium-transporting ATPase subunit beta-20607
Sodium/potassium-transporting ATPase subunit alpha-20809
Sodium/potassium-transporting ATPase subunit alpha-10202
Sodium/potassium-transporting ATPase subunit beta-30607
Sodium/potassium-transporting ATPase subunit gamma0607
Sodium/potassium-transporting ATPase subunit alpha-40607
Solute carrier organic anion transporter family member 4C10205
Sodium/potassium-transporting ATPase subunit alpha-20202
Sodium/potassium-transporting ATPase subunit alpha-3 0202
Sodium/potassium-transporting ATPase subunit beta-1 0202
Sodium/potassium-transporting ATPase subunit alpha-40202
Solute carrier organic anion transporter family member 4C10002
Solute carrier organic anion transporter family member 1A40001
Voltage-dependent L-type calcium channel subunit alpha-1D0404
Voltage-dependent L-type calcium channel subunit alpha-1S0404
Thromboxane A2 receptor 0216
Prostaglandin E2 receptor EP1 subtype0325
Prostaglandin E2 receptor EP4 subtype0314
Prostaglandin F2-alpha receptor0202
Prostaglandin F2-alpha receptor0224
Prostaglandin E2 receptor EP3 subtype0325
Prostaglandin E2 receptor EP2 subtype0314
Prostaglandin F2-alpha receptor0011
Prostaglandin D2 receptor0101
Solute carrier organic anion transporter family member 2A10101
Prostaglandin E2 receptor EP4 subtype0112
Prostaglandin E2 receptor EP2 subtype0112
Solute carrier family 22 member 70001
Histamine N-methyltransferase0001
Calcium release-activated calcium channel protein 10101
Protein orai-20101
Protein orai-30101
Kinesin-like protein KIF110101
Nucleotide-binding oligomerization domain-containing protein 20202
N-acetyltransferase Eis0303
replicative DNA helicase0002
recombinase A0022
UDP-glucuronosyltransferase 2B170001
Eyes absent homolog 20101
Angiotensin-converting enzyme0101
Angiotensin-converting enzyme 20101
chaperonin-containing TCP-1 beta subunit homolog3003
ubiquitin-conjugating enzyme E2 N0303
protein AF-9 isoform a0002
Opioid receptor, delta 1b 0202
Opioid receptor homologue0202
Proenkephalin-B0011
Kappa-type opioid receptor010415
Mu-type opioid receptor0202
Genome polyprotein 0303
Serine/threonine-protein kinase B-raf 0202
serine-protein kinase ATM isoform a5005
Estrogen receptor0033
Estrogen receptor beta0033
Chain A, GLUTATHIONE TRANSFERASE A1-10101
Chain A, Glutathione S-transferase P1-10101
Chain A, Glutathione S-transferase P1-10101
Chain B, Glutathione S-transferase P1-10101
Nrf21001
Hematopoietic prostaglandin D synthase0101
Glutathione S-transferase A10101
14 kDa phosphohistidine phosphatase0303
large T antigen0202
Pantothenate synthetase0202
Glutaminyl-peptide cyclotransferase0101
Ghrelin O-acyltransferase0101
Monoglyceride lipase0101
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN)0101
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN)0101
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN)0101
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN)0101
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN)0101
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN)0101
ClpP9009
Regulatory protein E20011
DNA topoisomerase 20001
Caspase-30404
DNA topoisomerase 2-alpha 0001
Luciferin 4-monooxygenase0101
Tyrosine-protein phosphatase 10101
Ectonucleotide pyrophosphatase/phosphodiesterase family member 20202
Vesicular glutamate transporter 30101
Regulatory-associated protein of mTOR0101
Target of rapamycin complex subunit LST80101
Sodium/bile acid cotransporter0606
NPC1-like intracellular cholesterol transporter 10101
pyruvate kinase PKM isoform b4004
Ornithine decarboxylase4004
Fatty acid-binding protein, liver0101
Peroxisome proliferator-activated receptor alpha0011
Potassium voltage-gated channel subfamily A member 50303
Potassium voltage-gated channel subfamily D member 20202
Chain A, BCL-2-RELATED PROTEIN A10011
unnamed protein product0101
heat shock protein HSP 90-alpha isoform 20103
bcl-2-like protein 11 isoform 10011
Heme oxygenase 1 0101
Lanosterol 14-alpha demethylase0123
Cytochrome P450 11B1, mitochondrial0303
Cytochrome P450 11B2, mitochondrial0303
Heme oxygenase 20101
Malate dehydrogenase, cytoplasmic0404
Cytochrome P450 1440033
Steroid C26-monooxygenase0033
Steroid C26-monooxygenase0033
Mycocyclosin synthase0011
Lanosterol 14-alpha demethylase0011
Lanosterol 14-alpha demethylase0011
Sterol 14-alpha demethylase0022
Sterol 14-alpha demethylase0112
14-alpha sterol demethylase 0022
heat shock protein 90, putative0002
likely tRNA 2'-phosphotransferase0101
Skn7p0002
heat shock protein 900022
calcineurin A1, putative0011
HSP40, subfamily A [Plasmodium falciparum 3D7]0002
Chain A, Uracil Phosphoribosyltransferase0101
Dipeptidyl peptidase 40202
Acetylcholinesterase0404
Potassium voltage-gated channel subfamily C member 10101
Gastrin/cholecystokinin type B receptor 0101
Cytochrome P450 1A2 0202
Chain A, probable fosfomycin resistance protein0011
Chain B, probable fosfomycin resistance protein0011
DNA polymerase catalytic subunit0101
DNA polymerase catalytic subunit0101
DNA polymerase alpha catalytic subunit0101
DNA polymerase delta catalytic subunit0101
UDP-N-acetylglucosamine 1-carboxyvinyltransferase0101
UDP-N-acetylglucosamine 1-carboxyvinyltransferase0101
Menin0011
Lecithin retinol acyltransferase0101
Protein Rev 0011
Aminoglycoside 3'-phosphotransferase 0001
Corticosteroid 11-beta-dehydrogenase isozyme 10213
6-phosphogluconate dehydrogenase, decarboxylating0404
Holo-[acyl-carrier-protein] synthase0101
G-protein coupled receptor 350112
CDGSH iron-sulfur domain-containing protein 10606
Voltage-dependent calcium channel subunit alpha-2/delta-10101
Beta-galactosidase0101
Lipopolysaccharide heptosyltransferase 10101
PA-I galactophilic lectin0011
Jacalin0011
Gamma-aminobutyric acid receptor subunit rho-30011
Hsf1 protein0056
Gamma-aminobutyric acid receptor subunit rho-20022
Sodium- and chloride-dependent GABA transporter 10101
Sodium- and chloride-dependent taurine transporter0202
Sodium- and chloride-dependent GABA transporter 10202
Sodium- and chloride-dependent GABA transporter 20303
Sodium- and chloride-dependent GABA transporter 30303
Sodium- and chloride-dependent betaine transporter0101
Sodium- and chloride-dependent GABA transporter 30101
4-aminobutyrate aminotransferase, mitochondrial0102
4-aminobutyrate aminotransferase, mitochondrial0203
Sterol O-acyltransferase 10011
Platelet glycoprotein VI0236
Sodium- and chloride-dependent GABA transporter 20101
Transitional endoplasmic reticulum ATPase0101
Smoothened homolog0112
Sonic hedgehog protein0102
Sonic hedgehog protein0101
Smoothened homolog0224
epidermal growth factor receptor isoform a precursor1102
Type-1 angiotensin II receptor0516
Mitogen-activated protein kinase kinase kinase 80101
Serine/threonine-protein kinase ULK30022
Chain A, DEOXYNUCLEOSIDE KINASE0101
Equilibrative nucleoside transporter 10101
Asialoglycoprotein receptor 10112
Chain A, GLUTAMATE RECEPTOR SUBUNIT 20101
Chain A, Glutamate Receptor Subunit 20101
Chain B, Glutamate Receptor Subunit 20101
Chain A, Slr1257 protein0011
Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing]0101
beta-2 adrenergic receptor5005
Metabotropic glutamate receptor 80202
Bifunctional aspartokinase/homoserine dehydrogenase 10101
Glutamate receptor ionotropic, kainate 10426
Metabotropic glutamate receptor 10213
Metabotropic glutamate receptor 20011
Metabotropic glutamate receptor 30011
Metabotropic glutamate receptor 40112
Metabotropic glutamate receptor 50224
Metabotropic glutamate receptor 60011
Metabotropic glutamate receptor 70011
Glutamate receptor ionotropic, kainate 10325
Metabotropic glutamate receptor 50124
Glutamate receptor ionotropic, kainate 20437
Metabotropic glutamate receptor 80011
Excitatory amino acid transporter 3 0001
Glutamate racemase0001
Metabotropic glutamate receptor 80112
Glutamate receptor ionotropic, kainate 40404
Glutamate carboxypeptidase 20101
Glutamate receptor ionotropic, kainate 20325
Glutamate receptor ionotropic, kainate 30303
Metabotropic glutamate receptor 70113
Metabotropic glutamate receptor 30113
Metabotropic glutamate receptor 40113
Glutamate receptor ionotropic, kainate 50303
Glutamate receptor ionotropic, kainate 50404
Glutamate racemase0001
Chain A, Glutamine Binding Protein0011
Neutral amino acid transporter A0404
Asc-type amino acid transporter 10202
Neutral amino acid transporter B(0)0404
Amino acid transporter0404
Parkin120012
ATP-binding cassette sub-family C member 90202
Solute carrier organic anion transporter family member 2B1 0607
ATP synthase subunit beta, mitochondrial0101
ATP synthase subunit delta, mitochondrial0101
ATP synthase subunit gamma, mitochondrial0101
ATP synthase subunit epsilon, mitochondrial0101
Cystic fibrosis transmembrane conductance regulator0112
Cholesteryl ester transfer protein0101
NACHT, LRR and PYD domains-containing protein 3 0101
Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E0011
Glycine receptor subunit alpha-10055
Sodium- and chloride-dependent glycine transporter 10101
Large neutral amino acids transporter small subunit 10808
Serine racemase0101
Sodium- and chloride-dependent glycine transporter 20101
Pancreatic alpha-amylase0101
Beta-glucuronidase0202
High mobility group protein B10033
High mobility group protein B10001
Corticosteroid 11-beta-dehydrogenase isozyme 20112
Canalicular multispecific organic anion transporter 10304
Chain A, 3-phosphoshikimate 1-carboxyvinyltransferase0101
Chain A, 3-phosphoshikimate 1-carboxyvinyltransferase0101
Glutamine synthetase 0101
Cytochrome P450 71B10102
Glutamine synthetase 0101
2-dehydro-3-deoxyphosphooctonate aldolase0101
Ricin0101
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase0011
Purine nucleoside phosphorylase 0012
Cocaine esterase0202
Vitamin D-binding protein0101
HLA class I histocompatibility antigen, A alpha chain 0011
Integrin beta-10101
Integrin alpha-40101
5-hydroxytryptamine receptor 2A0101
AP-2 complex subunit sigma0101
Calcitonin gene-related peptide type 1 receptor0101
Genome polyprotein 0202
Zinc finger protein 6640101
Vesicular acetylcholine transporter0101
Transient receptor potential cation channel subfamily V member 40101
calpain II, partial0101
SUMO-10101
Valosin-containing protein0101
TSHR protein1001
Estrogen receptor 10101
PINK12002
envelope glycoprotein0101
heat shock 70kDa protein 1A0202
galactokinase1001
neuropeptide Y receptor type 10011
neuropeptide Y receptor type 20011
small ubiquitin-related modifier 2 isoform b precursor0101
estrogen receptor beta isoform 10404
enteropeptidase precursor1001
fatty acid synthase0101
eukaryotic translation initiation factor 4 gamma 1 isoform 40101
heat shock cognate 71 kDa protein isoform 10202
eukaryotic translation initiation factor 4E isoform 10101
4-(cytidine 5'-phospho)-2-C-methyl-D-erithritol kinase1001
exodeoxyribonuclease V subunit RecD0202
exodeoxyribonuclease V subunit RecB0202
exodeoxyribonuclease V subunit RecC0202
heat shock cognate 71 kDa protein isoform 20202
Plasminogen activator inhibitor 10101
Endoplasmic reticulum chaperone BiP0101
Macrophage migration inhibitory factor0606
N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D0101
N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D0101
Zinc finger protein mex-50011
M1-family alanyl aminopeptidase0101
hypothetical protein CAALFM_CR05890CA0001
H3 histone acetyltransferase0001
BZLF20101
Chain A, CARBONIC ANHYDRASE II0011
Chain A, Protein (female-specific Histamine Binding Protein 2)0011
aryl hydrocarbon receptor nuclear translocator0001
transforming acidic coiled-coil-containing protein 30001
Histamine H3 receptor0101
Histamine N-methyltransferase 0101
Glutaminyl-peptide cyclotransferase0202
Equilibrative nucleoside transporter 40001
Histamine H4 receptor0123
Histamine H4 receptor0123
Histamine H4 receptor 0101
Carboxylic ester hydrolase 0102
Chain A, HISTIDINE-BINDING PROTEIN0011
Histidine-binding periplasmic protein0011
pyruvate kinase5005
N-glycosylase/DNA lyase0202
Aspartate aminotransferase, cytoplasmic0202
Lactoperoxidase0202
Single-stranded DNA cytosine deaminase1001
tyrosine-protein phosphatase non-receptor type 7 isoform 20303
Uracil nucleotide/cysteinyl leukotriene receptor0303
Stromelysin-10325
Urease subunit alpha0404
Ribonucleoside-diphosphate reductase large subunit0101
Urease subunit beta0404
Acid-sensing ion channel 30101
Polyunsaturated fatty acid 5-lipoxygenase07011
Caspase-10506
Aldo-keto reductase family 1 member C30404
Caspase-40303
Caspase-50303
Caspase-90303
Dehydrogenase/reductase SDR family member 90101
DNA repair protein RAD52 homolog isoform a0003
Cytochrome P450 3A50517
7,8-dihydro-8-oxoguanine triphosphatase0101
Toll-like receptor 80011
Toll-like receptor 70011
Chain A, membrane-associated prostaglandin E synthase-20101
3',5'-cyclic-AMP phosphodiesterase 0303
Phospholipase A2, major isoenzyme0202
Androgen receptor0527
Aldo-keto reductase family 1 member C40202
C-X-C chemokine receptor type 30101
Aldo-keto reductase family 1 member C2 0202
Prostaglandin D2 receptor 0202
Lactoylglutathione lyase0303
Aldo-keto reductase family 1 member C10202
Dehydrogenase/reductase SDR family member 90101
Prostaglandin D2 receptor 20112
Chain B, Pulmonary surfactant-associated protein D0101
Chain A, Pulmonary surfactant-associated protein D0101
Chain A, BETA-SPECTRIN0011
Chain A, Phospholipase C Delta-10011
Chain A, Inositol 1,4,5-trisphosphate receptor type 10011
Inositol-trisphosphate 3-kinase A0101
Inositol 1,4,5-trisphosphate receptor type 1 0022
Inositol 1,4,5-trisphosphate receptor type 20101
Inositol 1,4,5-trisphosphate receptor type 30112
Inositol polyphosphate-5-phosphatase A0101
Inositol 1,4,5-trisphosphate receptor type 10112
Chain A, Acetylcholinesterase0101
Interstitial collagenase0303
Acetylcholinesterase0202
3-oxoacyl-[acyl-carrier-protein] synthase 3 0101
Formamidopyrimidine-DNA glycosylase0101
Endonuclease III-like protein 10101
Putative FAD-containing monooxygenase MymA0101
Dihydrofolate reductase0303
Endonuclease 8-like 10101
NPYLR7B0022
Beta-2 adrenergic receptor0011
Beta-3 adrenergic receptor0011
Beta-1 adrenergic receptor0213
Beta-2 adrenergic receptor0202
Taste receptor type 2 member 380023
Taste receptor type 2 member 390011
Taste receptor type 2 member 400011
Taste receptor type 2 member 410011
Taste receptor type 2 member 430011
Taste receptor type 2 member 310022
Taste receptor type 2 member 450011
Taste receptor type 2 member 460011
Taste receptor type 2 member 300011
Taste receptor type 2 member 190011
Taste receptor type 2 member 200011
Taste receptor type 2 member 500011
Taste receptor type 2 member 600022
Taste receptor type 2 member 420011
Taste receptor type 2 member 160011
Taste receptor type 2 member 140022
Taste receptor type 2 member 130022
Taste receptor type 2 member 100011
Taste receptor type 2 member 90022
Taste receptor type 2 member 80011
Taste receptor type 2 member 70011
Taste receptor type 2 member 50011
Taste receptor type 2 member 40022
Taste receptor type 2 member 30011
Taste receptor type 2 member 10011
Chain A, Glutamate receptor 20011
Chain A, Glutamate receptor 20011
Chain C, Glutamate receptor 20011
Glutamate receptor ionotropic, kainate 40101
Acetylcholinesterase0505
Estrogen receptor beta0102
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial0101
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial0202
Cytochrome P450 26A10101
Camphor 5-monooxygenase0001
Epoxide hydrolase 10001
Cytochrome P450 2C11 0202
Steroid 21-hydroxylase0101
Steroid 17-alpha-hydroxylase/17,20 lyase 0101
Cholesterol side-chain cleavage enzyme, mitochondrial 0101
Indoleamine 2,3-dioxygenase 10304
Cytochrome P450 2A20101
Cytochrome P450 11B1, mitochondrial 0303
Cytochrome P450 7A1 0101
Estrogen receptor0102
Gonadotropin-releasing hormone receptor0112
Cytochrome P450 4F20202
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial0202
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial0101
Cytochrome P450 7A10101
Lanosterol 14-alpha demethylase 0202
Heparanase0011
Sodium channel protein type 10 subunit alpha0101
Dihydrofolate reductase0729
phosphoethanolamine/phosphocholine phosphatase isoform 10101
N(G),N(G)-dimethylarginine dimethylaminohydrolase 10404
Microtubule-associated protein tau0101
Fatty acid synthase0909
WD repeat-containing protein 50303
Histone-lysine N-methyltransferase 2A0303
Cytosolic endo-beta-N-acetylglucosaminidase0303
Indoleamine 2,3-dioxygenase 20303
Chain A, AMINOPEPTIDASE0101
Chain A, AMINOPEPTIDASE0101
Chain A, Leucine Aminopeptidase0101
Alkaline phosphatase, tissue-nonspecific isozyme0606
Intestinal-type alkaline phosphatase0404
Phospholipase A-2-activating protein0404
Alkaline phosphatase, placental type0101
Alkaline phosphatase, tissue-nonspecific isozyme 0202
Intestinal-type alkaline phosphatase0101
5'-nucleotidase0101
Synaptic vesicle glycoprotein 2A0202
integrase, partial0101
lens epithelium-derived growth factor p750101
SLC16A10 protein0002
Monocarboxylate transporter 100002
Potassium channel subfamily K member 180101
Amine oxidase [flavin-containing] B0909
Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial0101
Dual specificity tyrosine-phosphorylation-regulated kinase 1A0101
Renin0101
inositol monophosphatase 11001
Chain A, protease0101
Chain B, protease0101
Chain A, protease0011
Chain B, protease0011
Chain A, protease0011
Chain B, protease0011
Chain A, protease0011
Chain B, protease0011
Chain A, protease0011
Chain B, protease0011
Chain A, protease0011
Chain B, protease0011
Chain A, Protease0101
Chain B, Protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, PROTEASE RETROPEPSIN0101
Chain B, PROTEASE RETROPEPSIN0101
Chain A, Protease Retropepsin0101
Chain B, Protease Retropepsin0101
Chain A, Protease Retropepsin0101
Chain B, Protease Retropepsin0101
Gag-Pol polyprotein0202
Gag-Pol polyprotein0202
Gag-Pol polyprotein0202
CAAX prenyl protease 1 homolog0101
Plasmepsin V 0202
Type-1 angiotensin II receptor0213
Chain A, Antigen Cd11a (p180)0101
bcl-2-related protein A10303
3-hydroxy-3-methylglutaryl-coenzyme A reductase0101
Integrin beta-20101
Intercellular adhesion molecule 10101
Insulin receptor 0101
Integrin alpha-L0112
Acyl-CoA:cholesterol acyltransferase 0101
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast0101
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast0101
glyceraldehyde-3-phosphate dehydrogenase isoform 10101
dual specificity protein phosphatase 60101
Glutathione S-transferase Mu 10101
Prolyl 4-hydroxylase subunit alpha-10202
Prothrombin 0101
Acetylcholinesterase 0202
Nociceptin receptor0101
Melatonin receptor type 1A0213
Melatonin receptor type 1C0011
Melatonin receptor type 1A0112
Melatonin receptor type 1B0213
Melatonin receptor type 1C0112
Melatonin receptor type 1B0112
Nuclear factor erythroid 2-related factor 20001
Carboxylic ester hydrolase 0202
Large neutral amino acids transporter small subunit 1 0101
Amine oxidase [flavin-containing] B0404
Trace amine-associated receptor 10011
Trace amine-associated receptor 10022
Trace amine-associated receptor 10022
Trace amine-associated receptor 10033
Chain A, Methionyl-tRNA synthetase0011
Chain A, Methionyl-tRNA synthetase0011
Chain A, Aminopeptidase0101
Chain A, Methionine aminopeptidase0101
S-ribosylhomocysteine lyase0101
Adenylate cyclase type 50001
S-adenosylmethionine synthase isoform type-10001
S-adenosylmethionine synthase isoform type-20001
Chain B, DIHYDROFOLATE REDUCTASE0011
Chain B, DIHYDROFOLATE REDUCTASE0011
Chain B, DIHYDROFOLATE REDUCTASE0011
Thymidylate synthase 0202
Thymidylate synthase 0202
Fatty-acid amide hydrolase 10101
ATP-binding cassette sub-family C member 30102
Dihydrofolate reductase0405
Dihydrofolate reductase0303
Dihydrofolate reductase0101
Dihydrofolate reductase0506
Thymidylate synthase0303
Thymidylate synthase0505
Bifunctional dihydrofolate reductase-thymidylate synthase0303
Dihydrofolate reductase0303
Thymidylate synthase0202
Bifunctional dihydrofolate reductase-thymidylate synthase0303
Folate receptor beta0202
Folate receptor alpha0202
Dihydrofolate reductase0607
Histidine decarboxylase0134
Trifunctional purine biosynthetic protein adenosine-30303
Bifunctional purine biosynthesis protein ATIC0404
Reduced folate transporter0303
Folylpolyglutamate synthase, mitochondrial0103
Pteridine reductase 10404
Folylpolyglutamate synthase, mitochondrial0103
Bifunctional dihydrofolate reductase-thymidylate synthase0304
Bifunctional dihydrofolate reductase-thymidylate synthase0101
Trifunctional purine biosynthetic protein adenosine-30202
Dihydrofolate reductase 0303
Dihydrofolate reductase0203
Proton-coupled folate transporter0304
Multidrug resistance associated protein0102
Caspase 6, apoptosis-related cysteine peptidase0001
Cystathionine gamma-lyase0303
5-hydroxytryptamine receptor 3B0303
Cytochrome P450 11B1, mitochondrial0101
G-protein coupled receptor 0101
Matrilysin0101
Multidrug transporter MdfA0202
Amine oxidase [flavin-containing] A 0718
Amine oxidase [flavin-containing] A 0202
Chain A, HEAT SHOCK PROTEIN 900011
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 10101
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 30101
Chain A, Atp-dependent Molecular Chaperone Hsp820011
Chain A, Atp-dependent Molecular Chaperone Hsp820011
Chain B, Type 2 DNA topoisomerase 6 subunit B0011
Chain A, Virulence sensor histidine kinase phoQ0011
ATP-dependent molecular chaperone HSP820112
Virulence sensor histidine kinase PhoQ0011
ATP-dependent molecular chaperone HSC820101
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial0101
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial0112
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial0101
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial0101
Proto-oncogene tyrosine-protein kinase Src 0101
Histidine kinase 0101
Acyl-CoA desaturase 10202
Proteinase-activated receptor 10224
Nociceptin receptor0101
Mu-type opioid receptor0101
DNA gyrase subunit B0101
D-amino-acid oxidase0101
5-hydroxytryptamine receptor 1B0101
Chain B, Exotoxin A0011
Chain B, Exotoxin A0011
Chain B, Exotoxin A0011
Ubiquitin-like modifier activating enzyme 20101
SUMO1 activating enzyme subunit 10101
ubiquitin-like modifier-activating enzyme 10101
SUMO-conjugating enzyme UBC90101
ubiquitin-conjugating enzyme E2 variant 1 isoform a0101
Complement C1r subcomponent0101
Coagulation factor XII0202
Serine protease hepsin0202
Cathepsin D0101
Complement C1s subcomponent0101
Neutrophil collagenase0303
Collagenase 30202
Hepatocyte growth factor activator0213
Suppressor of tumorigenicity 14 protein0202
UDP-glucuronosyltransferase 1A80002
Nociceptin receptor0202
Hormone-sensitive lipase0101
Chain A, NAD-dependent deacetylase0101
Poly [ADP-ribose] polymerase 20101
NAD-dependent histone deacetylase SIR20101
Poly [ADP-ribose] polymerase 10101
NAD-dependent protein deacetylase HST20101
NAD(+) hydrolase SARM10202
NAD-dependent protein deacetylase sirtuin-20404
NAD-dependent protein deacetylase sirtuin-60202
NAD-dependent protein deacetylase sirtuin-10303
NAD-dependent protein deacylase sirtuin-5, mitochondrial0202
NAD-dependent protein deacetylase 0101
Equilibrative nucleoside transporter 10101
B2 bradykinin receptor0101
Transient receptor potential cation channel subfamily A member 10044
Neuronal acetylcholine receptor subunit alpha-40213
Acetylcholine receptor subunit alpha0213
Acetylcholine receptor subunit beta0213
Acetylcholine receptor subunit gamma0213
Acetylcholine receptor subunit delta0213
Neuronal acetylcholine receptor subunit alpha-40101
Acetylcholine receptor subunit beta-like 20202
Neuronal acetylcholine receptor subunit alpha-50022
Muscarinic acetylcholine receptor M40303
Neuronal acetylcholine receptor subunit alpha-70202
Acetylcholine-binding protein0112
Acetylcholine receptor subunit epsilon0011
Neuronal acetylcholine receptor subunit beta-30112
Neuronal acetylcholine receptor subunit alpha-20101
Neuronal acetylcholine receptor subunit alpha-60112
Cytochrome P450 2A130325
Neuronal acetylcholine receptor subunit alpha-50202
Liver carboxylesterase B-10101
Neuronal acetylcholine receptor subunit beta-30202
Neuronal acetylcholine receptor subunit beta-40202
Neuronal acetylcholine receptor subunit alpha-30202
Soluble acetylcholine receptor0101
Neuronal acetylcholine receptor subunit alpha-20202
Neuronal acetylcholine receptor subunit beta-20213
Neuronal acetylcholine receptor subunit alpha-60202
Integrin beta0011
Glycoprotein IIb0011
eyes absent homolog 2 isoform a2002
Phospholipase A2, membrane associated0001
3-oxo-5-alpha-steroid 4-dehydrogenase 1 0101
3-oxo-5-alpha-steroid 4-dehydrogenase 20101
Voltage-dependent L-type calcium channel subunit alpha-1C0101
Voltage-dependent L-type calcium channel subunit alpha-1S0101
C-terminal-binding protein 11001
Voltage-dependent L-type calcium channel subunit alpha-1D0101
Voltage-dependent L-type calcium channel subunit alpha-1F0101
Voltage-dependent L-type calcium channel subunit beta-40101
Voltage-dependent P/Q-type calcium channel subunit alpha-1A0101
Voltage-dependent T-type calcium channel subunit alpha-1G0112
Voltage-dependent calcium channel gamma-3 subunit0101
Voltage-dependent T-type calcium channel subunit alpha-1H0101
Cannabinoid receptor 10202
Voltage-dependent L-type calcium channel subunit beta-30101
Voltage-dependent calcium channel subunit alpha-2/delta-10304
Voltage-dependent calcium channel gamma-7 subunit0101
Voltage-dependent L-type calcium channel subunit beta-10101
Voltage-dependent calcium channel gamma-1 subunit0101
Voltage-dependent L-type calcium channel subunit beta-20101
Voltage-dependent R-type calcium channel subunit alpha-1E0101
Voltage-dependent calcium channel subunit alpha-2/delta-40101
Voltage-dependent calcium channel subunit alpha-2/delta-30101
Voltage-dependent calcium channel gamma-8 subunit0101
Bile acid receptor0202
Voltage-dependent calcium channel gamma-6 subunit0101
Voltage-dependent calcium channel subunit alpha-2/delta-20303
Voltage-dependent T-type calcium channel subunit alpha-1I0101
Voltage-dependent calcium channel gamma-4 subunit0101
Voltage-dependent calcium channel gamma-5 subunit0101
Voltage-dependent calcium channel gamma-2 subunit0101
Platelet-derived growth factor receptor beta0303
Platelet-derived growth factor receptor alpha 0202
Vascular endothelial growth factor receptor 20202
Corticotropin-releasing factor receptor 10001
Sodium- and chloride-dependent betaine transporter0101
kelch-like ECH-associated protein 10001
Calcium-activated potassium channel subunit alpha-10102
Calcium-activated potassium channel subunit beta-10001
FAD-linked sulfhydryl oxidase ALR0001
pyruvate kinase PKM isoform a1001
Bifunctional cytochrome P450/NADPH--P450 reductase0011
Potassium-transporting ATPase subunit beta0101
Potassium-transporting ATPase alpha chain 10101
Bombesin receptor subtype-30011
Potassium-transporting ATPase alpha chain 20001
Neuraminidase 0202
Neuraminidase 0202
Neuraminidase 0202
Neuraminidase0202
Neuraminidase0101
Neuraminidase0202
Sialidase0101
Acyl-CoA desaturase 10101
Neuraminidase 0202
Neuraminidase 0202
Neuraminidase0101
Neuraminidase0101
Sialidase-40101
Sialidase-10101
Sialidase-30101
Sialidase-20101
Lysine-specific histone demethylase 1A0304
Putative nucleoside diphosphate kinase0022
Nucleoside diphosphate kinase B0022
von Hippel-Lindau disease tumor suppressor0101
Epidermal growth factor receptor0202
Echinoderm microtubule-associated protein-like 40011
Chain H, Igg2b-kappa 40-50 Fab (heavy Chain)0101
Chain L, Igg2b-kappa 40-50 Fab (light Chain)0101
Chain A, Na, K-ATPase alpha subunit0011
Kruppel-like factor 50101
Sodium/potassium-transporting ATPase subunit alpha-1 0101
Sodium/potassium-transporting ATPase subunit beta-30101
MecA 0101
Chain A, Pyruvate kinase, M2 isozyme0101
Chain A, Phosphonopyruvate hydrolase0101
Chain A, Phosphoenolpyruvate-protein phosphotransferase0101
polyadenylate-binding protein 10101
Glyceraldehyde-3-phosphate dehydrogenase0101
DNA repair protein RAD52 homolog0101
MBT domain-containing protein 10101
Lethal(3)malignant brain tumor-like protein 40101
Lethal(3)malignant brain tumor-like protein 30101
Lethal(3)malignant brain tumor-like protein 10101
Peptidylglycine alpha-amidating monooxygenase0001
Integrin alpha-V 0101
Beta-tubulin 0101
Histone deacetylase 80101
Bromodomain-containing protein 40101
Protein Tat0011
Phosphatidylinositol 3-kinase regulatory subunit alpha0101
NAD-dependent protein deacetylase sirtuin-70101
Histone deacetylase 0101
Nuclear receptor corepressor 20101
Chain A, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A0101
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A0202
Serine hydroxymethyltransferase, mitochondrial0101
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A 0202
Phosphodiesterase 0101
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A0102
Beta-adrenergic receptor kinase 10202
Potassium voltage-gated channel subfamily A member 30101
Rhodopsin kinase GRK10101
G protein-coupled receptor kinase 50202
G protein-coupled receptor kinase 50101
P2X purinoceptor 40101
Beta-adrenergic receptor kinase 10001
Testosterone 17-beta-dehydrogenase 30101
G1/S-specific cyclin-E10101
Nuclear receptor subfamily 4 group A member 30101
Peroxiredoxin-like 2A0101
Chain A, Thymidylate Synthase0101
Chain A, Thymidylate Synthase0101
Chain A, Thymidylate Synthase0101
Serine hydroxymethyltransferase, cytosolic0112
Thymidylate synthase 0101
Adenosine deaminase0101
Adenosine deaminase 0101
Adenosine deaminase 0101
vasopressin V1b receptor1001
Tumor necrosis factor0101
Aldehyde oxidase 10101
Retinal dehydrogenase 10101
Aldehyde oxidase 10101
Aldehyde oxidase 1 0101
Alpha-1A adrenergic receptor0235
Alpha-1B adrenergic receptor0404
Muscarinic acetylcholine receptor M10112
Muscarinic acetylcholine receptor DM10202
DNA polymerase III, partial1001
XBP10101
DNA damage-inducible transcript 3 protein0101
Ubiquitin carboxyl-terminal hydrolase 10202
WD repeat-containing protein 480202
Muscarinic acetylcholine receptor M50101
Muscarinic acetylcholine receptor M30101
Muscarinic acetylcholine receptor M20101
Transforming growth factor beta-1 proprotein0101
Mothers against decapentaplegic homolog 3 0101
Cereblon isoform 40303
DNA-binding protein Ikaros0014
Programmed cell death protein 10101
DNA damage-binding protein 10224
E3 ubiquitin-protein ligase ZFP910001
Programmed cell death 1 ligand 10101
Zinc finger protein Aiolos0011
Sodium/potassium/calcium exchanger 40112
Sodium/potassium/calcium exchanger 20112
5-hydroxytryptamine receptor 1E0101
Beta-casein0101
Alpha-2A adrenergic receptor0101
Alpha-mannosidase 2C10011
Bromodomain-containing protein 20202
3-oxo-5-alpha-steroid 4-dehydrogenase 20202
luciferase0001
Progesterone receptor0416
Glucocorticoid receptor0112
Glucocorticoid receptor0011
Glutamine synthetase0011
Nociceptin receptor0011
Pannexin-10101
Solute carrier family 22 member 120202
Solute carrier organic anion transporter family member 1C10202
Pannexin-10101
Trace amine-associated receptor 50022
Glutamate 5-kinase0001
Chloroquine resistance transporter0101
Nuclear receptor subfamily 2 group E member 10033
Neuromedin-K receptor0011
NADH-cytochrome b5 reductase 3 0101
Thyroid peroxidase0101
Aminopeptidase N0101
Aminopeptidase N0101
Puromycin-sensitive aminopeptidase0101
Insulin-degrading enzyme0101
Amine oxidase [flavin-containing] B0101
DNA dC->dU-editing enzyme APOBEC-3F isoform a1001
Chromaffin granule amine transporter0101
Synaptic vesicular amine transporter0213
Synaptic vesicular amine transporter0101
NS5 0011
glycogen synthase kinase-3 beta isoform 10011
Polymerase basic protein 20011
RNA-directed RNA polymerase catalytic subunit0011
Polymerase acidic protein0022
Adenosylhomocysteinase0002
Adenosine receptor A10101
Genome polyprotein0011
DNA-directed RNA polymerase subunit beta0101
NH(3)-dependent NAD(+) synthetase0202
Arylacetamide deacetylase0102
DNA-directed RNA polymerase subunit beta0101
Chain A, HIV-1 PROTEASE0101
Chain B, HIV-1 PROTEASE0101
Chain A, POL polyprotein0101
Chain B, POL polyprotein0101
Chain A, POL polyprotein0101
Chain B, POL polyprotein0101
Chain A, Endothiapepsin0101
Chain A, Endothiapepsin0101
Gag-Pol polyprotein0101
Thromboxane-A synthase0001
Chain A, Activated Factor Xa Heavy Chain0101
Acetylcholine receptor subunit epsilon0101
Cholinesterase0101
Acetylcholinesterase0101
Cholinesterase0101
CDGSH iron-sulfur domain-containing protein 10101
Free fatty acid receptor 10011
Carnitine O-palmitoyltransferase 2, mitochondrial0101
Catechol O-methyltransferase0011
Cannabinoid receptor 20011
Peroxisome proliferator-activated receptor delta0325
Thrombin 0011
CDGSH iron-sulfur domain-containing protein 20101
Low-density lipoprotein receptor0101
Fibronectin0101
Macrophage colony-stimulating factor 1 receptor0101
Solute carrier family 2, facilitated glucose transporter member 40101
Ras-related C3 botulinum toxin substrate 10011
Proprotein convertase subtilisin/kexin type 90101
Adenosine transporter 10101
Chain A, Lysr-type Regulatory Protein0011
Chain A, Lysr-type Regulatory Protein0011
Chain A, Lysr-type Regulatory Protein0011
Chain A, 146aa long hypothetical transcriptional regulator0011
Chain A, Anthranilate phosphoribosyltransferase0101
Chain A, Anthranilate phosphoribosyltransferase0101
Chain A, Anthranilate phosphoribosyltransferase0101
Chain B, Anthranilate phosphoribosyltransferase0101
Chain C, Anthranilate phosphoribosyltransferase0101
Chain A, Anthranilate phosphoribosyltransferase0101
Anthranilate phosphoribosyltransferase0101
5'-AMP-activated protein kinase subunit beta-20001
Tyrosine-protein phosphatase YopH0101
Ubiquitin-like domain-containing CTD phosphatase 10101
5'-AMP-activated protein kinase subunit gamma-30001
5'-AMP-activated protein kinase subunit beta-10001
Chain A, Erk20101
Mitogen-activated protein kinase 20101
Protein kinase C gamma type0101
Tyrosinase0101
Mitogen-activated protein kinase 14 0112
Mitogen-activated protein kinase 10101
P2X purinoceptor 70101
P2X purinoceptor 70101
Exportin-10011
Pyruvate kinase PKM0011
Transcriptional activator protein LuxR0101
Free fatty acid receptor 30011
Chain A, Mitogen-activated protein kinase 140011
Chain A, Mitogen-activated protein kinase 140011
Chain A, Mitogen-activated protein kinase 140011
Chain A, Mitogen-activated protein kinase 140011
Chain A, Mitogen-activated protein kinase 140011
Chain A, Mitogen-activated protein kinase 140011
Chain A, Mitogen-activated protein kinase 140011
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 20101
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 20101
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 20101
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 20101
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 20101
melanocortin receptor 40112
Cyclin-C0112
Vascular endothelial growth factor receptor 30101
Protein delta homolog 10123
Vascular endothelial growth factor receptor 20101
RuvB-like 20112
RuvB-like 10101
Aldo-keto reductase family 1 member A10202
Aldo-keto reductase family 1 member A10101
Aldo-keto reductase family 1 member A10202
Aldo-keto reductase family 1 member B10101
Chain A, Mineralocorticoid receptor0101
Chain A, Mineralocorticoid receptor0101
Chain A, Ribosomal protein S6 kinase alpha-10101
Chain X, Tyrosine-protein kinase Lyn0101
Chain A, Dual specificity protein kinase TTK0011
Chain A, Dual specificity protein kinase TTK0011
Mast/stem cell growth factor receptor Kit0101
Bromodomain-containing protein 90011
Serine/threonine-protein kinase 30011
Bromodomain-containing protein 70011
Chain A, Protein (aspartate Aminotransferase)0011
Chain A, Aspartate Aminotransferase0011
Lysine-specific demethylase 4E0101
Delta-aminolevulinic acid dehydratase0101
NADP-dependent malic enzyme, mitochondrial0001
Solute carrier family 13 member 30101
Methyl-accepting chemotaxis protein NahY0011
Chain A, MALTOPORIN0011
Chain B, MALTOPORIN0011
Beta-lactamase 0101
Metallo-beta-lactamase type 20101
ATP-dependent 6-phosphofructokinase0101
Dihydropteroate synthase0101
Endothelin-1 receptor0101
fMet-Leu-Phe receptor0101
fMet-Leu-Phe receptor0101
Complement C50011
Retinoic acid receptor RXR-alpha0123
Peptidyl-prolyl cis-trans isomerase FKBP1A0213
Peptidyl-prolyl cis-trans isomerase FKBP1B0011
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform0101
Peptidyl-prolyl cis-trans isomerase FKBP50101
Splicing factor 3B subunit 30101
Alpha-1D adrenergic receptor0101
Alpha-1B adrenergic receptor0101
Alpha-1A adrenergic receptor0101
Peroxisome proliferator-activated receptor delta0011
90-kda heat shock protein beta HSP90 beta, partial0101
Tetracycline resistance protein, class B0001
Cannabinoid receptor 10101
Chain A, Pyridoxal kinase0101
Chain A, Pyridoxal Kinase0101
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A 0101
cAMP-specific 3',5'-cyclic phosphodiesterase 4D 0101
cAMP-specific 3',5'-cyclic phosphodiesterase 4C0101
cAMP-specific 3',5'-cyclic phosphodiesterase 4B0101
Adenosine receptor A10202
Adenosine receptor A10101
cAMP-specific 3',5'-cyclic phosphodiesterase 4A0101
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B0101
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A0101
Chain A, ykoF0011
Chain B, ykoF0011
Chain A, ThiT0011
Thiamine transporter ThiT0011
Transketolase0011
Thiamine-binding periplasmic protein0011
Mucosa-associated lymphoid tissue lymphoma translocation protein 10101
Alcohol dehydrogenase E chain0101
Alcohol dehydrogenase S chain0101
Urease subunit alpha0101
Urease subunit beta 0101
Chain A, ODORANT-BINDING PROTEIN0101
Chain A, ODORANT-BINDING PROTEIN0101
Chain B, Odorant-binding Protein0101
Chain A, ODORANT-BINDING PROTEIN0101
Chain A, ODORANT-BINDING PROTEIN0101
Chain A, ODORANT-BINDING PROTEIN0101
Secreted chorismate mutase0202
Heat sensitive channel TRPV30011
Transient receptor potential cation channel subfamily A member 10112
Transient receptor potential cation channel subfamily M member 80112
Chain X, Thyroid hormone receptor beta-10022
Chain X, Thyroid hormone receptor beta-10022
Proliferating cell nuclear antigen0202
Malate dehydrogenase, mitochondrial0101
Monocarboxylate transporter 80001
Solute carrier organic anion transporter family member 1C10001
chaperonin GroEL1001
Endolysin0011
Chain A, Carbonic anhydrase 10101
Carbonic anhydrase 20101
Chain A, PLASMINOGEN0011
Chain A, PLASMINOGEN0011
Cytochrome P450 4B10101
Cytochrome P450 2A70101
Cytochrome P450 3A70101
Cytochrome P450 2F10101
Cytochrome P450 2C180101
Cytochrome P450 4F80101
Cytochrome P450 4A110101
Cytochrome P450 4F30101
Cytochrome P450 4A220101
Vitamin D 25-hydroxylase0101
Cytochrome P450 2U10101
Cytochrome P450 2W10101
Cytochrome P450 2S10101
Cytochrome P450 3A43 0101
REST corepressor 30101
procathepsin L isoform 1 preproprotein0101
Chain A, PAPAIN1001
Janus kinase 2 (a protein tyrosine kinase)0101
Lysozyme C-10101
Glycoprotein hormones alpha chain1001
Protein kinase C alpha type0101
Protein kinase C delta type0101
Protein kinase C epsilon type0101
Protein kinase C zeta type0101
Protein kinase C gamma type0101
Protein kinase C beta type0101
Protein kinase C eta type0101
Calcium-dependent protein kinase 40101
Emopamil-binding protein-like0101
Protein kinase C theta type0101
Solute carrier organic anion transporter family member 4A10001
Chain A, Dihydrofolate Reductase0011
Chain A, Dihydrofolate reductase0101
Chain A, dihydrofolate reductase (DHFR)0101
Chain A, Dihydrofolate reductase0101
Chain A, Dihydrofolate reductase0101
Dihydrofolate reductase 0102
Dihydrofolate reductase type 10102
Dihydrofolate reductase0101
Dihydrofolate reductase0101
Dihydrofolate reductase type 1 from Tn40030101
Dihydrofolate reductase0101
Bifunctional dihydrofolate reductase-thymidylate synthase0101
Bifunctional dihydrofolate reductase-thymidylate synthase0101
Dihydrofolate reductase0101
Dihydrofolate reductase0101
Dihydrofolate reductase 0101
Dihydrofolate reductase 0101
Chain A, CARBONIC ANHYDRASE II0101
Chain A, Trp Rna-binding Attenuation Protein0011
Chain K, Trp Rna-binding Attenuation Protein0011
Chain B, tryptophanyl-tRNA synthetase0011
Chain C, Tryptophanyl-tRNA synthetase II0011
Tryptophan 2,3-dioxygenase0102
Tryprostatin B synthase0001
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase0011
Chain A, Uracil-DNA Glycosylase0101
Solute carrier family 2, facilitated glucose transporter member 90112
Chain A, Arginase 10101
Aldo-keto reductase family 1 member A10101
Aldo-keto reductase family 1 member B70101
D-alanyl-D-alanine dipeptidase0101
Transcription intermediary factor 1-alpha0101
Pancreatic triacylglycerol lipase0101
Succinate-semialdehyde dehydrogenase, mitochondrial0101
E3 ubiquitin-protein ligase TRIM330101
Sterol 14-alpha-demethylase0011
14-alpha sterol demethylase 0011
14-alpha sterol demethylase 0011
Cholesterol 24-hydroxylase0213
Proprotein convertase subtilisin/kexin type 70101
Vitamin K epoxide reductase complex subunit 1-like protein 10101
Vitamin K epoxide reductase complex subunit 10101
Vitamin K epoxide reductase complex subunit 1-like protein 10101
Vitamin K epoxide reductase complex subunit 1 0202
twin arginine protein translocation system - TatA protein0001
Butyrophilin subfamily 3 member A10012
Geranylgeranyl pyrophosphate synthase0203
Farnesyl pyrophosphate synthase0202
Farnesyl diphosphate synthase0101
Matrix metalloproteinase-140101
Farnesyl pyrophosphate synthase 0202
Geranylgeranyl pyrophosphate synthase0202
Farnesyl pyrophosphate synthase 0101
H0101
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]